EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.
Contact:
EOS Med Chem, Medicinal Chemical is Big
執大象，天下往，往而無害，安平泰
Ms Nina
Youtube: https://youtu.be/r5cJdXKNXHk
Tel: 0086-531-69905422
SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China
1,2-Dihydrobudesonide-d8, CAS: /, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈D₈O₆.
(S,S)-Dihydro Bupropion-d9 Hydrochloride, CAS: 1392209-60-7, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₉Cl₂NO.
(S,S)-Hydroxy Bupropion, CAS: 192374-14-4, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈ClNO₂.
11,16,17,21-Tetrahydroxypregna-1,4-diene-3,20-hydrazinecarboxamide, CAS: /, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₆O₆.
11-Keto Budesonide(Mixture of Diastereomers), CAS: 216453-74-6, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂O₆.
1-(3,5-Dichlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone, CAS: 1193779-48-4, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇Cl₂NO.
1-(3-Chlorophenyl)-1,2-propanedione, CAS: 10557-17-2, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇ClO₂.
11β,16α,17α,21-Tetrahydroxypregna-1,4-diene-3,20-dione, CAS: 13951-70-7, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₆.
11β,16α,17α,21-Tetrahydroxypregna-1,4-diene-3,20-dione-d3, CAS: /, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅D₃O₆.
1-(3-Chlorophenyl)-1,2-propanedione 2-Oxime, CAS: 56472-71-0, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈ClNO₂.
1-(3-Chlorophenyl)-1-hydroxy-2-propanone, CAS: 857233-13-7, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉ClO₂.
11β,16α,17α,21-Tetrahydroxypregna-1,4-diene-3,20-oxime, CAS: /, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀N₂O₆.
11β,16β,17α,21-Tetrahydroxypregna-1,4-diene-3,20-dione, CAS: /, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₆.
1-(3-Chlorophenyl)-2-(hydroxyamino)-1-propanol, CAS: /, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀ClNO₂.
1-(3-Chlorophenyl)-2-hydroxy-1-propanone, CAS: 152943-33-4, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉ClO₂.
14,15-Dehydro Budesonide, CAS: 131918-64-4, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂O₆.
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione, CAS: 3754-05-0, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₆.
1-Chloro-3-[(1Z)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-propen-1-yl]-benzene, CAS: 291275-45-1, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃ClOSi.
2,4,5-Tribromophenol, CAS: 14401-61-7, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₃O.
16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers), CAS: 1040085-99-1, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₆.
16α-Butyloxyprednisolone(Budenoside Impurity), CAS: 113930-13-5, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
2-(tert-Butylamino)-3’,4’-dichloropropiophenone Hydrochloride, CAS: 1346598-72-8, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈Cl₃NO.
2-(tert-Butylamino)-3’,4’-dichloropropiophenone-d9 Hydrochloride, CAS: /, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉D₉Cl₃NO.
17α-Des-(2-hydroxyacetyl)budesonide 17α-Carboxylic Acid, CAS: 192057-49-1, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂O₆.
17α-Des-(2-hydroxyacetyl)budesonide 17α-Carboxylic Acid-d8, CAS: /, stock: 8.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄D₈O₆.
2-(tert-Butylamino)-3’,5’-dichloropropiophenone Hydrochloride, CAS: 1346603-00-6, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈Cl₃NO.
2-(tert-Butylamino)-3’,5’-dichloropropiophenone-d9 Hydrochloride, CAS: /, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉D₉Cl₃NO.
21-Acetoxy-11-oxo-16α,17α-propylmethylenedioxpregna-1,4-diene-3,20-dione, CAS: 1831164-04-5, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₄O₇.
21-Acetoxy-11β-hydroxy-16α,17α-propylmethylenedioxpregna-1,4-diene-3,20-dione, CAS: 51333-05-2, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆O₇.
2-Bromo-1-(3,4-dichlorophenyl)propan-1-one, CAS: 87427-61-0, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇BrCl₂O.
2-Bromo-1-(3,5-dichlorophenyl)-1-propanone, CAS: 92821-91-5, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇BrCl₂O.
2’-O-Butyryladenosine 3’,5’-cyclic phosphate DMAP, CAS: /, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₅O₇P • C₇H₁₀N₂.
21-Acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione, CAS: 3044-42-6, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈O₅.
21-Acetyloxy Budesonide-d8, CAS: /, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈D₈O₇.
2-Bromo-2’-chloropropiophenone, CAS: 75815-22-4, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈BrClO.
2’-O-Monobutyryladenosine-3’, 5’-cyclic Monophosphate Sodium Salt, CAS: 55443-13-5, stock: 10g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₅NaO₇P.
21-Butyryloxy Budesonide, CAS: /, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₀O₇.
21-Dehydro Budesonide, CAS: 85234-63-5, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂O₆.
2-Chloro-1-(3-chlorophenyl)-1-propanone, CAS: 34841-41-3, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈Cl₂O.
Bucladesine Sodium Salt, CAS: 16980-89-5, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄N₅NaO₈P.
N6-Monobutyryladenosine 3’:5’-Cyclic Monophosphate Sodium Salt, CAS: 70253-67-7, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₅NaO₇P.
21-Dehydro Budesonide-d8, CAS: /, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄D₈O₆.
22R-6β-Hydroxy Budesonide, CAS: 93861-52-0, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
3,5-Dichloropropiophenone, CAS: 92821-92-6, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈Cl₂O.
O2’-Monobutyryl Cyclic AMP, CAS: 15392-98-0, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₅O₇P.
22S-6β-Hydroxy Budesonide, CAS: 93861-51-9, stock: 5.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
23-Chlorobudesonide, CAS: /, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃ClO₆.
23-Hydroxybudesonide, CAS: 109423-03-2, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
24-Hydroxybudesonide(Mixture of Diastereomers), CAS: /, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
3-Deschloro-2-chloro Bupropion Hydrochloride, CAS: 1049718-57-1, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈ClNO • (HCl).
3-Deschloro-2-chloro Bupropion-d9 Hydrochloride, CAS: 1346604-03-2, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀D₉Cl₂NO.
6α-Hydroxy Budesonide, CAS: 577777-51-6, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
3-Deschloro-3-bromo Bupropion Hydcrochloride, CAS: 1049718-43-5, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉BrClNO.
6α-Hydroxy Budesonide-d8, CAS: /, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₈O₇.
6β-Hydroxy 21-Acetyloxy Budesonide, CAS: 93789-69-6, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆O₈.
3-Deschloro-4-chloro Bupropion Hydrochloride, CAS: 1049718-72-0, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉Cl₂NO.
3-Fluoropropiophenone, CAS: 455-67-4, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉FO.
6β-Hydroxy 21-Acetyloxy Budesonide-d8, CAS: /, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈D₈O₈.
6β-Hydroxy Budesonide, CAS: 88411-77-2, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
3’-Chloropropiophenone, CAS: 34841-35-5, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉ClO.
3’-Dechloro-3’-bromo Bupropion Fumarate, CAS: 1251850-99-3, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂BrNO₅.
6β-Hydroxy Budesonide-d8, CAS: /, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₈O₇.
9,11-Anhydrobudesonide(Mixture of Diastereomers), CAS: 313474-58-7, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂O₅.
3’-Dechloro-3’-bromo Bupropion-d9 Fumarate, CAS: /, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃D₉BrNO₅.
3’-Dechloro-4’-chloro Bupropion Fumarate, CAS: 1251851-01-0, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂ClNO₅.
9α-Bromobudesonide, CAS: 313474-59-8, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃BrO₆.
Budesonide, CAS: 51333-22-3, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₆.
3’-Dechloro-4’-chloro Bupropion-d9 Fumarate, CAS: /, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃D₉ClNO₅.
4-Chloro Bupropion Fumarate, CAS: 1193779-36-0, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁Cl₂NO₅.
Budesonide 21-Sulfate, CAS: 1436796-04-1, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₉S.
Budesonide-d6, CAS: 1134189-63-1, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈D₆O₆.
4-Chloro Bupropion-d9 Fumarate, CAS: 1346606-37-8, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₉Cl₂NO₅.
Budesonide-d8, CAS: 1105542-94-6, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₈O₆.
Butanal-d8, CAS: 84965-36-6, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄D₈O.
4-Fluoro Bupropion, CAS: 1076198-12-3, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈FNO.
Cortisol 17,21-diacetate, CAS: 3517-48-4, stock: 2.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
Desonide, CAS: 638-94-8, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂O₆.
4-Fluorohydroxy Bupropion, CAS: 1076198-13-4, stock: 4.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈FNO₂.
4’-Chloropropiophenone, CAS: 08/05/6285, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉ClO.
Di-Norbudesonide(Mixture of Diastereomers), CAS: 1040085-98-0, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀O₆.
Prednisolone 17,21-Diacetate, CAS: 17652-24-3, stock: 4.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂O₇.
5-Chloro Bupropion Fumarate, CAS: 1193779-50-8, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁Cl₂NO₅.
5-Chloro Bupropion-d9 Fumarate, CAS: 1346606-75-4, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₉Cl₂NO₅.
Pregna-1,4-dien-11β,17α,20β,21-tetrol-3-one 17,21-Diacetate, CAS: /, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₇.
6-(3-Chlorophenyl)-6-hydroxy-5-methyl-3-thiomorpholine Carboxylic Acid(Mixture of Diastereomers), CAS: /, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂ClNO₄S.
Bupropion Hydrochloride, CAS: 31677-93-7, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉Cl₂NO.
Bupropion Hydrochloride (1.0 mg/mL in Methanol), CAS: 31677-93-7, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉Cl₂NO.
Bupropion-d9 Hydrochloride, CAS: 1189725-26-5, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀D₉Cl₂NO.
Deschloro Bupropion Hydrochloride, CAS: 63199-74-6, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀ClNO.
Deschloro Bupropion-d9 Hydrochloride, CAS: 1346601-65-7, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₉ClNO.
Dihydro Bupropion (Threo and Erythro mixture (1:1)) Maleate, CAS: /, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄ClNO₅.
erythro-Dihydro Bupropion β-D-Glucuronide, CAS: /, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClNO₇.
erythro-Dihydro Bupropion-d9 Hydrochloride, CAS: /, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₉Cl₂NO.
Hydroxy Bupropion, CAS: 357399-43-0, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈ClNO₂.
Hydroxy Bupropion-d6, CAS: 1216893-18-3, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₆ClNO₂.
rac Erythro Dihydrobupropion β-D-Glucuronide-d9, CAS: /, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₉ClNO₇.
rac erythro-Dihydro Bupropion, CAS: 99102-04-2, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀ClNO.
rac erythro-Dihydro Bupropion N-β-D-Glucuronide, CAS: /, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClNO₇.
rac erythro-Dihydro Bupropion-d9, CAS: 1217684-77-9, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₉ClNO.
rac threo-Dihydro Bupropion, CAS: 92264-82-9, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀ClNO.
rac threo-Dihydro Bupropion Hydrochloride, CAS: 1396889-62-5, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁Cl₂NO.
rac threo-Dihydro Bupropion β-D-Glucuronide, CAS: /, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClNO₇.
rac threo-Dihydro Bupropion Maleate, CAS: /, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄ClNO₅.
rac threo-Dihydro Bupropion N-β-D-Glucuronide, CAS: /, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClNO₇.
rac threo-Dihydro Bupropion-d9, CAS: 1217815-08-1, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₉ClNO.
rac-erythro-Dihydro Bupropion Hydrochloride, CAS: 80478-43-9, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁Cl₂NO.
rac-threo-Dihydro Bupropion-d9 Hydrochloride, CAS: 1392209-60-7, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₉ClNO • HCl.
rel-(1R,2S)-erythro-Dihydro Bupropion Maleate, CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄ClNO₅.
tert-Butyl-d9-amine Hydrobromide, CAS: 134071-63-9, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃D₉BrN.
threo-Dihydro Bupropion Hydrochloride, CAS: 80478-42-8, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀ClNO • HCl.
Bucillamine, CAS: 65002-17-7, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃NO₃S₂.
Bucillamine-d6, CAS: /, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇D₆NO₃S₂.
2-Bromoethylamine Hydrobromide, CAS: 2576-47-8, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₇Br₂N.
Di-tert-butyl-2-bromoethyliminodiacetate, CAS: 146432-43-1, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆BrNO₄.
N-(2-Bromoethyl)-phenylmethyl ester carbamic acid, CAS: 53844-02-3, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂BrNO₂.
N-t-Boc-2-bromoethylamine (Technical grade, ~90%), CAS: 39684-80-5, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄BrNO₂.
N-t-Boc-2-bromoethylamine-d4, CAS: 1250986-06-1, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀D₄BrNO₂.
(+)-2-Butanol, CAS: 4221-99-2, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O.
(-)-Rhododendrol, CAS: 501-96-2, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₂.
(1R-cis)-2-Aminocyclobutanol Hydrochloride, CAS: 206751-78-2, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO •HCl.
(1S,2S,3S)-2,3-Bis(benzoyloxymethyl)cyclobutanol, CAS: 132294-17-8, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₅.
(1S-cis)-2-Aminocyclobutanol Hydrochloride, CAS: 206751-79-3, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO •HCl.
(2R)-1-Morpholino-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one, CAS: 135270-08-5, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₁NO₄.
(2R)-2,3-Dimethyl-1-butanol, CAS: 15019-27-9, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
(2R)-2,3-Dimethyl-1-butanol-d3, CAS: 1329509-41-2, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁D₃O.
(2R)-2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-1-butanol, CAS: 1309610-41-0, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂Si.
(2S,3R)-3-Bromo-2-butanol Acetate, CAS: 73346-91-5, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁BrO₂.
(2S,3S)-3-Amino-4-[bis(4-methoxyphenyl)phenylmethoxy]-2-butanol, CAS: 956092-70-9, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉NO₄.
(2S,3S,5S)-2-(N,N-Dibenzylamino)-3-hydroxy-5-amino-1,6-diphenylhexane, CAS: 156732-15-9, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₆N₂O.
(3R)-2,3-Dimethyl-4-(phenylsulfonyl)-2-butanol, CAS: 93748-50-6, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₃S.
(3S)-2,3-Dimethyl-4-[(tetrahydro-2H-pyran-2-yl)oxy]-2-butanol-d6, CAS: /, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆D₆O₃.
(±)-1,2-Diphenyl-1-[2-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol, CAS: /, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁NO₂.
(±)-1,2-Diphenyl-1-[2-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol-d5, CAS: /, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆D₅NO₂.
(±)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol, CAS: 748-97-0, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁NO₂.
(±)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol-d5, CAS: /, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆D₅NO₂.
(±)-2-Phenylbutanol, CAS: 2035-94-1, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
(R)-(+)-2-Amino-3-methyl-1,1-diphenyl-1-butanol, CAS: 86695-06-9, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO.
(R)-(-)-2-Amino-1-butanol, CAS: 5856-63-3, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO.
(R)-(-)-2-Butanol, CAS: 14898-79-4, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O.
(R)-3-Aminobutan-1-ol, CAS: 61477-40-5, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO.
(R)-4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, CAS: 197711-99-2, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂.
(R)-4-Amino-2-methyl-1-butanol, CAS: 88390-32-3, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
(R)-DRF053 Dihydrochloride, CAS: 1241675-76-2, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇N₇O • 2(HCl).
(R,R)-Ethambutol Dihydrochloride, CAS: 134566-79-3, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₆Cl₂N₂O₂.
(R,R)-Ethambutol-d4 Dihydrochloride, CAS: /, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₂D₄Cl₂N₂O₂.
(R,S)-Ethambutol, CAS: 10054-06-5, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₄N₂O₂.
(S)-(+)-2-Methyl-1-butanol p-Toluenesulfonate, CAS: 38261-81-3, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₃S.
(S)-(+)-4-Phenyl-2-butanol, CAS: 22148-86-3, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
(S)-(-)-2-Amino-3,3-dimethyl-1,1-diphenyl-1-butanol, CAS: 144054-70-6, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO.
(S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol, CAS: 130432-39-2, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO • HCl.
(S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol, CAS: 78603-95-9, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO.
(S)-(-)-2-Methylbutanol, CAS: 1565-80-6, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂O.
(S)-2,3-Dimethyl-1-butanol, CAS: 15071-36-0, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
(S)-2,3-Dimethyl-4-(phenylthio)-2-butanol, CAS: 114694-30-3, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈OS.
(S)-2-Isopropylamino-3-methyl-1-butanol, CAS: 112211-88-8, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₉NO.
(S)-3-Aminobutan-1-ol, CAS: 61477-39-2, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO.
(S)-4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, CAS: 197712-01-9, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂.
(S)-4-Benzyl-3-((S)-2,3-dimethylbutanoyl)oxazolidin-2-one, CAS: /, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁NO₃.
(S)-Homophenylalaninol-d2, CAS: /, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃D₂NO.
(T-4)-[(1R,2R)-α,α-Diphenyl-2-pyrrolidinemethanolato-κN1,κO2][1,2-ethanediolato(2-)-κO1,κO2]boron, CAS: 1631719-79-3, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂B₃NO₃²⁻.
(Z)-retro-α-Ionol, CAS: 55093-47-5, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂O.
1,1,1,3,3,3-Hexafluoro-2-methyl-2-propanol, CAS: 1515-14-6, stock: 9.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄F₆O.
Brompromazine Hydrochloride, CAS: 15502-93-9, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀BrClN₂S.
1,1,1-Tris(hydroxymethyl)propane, CAS: 77-99-6, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O₃.
1,1,1-Tris(hydroxymethyl)propane-d5, CAS: 103782-76-9, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉D₅O₃.
Brompromazine-d6 Hydrochloride, CAS: /, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄D₆BrClN₂S.
1,1-Dimethoxy-2-butanol, CAS: 7472-25-5, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O₃.
1,1-Dimethyl-1-propanol, CAS: 75-85-4, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂O.
1,1-Dimethyl-1-propanol-d6, CAS: 75295-95-3, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆D₆O.
1,3-Butanediol, CAS: 107-88-0, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O₂.
1,4-Dibromo-2-butanol, CAS: 19398-47-1, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈OBr₂.
1-(2-Propyn-1-yl)cyclobutanol, CAS: 37418-60-3, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O.
1-(3-Pyridyl)-1,4-butanediol, CAS: 76014-83-0, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₂.
1-(3-Pyridyl-13C3, 15N)-1,4-butanediol, CAS: /, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₁₃¹⁵NO₂.
1-(3-Pyridyl-13C6)-1,4-butanediol, CAS: /, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₆H₁₃NO₂.
1-(3-Pyridyl-d4)-1,4-butanediol, CAS: /, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉D₄NO₂.
1-(4-Bromo-3-methylphenyl)cyclobutanol, CAS: 1448610-48-7, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃OBr.
1-(5-Bromothiazol-2-yl)cyclobutanol, CAS: 1312534-98-7, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NOSBr.
1-(Dimethylamino)-2-methyl-2-butanol, CAS: 74347-10-7, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₇NO.
1-Bromo-3-methyl-2-butanol, CAS: 1438-12-6, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁BrO.
1-Butan-1,1-d2-ol, CAS: 32586-14-4, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈D₂O.
1-Butan-d9-ol, CAS: 25493-17-8, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CD₃CD₂CD₂CD₂OH.
1-Butanol (n-Butyl Alcohol), CAS: 71-36-3, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O.
1-Butanol-d, CAS: 4712-38-3, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉DO.
1-Butanol-d10 (n-Butyl Alcohol-d10), CAS: 34193-38-9, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄D₁₀O.
1-Phenyl-1-butanol, CAS: 614-14-2, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
1-Pyrenebutanol, CAS: 67000-89-9, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O.
2,2,3,3,4,4,4-Heptafluoro-1-butanol, CAS: 375-01-9, stock: 6.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃F₇O.
2,2,3,3,4,4-Hexafluoro-1-butanol, CAS: 60838-59-7, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄H₆O.
2,2-Bis(allyloxymethyl)-1-butanol, CAS: 682-09-7, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₃.
2,2-Dimethyl-1-butanol, CAS: 1185-33-7, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
2,2-Dimethyl-1-butanol-d6, CAS: 101419-74-3, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈D₆O.
2,3-Epoxybutanol, CAS: 872-38-8, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O₂.
2,4,4-Trimethyl-2-pentanol, CAS: 690-37-9, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈O.
2-(4-Chlorobutoxy)tetrahydropyran, CAS: 41302-05-0, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇ClO₂.
2-(4-Hydroxybutoxy)tetrahydrofuran, CAS: 64001-06-5, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆O₃.
2-(N-Benzyl-N-methyl)amino-2-phenylbutanol, CAS: 1330183-29-3, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO.
2-(N-Benzyl-N-methyl)amino-2-phenylbutanol-d5, CAS: 1330265-76-3, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈D₅NO.
2-Amino-3-methyl-1-butanol, CAS: 16369-05-4, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
2-Amino-β-methyl-9H-purine-9-butanol 9-Acetate, CAS: 174155-70-5, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₅O₂.
2-Methyl-1-propanol(Isobutyl Alcohol), CAS: 78-83-1, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O.
2-Methyl-1-propanol-d7, CAS: 1219804-53-1, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃D₇O.
2-Methyl-4-(methylamino)butan-2-ol, CAS: 866223-53-2, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₅NO.
2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-butanol, CAS: /, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₄O₂Si.
2-Benzylamino-2-phenylbutanol, CAS: 1178412-63-9, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO.
2-Benzylamino-2-phenylbutanol-d5, CAS: 1246818-61-0, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆D₅NO.
2-Butanol, CAS: 78-92-2, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O.
2-Butanol-d3, CAS: 53716-61-3, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇D₃O.
2-Butyl-4-tetrahydropyranoxy-1-butanol, CAS: /, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₆O₃.
2-Ethyl-1-butanol, CAS: 97-95-0, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
2-Ethyl-2-propen-1-ol, CAS: 4435-54-5, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O.
2-Fluorophenol, CAS: 367-12-4, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅FO.
2-Mercapto-3-butanol, CAS: 54812-86-1, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀OS.
2-Methoxyethanol, CAS: 109-86-4, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₈O₂.
2-Methyl-1,3-propandiol (β-Hydroxyisobutanol), CAS: 2163-42-0, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O₂.
2-Methyl-1-phenyl-2-butanol, CAS: 772-46-3, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O.
2-Methyl-1-phenyl-2-propanol, CAS: 100-86-7, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
2-Methyl-2-pentanol, CAS: 590-36-3, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
2-Methyl-4,4,4-trifluorobutanol, CAS: 107103-95-7, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉OF₃.
2-Methyl-4-(phenylthio)-2-butanol-d6, CAS: /, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₆OS.
2-Methylamino-2-phenylbutanol, CAS: 78483-47-3, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO.
2-Methylbutyl Chloroformate, CAS: 20412-39-9, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁ClO₂.
2-O-[4-Oxo-4-(3-pyridinyl)butyl]thymidine, CAS: 696584-91-5, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃N₃O₆.
2-Phenethyl-2-propanol, CAS: 103-05-9, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O.
2’-Deoxy-6-O-[4-hydroxy-4-(3-pyridinyl)butyl]guanosine, CAS: 502507-69-9, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₆O₅.
2R-Azido-1,4-dichloro-3S-butanol, CAS: /, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇Cl₂N₃O.
(Z)-3-Hydroxydemethylbromhexine, CAS: /, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈Br₂N₂O.
2,4-Dichloro-1,3,5-triazine, CAS: 2831-66-5, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃HCl₂N₃.
2S,3S,5S-2,5-Diamino-3-hydroxy-1,6-diphenylhexane, Dihydrochloride, CAS: 156769-85-6, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆Cl₂N₂O.
3,3,4,4,4-Pentafluorobutan-1-ol, CAS: 54949-74-5, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅F₅O.
3,3-Azo-1-butanol, CAS: 25055-82-7, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈N₂O.
3,3-Bis(2-methoxybenzyl)pent-4-en-1-ol, CAS: 1384881-68-8, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₃.
3,3-Bis(2-methoxybenzyl)pent-4-en-1-ol-d4, CAS: /, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₄O₃.
3-Cyclohexyl-6,8-dibromo-3-methyl-1,2,3,4-tetrahydroquinazolinium Chloride, CAS: 1660957-93-6, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁Br₂ClN₂.
3,3-Bis(3-methoxybenzyl)pent-4-en-1-ol, CAS: 1384881-67-7, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₃.
3-Cyclohexyl-6,8-dibromo-3-methyl-1,2,3,4-tetrahydroquinazolinium Trifluoroacetic Acid Salt, CAS: /, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂Br₂F₃N₂O₂.
6,8-Dibromo-1,2,3,4-tetrahydro-3-methyl-quinazoline Hydrochloride, CAS: 1796928-60-3, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁Br₂ClN₂.
3,3-Bis(3-methoxybenzyl)pent-4-en-1-ol-d4, CAS: /, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₄O₃.
3,3-Bis(4-bromobenzyl)pent-4-en-1-ol, CAS: 1384881-65-5, stock: 10g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀Br₂O.
6,8-Dibromo-3-cyclohexyl-2,3-dihydroquinazolin-4(1H)-one, CAS: /, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆Br₂N₂O.
Bromhexine Hydrochloride, CAS: 611-75-6, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁Br₂ClN₂.
3,3-Bis(4-bromobenzyl)pent-4-en-1-ol-d4, CAS: /, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆D₄Br₂O.
3,3-Bis(4-chlorobenzyl)-1-phenylpent-4-en-1-ol, CAS: 1384881-74-6, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄Cl₂O.
Bromhexine N Oxide, CAS: /, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀Br₂N₂O.
N-(4-Bromo-2-(hydroxymethyl)phenyl)acetamide, CAS: 50739-71-4, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀BrNO₂.
3,3-Bis(4-chlorobenzyl)-1-phenylpent-4-en-1-ol-d5, CAS: /, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₉D₅Cl₂O.
3,3-Bis(4-methoxybenzyl)pent-4-en-1-ol, CAS: 1384881-63-3, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₃.
N-Cyano-1-chloroformamidine, CAS: 25816-30-2, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₂ClN₃.
3,3-Bis(4-methoxybenzyl)pent-4-en-1-ol-d4, CAS: /, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₄O₃.
3,3-Bis(4-methylbenzyl)pent-4-en-1-ol, CAS: 1384881-62-2, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O.
3,3-Bis(4-methylbenzyl)pent-4-en-1-ol-d4, CAS: /, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₄O.
3,3-Bis(4-methylthio)benzylpent-4-en-1-ol, CAS: 1384881-64-4, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆OS₂.
3,3-Bis(4-methylthio)benzylpent-4-en-1-ol-d4, CAS: /, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₄OS₂.
3,3-Dibenzyl-1-phenylpent-4-en-1-ol, CAS: 1384881-72-4, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆O.
3,3-Dibenzyl-1-phenylpent-4-en-1-ol-d5, CAS: /, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₁D₅O.
3,3-Dimethyl-1-butanol, CAS: 624-95-3, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
3,3-Dimethyl-2-butanol, CAS: 464-07-3, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
3,3-Dimethyl-2-butanol-d3, CAS: 55755-07-2, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁D₃O.
3,4-Epoxybutanol, CAS: 19098-31-8, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O₂.
3,3-Difluorocyclobutanol, CAS: 637031-88-0, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆F₂O.
3-((2-Mercapto-1-methylpropyl)thio)-2-butanol, CAS: 54957-02-7, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈OS₂.
3-(2-Chlorophenyl)cyclobutanol, CAS: 1182960-42-4, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁OCl.
3-(4-Bromophenyl)cyclobutanol, CAS: 1183047-51-9, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁OBr.
3-(Benzyloxy)cyclobutanol, CAS: 100058-61-5, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄O₂.
3-(Boc-amino)-3-methyl-1-butanol, CAS: 167216-22-0, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₁NO₃.
3-(Hydroxymethyl)cyclobutanol, CAS: 1245647-03-3, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O₂.
3-Amino-2,3-dimethylbutan-2-ol, CAS: 89585-13-7, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₅NO.
3-Amino-3-(4-Bromophenyl)cyclobutanol, CAS: 1199556-66-5, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂NOBr.
3-Amino-3-methylbutan-1-ol, CAS: 42514-50-1, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
3-Aminocyclobutanol, CAS: 4640-44-2, stock: 6.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀ClNO.
3-Aminocyclobutanol Hydrochloride, CAS: 1036260-25-9, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO•HCl.
3-Dimethylamino-1,1-di-2-thienyl-1-butanol, CAS: 6293-00-1, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉NOS₂.
3-Ethyl-3-hexanol, CAS: 597-76-2, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈O.
3-Fluoro-3-methylButan-1-ol, CAS: 944264-99-7, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁FO.
3-Fluorocyclobutanol, CAS: 1380170-67-1, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇OF.
3-Hydroxybutyraldehyde Dimethyl Acetal, CAS: 39562-58-8, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O₃.
3-Mercapto-3-methyl-1-butanol, CAS: 34300-94-2, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂OS.
3-Mercapto-3-methylbutanol-d6, CAS: 162404-35-5, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆D₆OS.
3-Mercapto-3-methylbutyl Formate, CAS: 50746-10-6, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₂S.
3-Mercapto-3-methylbutyl-d6 Formate, CAS: 162404-32-2, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆D₆O₂S.
3-Methyl-1-pentanol, CAS: 589-35-5, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
3-Methyl-2-butanol-D7, CAS: /, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅D₇O.
3-Methyl-3-(methylamino)-1-butanol, CAS: 17945-49-2, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₅NO.
3-Methylbutyl 4-Nitrobenzoate, CAS: 38120-06-8, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₄.
3-Phenyl-1-butanol, CAS: 2722-36-3, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
3-[(Tetrahydro-2H-pyran-2-yl)oxy]-1-butanol, CAS: 40595-23-1, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈O₃.
4,4,4-Trifluoro-1-butanol, CAS: 461-18-7, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇F₃O.
4,4-Dimethoxybutan-1-ol, CAS: 23068-87-3, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O₃.
4,4,4-Trifluoro-3-(trifluoromethyl)-1-butanol, CAS: 17327-35-4, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆F₆O.
4-(1-Azepanyl)-1-butanol, CAS: 114960-98-4, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₁NO.
4-(1-Boc-4-Piperidyl)-1-Butanol, CAS: 142355-83-7, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₇NO₃.
4-(1-Piperidinyl)-1-butanol Hydrochloride, CAS: 109967-02-4, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO • HCl.
4-(3-Pyridyl)-1-butanol, CAS: 60753-14-2, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO.
4-(4-Morpholinyl)-1-butanol, CAS: 5835-79-0, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₇NO₂.
4-(4-Pyridyl)-1-butanol Hydrochloride, CAS: 90642-84-5, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO • HCl.
4-(Acetylmethylamino)-1-(3-pyridyl)-1-butanol, CAS: 887352-16-1, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈N₂O₂.
4-(Acetylmethylamino)-1-(3-pyridyl)-1-butanol-d6, CAS: 887352-16-1, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂D₆N₂O₂.
4-(Dimethyl-tert-Butylsilyloxy)butan-1-ol, CAS: 87184-99-4, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₄O₂Si.
4-(Isopropylamino)butanol, CAS: 42042-71-7, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₇NO.
4-(Methyl-d3-nitrosamino)-1-(3-pyridyl)-1-butanol, CAS: 1020719-61-2, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂D₃N₃O₂.
4-(Methylamino)-1-(3-pyridyl)-1-butanol-1,2’,3’,4’,5’,6’-13C6, CAS: 1216991-24-0, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₆H₁₆N₂O.
4-(Methylamino)-1-(3-pyridyl)-1-butanol-d3, CAS: 1189642-32-7, stock: 7.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃D₃N₂O.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, CAS: 76014-81-8, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (1.0 mg/mL in Methanol), CAS: 76014-81-8, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol N-β-D-Glucuronide, CAS: 350508-29-1, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃N₃O₈.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol O-2,3,4-Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₁N₃O₁₁.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol O-β-D-Glucuronide Sodium Salt(Mixture of Diastereomers) (>90%), CAS: /, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂N₃NaO₈.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol-1,2’,3’,4’,5’,6’-13C6, CAS: 1189877-28-8, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₆H₁₅N₃O₂.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol-d3 O-β-D-Glucuronide (Major)(Mixture of Diastereomers), CAS: /, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀D₃N₃O₈.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol-d5, CAS: 1794885-45-2, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀D₅N₃O₂.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol-d5 O-β-D-Glucuronide (Major)(Mixture of Diastereomers), CAS: /, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈D₅N₃O₈.
4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanol, CAS: 85352-99-4, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₃.
4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanol-d3, CAS: /, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂D₃N₃O₃.
4-(Methylnitrosamino)-1-[(3-pyridyl)-4-carboxy]-1-butanol, CAS: 1246817-89-9, stock: 8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅N₃O₄.
4-(Methylnitrosamino-d3)-1-(3-pyridyl)-1-butanol N-β-D-Glucuronide, CAS: /, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀D₃N₃O₈.
4-(N-Methyl-N-4’-Nitrobenzenesulfonyl-amino)-1-(3-pyridyl)-1-butanol, CAS: 1346602-20-7, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O₅S.
4-(N-Methyl-N-nitrosamino)-4-(3-pyridyl)butane-1-ol, CAS: 59578-66-4, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂.
4-(N-Methyl-N-propenylamino)-1-(3-pyridyl)-1-butanol Preparation Kit, CAS: 870193-42-3, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀N₂O.
4-(N-Methyl-N-tert-butyloxycarbonyl-amino)-1-(3-pyridyl)-1-butanol, CAS: 1346603-44-8, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₄N₂O₃.
4-(N-Methyl-N-trifluoroacetamide)-1-(3-pyridyl)-1-butanol, CAS: 1346600-78-9, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅F₃N₂O₂.
4-(N-Methylamino)-4-(3-pyridyl)butane-1-ol, CAS: 59578-64-2, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O.
4-(Perfluorooctyl)-2-methyl-2-butanol, CAS: 141183-94-0, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁F₁₇O.
4-(Phenylmethoxy)benzenebutanol, CAS: 130783-40-3, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₂.
4-(t-Boc-amino)-1-butanol, CAS: 75178-87-9, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO₃.
4-(Z-Amino)-1-butanol, CAS: 17996-13-3, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₃.
4-Amino-1-butanol, CAS: 13325-10-5, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO.
4-Amino-2-methyl-1-butanol, CAS: 44565-27-7, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
4-Azido-1-methanesulfonate-1-butanol, CAS: 320573-75-9, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁N₃O₃S.
4-Azidobutanol, CAS: 54953-78-5, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉N₃O.
4-Azidobutanol 1-(4-Methylbenzenesulfonate), CAS: 389131-94-6, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅N₃O₃S.
4-(Phenylmethoxy)-benzenebutanol 1-Mmethanesulfonate, CAS: 202595-06-0, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂O₄S.
4-Amino-2-methyl-2-butanol, CAS: 26734-08-7, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
4-Bromo-1-butanol 1-Nitrate, CAS: 146563-40-8, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈BrNO₃.
4-Benzylamino-1-butanol, CAS: 59578-63-1, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO.
4-Benzyloxy-1-butanol, CAS: 4541-14-4, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O₂.
4-Bromo-1-butanol, CAS: 33036-62-3, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉BrO.
4-Bromo-1-butyl Acetate, CAS: 4753-59-7, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁BrO₂.
4-Bromo-2-methyl-2-butanol, CAS: 35979-69-2, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁BrO.
4-Butoxybutanol, CAS: 4161-24-4, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈O₂.
4-Chloro-1-butanol (Technical Grade), CAS: 928-51-8, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉ClO.
4-Chloro-2-methyl-2-butanol, CAS: 1985-88-2, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁ClO.
4-Chlorobutyl Acetate, CAS: 6962-92-1, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁ClO₂.
4-Decanolide, CAS: 706-14-9, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₂.
4-Diisopropylamino-1-butanol, CAS: 103859-38-7, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₃NO.
4-Dimethylamino-1-butanol, CAS: 13330-96-6, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₅NO.
4-Fluoro-1-butanol, CAS: 372-93-0, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉FO.
4-Fluoro-δ-(4-fluorophenyl)benzenebutanol, CAS: 50337-85-4, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆F₂O.
4-Hydroxy-1-(3-pyridyl)-1-butanone, CAS: 59578-62-0, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₂.
4-Hydroxy-1-(3-pyridyl)-1-butanone-13C6, CAS: /, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₆H₁₁NO₂.
4-Hydroxy-2-butanone, CAS: 590-90-9, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O₂.
4-Methanesulfonyloxybutanol-d4, CAS: /, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈D₄O₄S.
4-Methoxy-1-butanol, CAS: 111-32-0, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂O₂.
4-Methyl-2-pentanol, CAS: 108-11-2, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O.
4-Phenyl-1-butanol, CAS: 3360-41-6, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
4-Phenyl-2-butanol, CAS: 2344-70-9, stock: 2.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
4-Tetrahydropyranyloxy-butan-1-ol, CAS: 51326-51-3, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈O₃.
4-[(1E)-2-phenyldiazenyl]-Benzenebutanol, CAS: 156017-70-8, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₂O.
4-[N-(Methyl-d3)-N-nitrosamino]-4-(3-pyridyl)butane-1-ol, CAS: 1184990-35-9, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂D₃N₃O₂.
4-[N-(Methyl-d3)amino]-4-(3-pyridyl)butane-1-ol, CAS: 1189470-76-5, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃D₃N₂O.
6-Methylheptanal, CAS: 63885-09-6, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆O.
6-Methylheptanal-d7, CAS: 1795020-75-5, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉D₇O.
Acetoin, CAS: 513-86-0, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O₂.
Acetoin-13C4, CAS: /, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₄H₈O₂.
Aftin 4, CAS: 866893-90-5, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈N₆O.
Aluminum tert-Butoxide, CAS: 556-91-2, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O•1/3Al.
Aminobutanol, CAS: 96-20-8, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO.
Aminopurvalanol A, CAS: 220792-57-4, stock: 10g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆ClN₇O.
Amylocaine Hydrochloride, CAS: 532-59-2, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁NO₂ •HCl.
Azaperol, CAS: 09/05/2804, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄FN₃O.
BAY 1000394, CAS: 1223498-69-8, stock: 5.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁F₃N₄O₃S.
Bis[1,2-bis(diphenylphosphino)ethane]dichlororuthenium, CAS: 16594-81-3, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₄₈Cl₂P₄Ru.
BMY 14802 Hydrochloride, CAS: 105565-55-7, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂F₂N₄O • HCl.
Butanone Cyanohydrin, CAS: 04/08/4111, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉NO.
Butoxy(tert-butyl)dimethylsilane, CAS: 37170-50-6, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₄OSi.
Butoxypolypropylene Glycol, CAS: 9003-13-8, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₃H₆O)nC₄H₁₀O.
Butyl 2-Butyl Ether, CAS: 999-65-5, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈O.
cis-2-Aminocyclobutanol Hydrochloride, CAS: 2070860-49-8, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO •HCl.
cis-3-[Dimethylamino)methyl]cyclobutanol, CAS: 1821838-71-4, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₅NO.
Cyclobutanol, CAS: 2919-23-5, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O.
D-Valinol, CAS: 09/09/4276, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
Decarboxy Fexofenadine, CAS: 185066-37-9, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₉NO₂.
Decarboxy Fexofenadine-d3, CAS: /, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₆D₃NO₂.
Descarboxy Fexofenadine Hydrochloride, CAS: /, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₀ClNO₂.
Dihydrozeatin, CAS: 14894-18-9, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O.
Dihydrozeatin 7-Glucoside, CAS: 91599-03-0, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₅O₆.
Dihydrozeatin 9-Glucoside, CAS: 73263-99-7, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₅O₆.
Dihydrozeatin Hydrochloride, CAS: 1402800-82-1, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O •HCl.
Diphenidol Hydrochloride, CAS: 3254-89-5, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈ClNO.
Diphenidol Hydrochloride, CAS: 3254-89-5, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₇NO • HCl.
DL-3-(BOC-Amino)-1-butanol, CAS: 146514-31-0, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO₃.
Ethambutol, CAS: 74-55-5, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₄N₂O₂.
Bromperidol, CAS: 10457-90-6, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃BrFNO₂.
Ethambutol Dihydrochloride, CAS: 1070-11-7, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₆Cl₂N₂O₂.
Ethambutol-d4 Dihydrochloride, CAS: 1129526-19-7, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₂D₄Cl₂N₂O₂.
Bromperidol-d4, CAS: 1216919-75-3, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉D₄BrFNO₂.
ICI 118551 Hydrochloride, CAS: 72795-01-8, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈ClNO₂.
ICI 118551-d7 Hydrochloride, CAS: 1330181-02-6, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁D₇ClNO₂.
Isoamyl Acetate, CAS: 123-92-2, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₂.
Isoamyl Acetate-d4, CAS: /, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀D₄O₂.
Isoamyl Alcohol, CAS: 123-51-3, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂O.
Isopentanol-d7, CAS: /, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅D₇O.
Isopentyl Mesylate, CAS: 16156-55-1, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄O₃S.
Isopentyl Nitrite, CAS: 110-46-3, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁NO₂.
α-d-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol Hydrochloride, CAS: 63526-63-6, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆ClNO.
α-Methyl-α-[3-(methylnitrosoamino)propyl]-3-pyridinemethanol, CAS: 127171-58-8, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇N₃O₂.
α-Methyl-α-[3-(methylnitrosoamino)propyl]-3-pyridinemethanol-d3, CAS: /, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄D₃N₃O₂.
α-[2-(Dimethylamino)-1-methylethyl]-α-phenyl-Benzeneethanol 1-Acetate, CAS: 53990-51-5, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₇NO₂.
β-Amino-4-octylbenzenebutanol Hydrochloride, CAS: 168560-42-7, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂ClNO.
β-Hydroxyisobutanol-d3, CAS: /, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇D₃O₂.
γ-Butyrolactone-d4, CAS: 1224441-94-4, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂D₄O₂.
L-2-Aminobutanol, CAS: 5856-62-2, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO.
L-2-Aminobutanol-d5, CAS: 1217783-40-8, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆D₅NO.
L-Propoxyphene-d5 Hydrochloride, CAS: 1276197-49-9, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅D₅ClNO₂.
L-Valinol, CAS: 2026-48-4, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO.
Linsitinib, CAS: 867160-71-2, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃N₅O.
Linsitinib-d3, CAS: /, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₀D₃N₅O.
Lithium tert-Butoxide, CAS: 1907-33-1, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉LiO.
Mebeverine Alcohol, CAS: 14367-47-6, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₇NO₂.
Mebeverine Alcohol-d5, CAS: 14367-47-6, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂D₅NO₂.
Methysergide Maleate, CAS: 129-49-7, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁N₃O₆.
MRE-269 β-D-Glucuronide, CAS: /, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₇N₃O₉.
N-Boc-(R)-2-amino-1-butanol, CAS: 150736-71-3, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO₃.
N-Boc-(S)-2-Amino-1-butanol, CAS: 150736-72-4, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO₃.
Potassium tert-Butoxide, CAS: 865-47-4, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉KO.
Potassium tert-Butoxide (20% solution in THF), CAS: 865-47-4, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉KO.
Purvalanol A, CAS: 212844-53-6, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅ClN₆O.
R-(+)-Dihydrozeatin, CAS: 37789-32-5, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O.
rac-4-(Methylamino)-1-(3-pyridyl)-1-butanol, CAS: 76030-54-1, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O.
rac-γ-Nonanolactone, CAS: 104-61-0, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆O₂.
Reduced Haloperidol, CAS: 34104-67-1, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅ClFNO₂.
Reduced Haloperidol-d4, CAS: 1246820-79-0, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁D₄ClFNO₂.
Roscovitine, CAS: 186692-46-6, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆N₆O.
S-(-)-Dihydrozeatin, CAS: 14742-97-3, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O.
Sandalore (90%), CAS: 65113-99-7, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O.
Terfenadine, CAS: 50679-08-8, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₁NO₂.
Terfenadine N-Oxide, CAS: 634901-83-0, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₁NO₃.
Terfenadine-d10, CAS: /, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₁D₁₀NO₂.
Terfenadine-d3, CAS: 192584-82-0, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₈D₃NO₂.
Tert-butyl Alcohol, CAS: 75-65-0, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O.
tert-Butyl Alcohol-d10, CAS: 53001-22-2, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄D₁₀O.
threo-ICI 118551 Hydrochloride, CAS: 72795-04-1, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈ClNO₂.
Titanium Butoxide, CAS: 5593-70-4, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₆O₄Ti.
trans-2-Aminocyclobutanol Hydrochloride, CAS: 1609406-69-0, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO •HCl.
trans-3-[(Dimethylamino)methyl]-cyclobutanol, CAS: 1821832-60-3, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₅NO.
(+)-(18-Crown-6)-2,3,11,12-tetracarboxylic Acid, CAS: 61696-54-6, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄O₁₄.
(+)-(1R,2R,5R)--Ethyl [(2-Hydroxypinan-3-ylene)amino]acetate-13C2, CAS: /, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂¹³C₂H₂₃NO₃.
(+)-Muscarine Chloride, CAS: 2303-35-7, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₀ClNO₂.
(+)-Nitrendipine, CAS: 80890-07-9, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂O₆.
(+/-)-Methoxyverapamil, CAS: 16662-47-8, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₁ClN₂O₅.
(+/-)-SDZ-201106(DPI-201106), CAS: 97730-95-5, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₀N₄O₂.
(-)-Nitrendipine, CAS: 80873-62-7, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂O₆.
(1R,3aR,7aR)-1-[(1R)-1,5-Dimethyl-5-[(trimethylsilyl)oxy]hexyl]octahydro-7a-methyl-4H-inden-4-one-d6, CAS: 122958-40-1, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄D₆O₂Si.
(1R,6R)-rel-6-(2,3-Dichlorophenyl)-2-methyl-4-oxo-2-cyclohexene-1-carboxylic Acid Methyl Ester, CAS: 1207068-16-3, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Cl₂O₃.
(1R,6S)-rel-6-(2,3-Dichlorophenyl)-2-methyl-4-oxo-2-cyclohexene-1-carboxylic Acid Methyl Ester, CAS: 1207068-17-4, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Cl₂O₃.
(1R,7AR)-1-((R)-6-Hydroxy-6-methylheptan-2-yl)-7A-methylhexahydro-1H-inden-4(2H)-one-d6, CAS: /, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆D₆O₂.
(1S,4S,6S)-4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-methyl-7-oxabicyclo[4.1.0]heptan-2-one, CAS: 326496-92-8, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₄O₃Si.
(25R)-5β-Cholestane-3α,7α,12α,26-tetrol, CAS: 27857-14-3, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₈O₄.
(2R)-2-Deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranose 3,5-Dibenzoate, CAS: 1639301-16-8, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉FO₆.
(2R)-2-Deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranose 3,5-Dibenzoate, CAS: 1199809-22-7, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉FO₆.
(2R)-2-Deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl Chloride 3,5-Dibenzoate, CAS: 1500076-79-8, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈ClFO₅.
(2R,3R,E)-2-Amino-3-hydroxyoctadec-4-en-1-yl dimethyl Phosphate-13C2,D2, CAS: /, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃¹³C₂H₄₈D₂NO₇P.
(2R,4R)-rel-1,2,3,4-Tetrahydro-6-methyl-2,4-bis(2-nitrophenyl)-5-pyrimidinecarboxylic Acid Methyl Ester, CAS: 80742-11-6, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈N₄O₆.
(2S,3R,E)-2-Aminooctadec-4-ene-1,3-diol-D2, CAS: /, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₅D₂NO₂.
(2S,3S)-5-(2-Aminoethyl)-2,3-dihydro-3-hydroxy-2-(4-hydroxyphenyl)-1,5-benzothiazepin-4(5H)-one, CAS: 115992-91-1, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₂O₃S.
(2S,3S)-5-(2-Aminoethyl)-2,3-dihydro-3-hydroxy-2-(4-hydroxyphenyl)-1,5-benzothiazepin-4(5H)-one-d4, CAS: /, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄D₄N₂O₃S.
7,7’-Bis(4-bromobenzoyl) Isoindigo, CAS: 1798431-98-7, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₁₆Br₂N₂O₄.
7-(4-Bromobenzoyl)-1,3-dihydro-2H-indol-2-one, CAS: 91713-91-6, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀BrNO₂.
(2Z)-[(1R,4R,6S)-4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-methyl-7-oxabicyclo[4.1.0]hept-2-ylidene]-acetic Acid Ethyl Ester, CAS: 326496-94-0, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₀O₄Si.
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt, CAS: 254452-96-5, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄FNO₄ •1/2Ca.
7-(4-Bromobenzoyl)-3,3-dibromo-1,3-dihydro-2H-indol-2-one, CAS: 1797880-03-5, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈Br₃NO₂.
AHR 10240 Dimer, CAS: /, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₁₈Br₂N₂O₄.
(3R,5S)-5-(3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)oxiran-2-yl)-3,5-dihydroxypentanoic Acid, CAS: 1980814-87-6, stock: 4.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄FNO₅.
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxy-N-methyl-N-((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)hept-6-enamide, CAS: 2193053-71-1, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₃FN₄O₁₀S.
2-(2-Amino-5-bromobenzoyl)-5-methylpyridine, CAS: 1798043-23-8, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrN₂O.
AHR 11652, CAS: 241825-88-7, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈BrNO₃.
(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt, CAS: 254452-88-5, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄FNO₄ •1/2Ca.
2-(2-Amino-5-bromobenzoyl)pyridine, CAS: 1563-56-0, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉BrN₂O.
2-(2-Amino-5-bromobenzoyl)pyridine-d4, CAS: 1246820-98-3, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅D₄BrN₂O.
Bromfenac Ethyl Ester, CAS: 102414-22-2, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆BrNO₃.
Bromfenac Methyl Ester, CAS: /, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄BrNO₃.
(3S,5S)-Rosuvastatin Calcium Salt, CAS: /, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇FN₃O₆S•1/2Ca.
2-Bromo-N-[4-bromo-2-(2-pyridinylcarbonyl)phenyl]-acetamide, CAS: 1694-64-0, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀Br₂N₂O₂.
2-Bromo-N-[4-bromo-2-(2-pyridinylcarbonyl)phenyl]-acetamide-d4, CAS: /, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₆D₄Br₂N₂O₂.
Bromfenac N-Allyloxycarbonyl Allyl-α-D-glucuronide, CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₈BrNO₁₁.
(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt, CAS: 254452-92-1, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄FNO₄ •1/2Ca.
(4-Chloro-2-methylphenoxy)-[(2-methoxyphenyl)methylene]hydrazide Acetic Acid, CAS: 356102-14-2, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇ClN₂O₃.
Bromfenac N-Allyloxycarbonyl Allyl-β-D-glucuronide, CAS: /, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₈BrNO₁₁.
Bromfenac N-Allyloxycarbonyl Methyl Ester, CAS: /, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆BrNO₅.
(4S)-4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Monomethyl Ester, CAS: 105580-47-0, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅Cl₂NO₄.
(4S,6R)-1-[(E)-[(1R,3aS,4E,7aR)-1-[(1R)-1,5-Dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]methyl]-1,3,4,5,6,7-hexahydro-benzo[c]thiophene-4,6-diol 2,2-Dioxide, CAS: 160796-62-3, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₄S.
3-Amino-6-bromo-4-(2-pyridinyl)-2(1H)-quinolinone, CAS: 77616-97-8, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀BrN₃O.
Bromfenac N-β-D-Glucoside, CAS: 212266-82-5, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂BrNO₈.
Bromfenac Sodium Sesquihydrate, CAS: 120638-55-3, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁BrNNaO₃•1.5H₂O.
(5-Chloro-2-methoxyphenyl)hydrazine, CAS: 202823-24-3, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉ClN₂O.
Bromfenac-d7 Sodium Sesquihydrate, CAS: 1794937-11-3, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₄D₇BrNNaO₃•1.5H₂O.
(±)-Decanoylcarnitine Chloride, CAS: 18822-87-2, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄NO₄⁺ • Cl ⁻.
Ceric Ammonium Sulfate Dihydrate, CAS: 10378-47-9, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (NH₄)₄Ce(So₄)₄ • (2H ₂O).
WAY 127039-A-1 Sodium Salt, CAS: 1391052-54-2, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉BrNNaO₄.
(E)-2-Cyanoethyl 3-Aminobut-2-enoate, CAS: 88977-32-6, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₂O₂.
(E)-3S,5R-Bis[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methyl-cyclo[4.1.0]hept-2-ylidene-ethanol, CAS: /, stock: 9.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₄O₃Si₂.
7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one, CAS: 62659-65-8, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 62659-65-8.
(E)-3S,5R-Bis[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methyl-cyclo[4.1.0]hept-2-ylidene]-acetic Acid Ethyl Ester, CAS: /, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₆O₄Si₂.
(E)-Dehydro Cilnidipine, CAS: 146845-34-3, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆N₂O₇.
7-Bromo-5-(pyridin-2-yl)-1H-benzo[e][1,4]diazepin-2(3H)-one, CAS: /, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀BrN₃O.
(E)-Ethyl 3-Hydroxy-2-((Z)-(2-hydroxy-6,6-dimethylbicyclo[3.1.1]heptan-3-ylidene)amino)octadec-4-enoate, CAS: /, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇¹³C₂H₅₀NO₄.
(E)-Ethyl Tetradec-2-enoate, CAS: 38112-60-6, stock: 10g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₀O₂.
(αR)-N-[3-[3-(Difluoromethyl)phenyl]propyl]-α-methyl-1-naphthalenemethanamine, CAS: 1025064-41-8, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃F₂N.
(αS,βS)-β-[(2-Aminophenyl)thio]-α-hydroxy-4-methoxybenzenepropanoic Acid, CAS: 42399-48-4, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇NO₄S.
(εR,1R,3aR,4S,7aR)-Octahydro-4-hydroxy-α,α,ε,7a-tetramethyl-1H-indene-1-pentanol-d6, CAS: /, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈D₆O₂.
(R)-(+)-Felodipine, CAS: 119945-59-4, stock: 8.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉Cl₂NO₄.
(R)-(+)-Felodipine-d5, CAS: 1217716-73-8, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄D₅Cl₂NO₄.
N-(4-Bromo-2-picolinoylphenyl)-2-chloroacetamide, CAS: 41526-21-0, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀BrClN₂O₂.
(R)-Afacifenacin, CAS: /, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆F₃N₃O₂.
N-(4-Bromo-2-picolinoylphenyl)-2-chloroacetamide-d4, CAS: /, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₆D₄BrClN₂O₂.
(R)-Lercanidipine Hydrochloride, CAS: 187731-34-6, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₂ClN₃O₆.
(R)-Lercanidipine-d3 Hydrochloride, CAS: 1217724-52-1, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₉D₃ClN₃O₆.
(R)-N-Benzyl-1-(1-naphthyl)ethylamine, CAS: 66469-40-7, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉N.
(R,E)-7-(4-(4-Fluorophenyl)-2-(2-hydroxy-N,2-dimethylpropylsulfonamido)-6-isopropylpyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate(Rosuvastatin Impurity), CAS: /, stock: 4.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁FN₃O₇S•1/2Ca.
(R,R)-Diltiazem Hydrochloride, CAS: 42399-54-2, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆N₂O₄S•HCl.
(S)-(+)-Manidipine Hydrochloride, CAS: 126451-47-6, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₉ClN₄O₆.
(S)-(-)-Felodipine, CAS: 105618-03-9, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉Cl₂NO₄.
(S)-(-)-Felodipine-d5, CAS: 1217744-87-0, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄D₅Cl₂NO₄.
(S)-Lercanidipine Hydrochloride, CAS: 184866-29-3, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₂ClN₃O₆.
(S)-Lercanidipine-d3 Hydrochloride, CAS: 1217740-02-7, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₉D₃ClN₃O₆.
(S)-4-(Trifluoromethyl)-phenyl Glycidyl Ether, CAS: 256372-58-4, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉F₃O₂.
(Z)-1,2-Diphenyl-1-(4-hydroxyphenyl)-1-butene, CAS: 69967-80-2, stock: 6.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀O.
(Z)-1,2-Diphenyl-1-(4-hydroxyphenyl)-1-butene (contain up to 10% E-isomer), CAS: 69967-80-2, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀O.
(Z)-3S,5R-Bis[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methyl-cyclo[4.1.0]hept-2-ylidene-ethanol, CAS: /, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₄O₃Si₂.
(Z)-Cinnamyl Cilnidipine, CAS: 146924-45-0, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈N₂O₇.
(Z)-Dehydro Cilnidipine, CAS: 146845-35-4, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆N₂O₇.
(Z)-Ethyl 2-(2,3-Dichlorobenzylidene)-3-oxobutanoate-13C4, CAS: /, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₄H₁₂Cl₂O₃.
(Z)-Flunarizine, CAS: 693765-11-6, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆F₂N₂.
(Z)-Pitavastatin Calcium Salt, CAS: 1159588-21-2, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄FNO₄•1/2Ca.
1,2,3,4-Tetrahydro-6-methyl-2,4-bis(2-nitrophenyl)-5-pyrimidinecarboxylic Acid Methyl Ester-d3 (Mixture of Diastereomers), CAS: /, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅D₃N₄O₆.
1,3-Dihydroxyacetone Dimer, CAS: 26776-70-5, stock: 5.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₆.
1,3-Propanedithiol, CAS: 109-80-8, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₈S₂.
1,4-Bis(benzhydryl)piperazine, CAS: 216581-01-0, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₀N₂.
1,4-Dihydro-2,6-dimethyl-3-(2-cyanoethoxycarbonyl)-5-ethoxycarbonyl-4-(2,3-dichlorophenyl)pyridine-13C4, CAS: /, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆¹³C₄H₂₀Cl₂N₂O₄.
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Ethyl 5-[2-(4-methyl-1-piperazinyl)ethyl] Ester, CAS: 797013-83-3, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂N₄O₆.
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Ethyl 5-[2-[(2-hydroxybenzoyl)amino]ethyl] Ester, CAS: 92565-34-9, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇N₃O₈.
1,6-Epoxyisodihydrocarvone, CAS: 39903-97-4, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₂.
1,2-Benzisoxazol-3-ylacetic Acid-13C2, CAS: /, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³C₂H₇NO₃.
1-(1-((3,3-Diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic Acid(Lercanidipine Impurity), CAS: /, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₁N₃O₆.
1-(4-(3-Bromophenyl)thiazol-2-yl)guanidine Hydrobromide, CAS: 1006032-17-2, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉BrN₄S • x HBr.
1-(5-Isoquinolinesulfonyl)-1H-hexahydro-1,4-diazepine, Dihydrochloride, CAS: 203911-27-7, stock: 5.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉Cl₂N₃O₂S.
1-(Benzyloxycarbonyl)-4-phenylpiperidine-4-carboxylic Acid, CAS: 181641-61-2, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁NO₄.
1-(Chlorophenylmethyl)-4-fluorobenzene, CAS: 365-21-9, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀ClF.
1-Benzyl-4-cyano-4-phenylpiperidine Hydrochloride, CAS: 71258-18-9, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁ClN₂.
1-Benzyl-4-phenyl-4-piperidinecarboxylic Acid Hydrochloride, CAS: 1013330-27-2, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂ClNO₂.
1-Bis(4-fluorophenyl)methyl Piperazine-d8, CAS: /, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₀D₈F₂N₂.
1-Bromo-3,4-dichlorobenzene-D2, CAS: /, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HD₂BrCl₂.
1-Bromo-4-(1-(trifluoromethyl)cyclopropyl)benzene, CAS: 1227160-18-0, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈F₃Br.
1-Cinnamylpiperazine, CAS: 18903-01-0, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈N₂.
1-Hydroxy-7,8-epoxy-vitamin D3, CAS: 2227309-93-3, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₃.
1-Keto-7,8-epoxy-vitamin D3, CAS: 2227309-94-4, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₂O₃.
1-Keto-vitamin D3, CAS: 86307-40-6, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₂O₂.
1-Methyl-1H-imidazole-2-acetic Acid Hydrochloride, CAS: 131654-57-4, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉ClN₂O₂.
1-Methyl-1H-imidazole-2-acetic Acid-d3 Hydrochloride, CAS: /, stock: 7.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆D₃ClN₂O₂.
1-Naphthylphosphoric Acid Calcium Salt, CAS: 4588-86-7, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇O₄P • 1/2Ca.
1-Stearoyl-2-arachidonoyl-sn-glycerol, CAS: 65914-84-3, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₂O₅.
1-[(2-Chlorophenyl)phenylmethyl]piperazine, CAS: 109036-15-9, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉ClN₂.
1-[4-(Diphenylmethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone, CAS: 41332-24-5, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₂N₂O.
1-[4-(Diphenylmethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone-d8, CAS: 1346599-18-5, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₄D₈N₂O.
1-[Phenyl(3,4,5-trimethoxyphenyl)methyl]piperazine Oxalate, CAS: 1177305-82-6, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₂O₃ • C ₂H₂O₄.
1-{Phenyl[2-(trifluoromethyl)phenyl]methyl}piperazine Oxalate, CAS: 1177344-03-4, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₂F₃ • C ₂H₂O₄.
1-{Phenyl[4-(trifluoromethyl)phenyl]methyl}piperazine Oxalate, CAS: 1177280-32-8, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₂F₃.C₂H₂O₄.
10-Methacryloyldecylphosphate, CAS: 85590-00-7, stock: 5.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₇O₆P.
1H,1H-Perfluoro(2,5,8,11,14-pentamethyl-3,6,9,12,15-oxaoctadecan-1-ol), CAS: 27617-34-1, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃F₃₅O₆.
1H,1H-Perfluoro(2,5,8,11-tetramethyl-3,6,9,12-tetraoxapentadecan-1-ol), CAS: 141977-66-4, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃F₂₉O₅.
1R,3R,αR-Deltamethrin, CAS: 55700-99-7, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉Br₂NO₃.
1S,3R,αR-Deltamethrin, CAS: 106454-65-3, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉Br₂NO₃.
1S,3R,αS-Deltamethrin, CAS: 64364-03-0, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉Br₂NO₃.
1S,3S,αR-Deltamethrin, CAS: 64364-01-8, stock: 7.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉Br₂NO₃.
1S,3S,αS-Deltamethrin, CAS: 64364-02-9, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉Br₂NO₃.
2,2-Bis(3,5-difluoro-4-hydroxyphenyl)hexafluoropropane, CAS: 114611-30-2, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₆F₁₀O₂.
2,2’-(4-10-bis(2,3-dihydoxy-1-(hydroxymethyl)propyl)-1,4,7-10-tetraazacyclododecane-1,7-diyl)diacetic Acid Dicalcium Salt, CAS: /, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂N₄O₉ • 2Ca ²⁺.
2,2’-[1,2-Diazenediylbis(4,1-phenyleneimino)bis[N,N,N-triethyl-2-oxo-ethanaminium] Dichloride, CAS: /, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₄Cl₂N₆O₂.
2,3-Anhydro Rosuvastatin Calcium Salt, CAS: /, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(C₂₂H₂₇FN₃O₅S⁻)•Ca²⁺.
2,3-Dichlorotoluene, CAS: 32768-54-0, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆Cl₂.
2,3-Dihydro-1,4-benzodioxin-2-carboxylic Acid Ethyl Ester, CAS: 4739-94-0, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂O₄.
2,6-Bis(3,4-dimethoxyphenyl)-2,6-diisopropylheptanedinitrile, CAS: /, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₉ClN₂O₄.
2,6-Dibromo-4-chloroaniline-D1, CAS: /, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃DBr₂ClN.
2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid monomethyl ester, CAS: 64603-72-1, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄N₂O₆.
2-(1-Naphthalenylcarbonyl)propanedinitrile, CAS: 1236038-48-4, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈N₂O.
2-(2-Isopropyl-5-methylphenoxy)ethanamine, CAS: 26583-34-6, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉NO.
2-(3,4-Dimethoxyphenyl)-2-isopropyl-d7-5-oxopentanenitrile, CAS: /, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₆NO₃.
2-(3,4-Dimethoxyphenyl)-N-methylethylamine, CAS: 3490-06-0, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO₂.
2-(3-Chlorophenyl)-2-methylpropan-1-amine, CAS: 92015-24-2, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄ClN.
(2-Amino-5-bromophenyl)methanol, CAS: 20712-12-3, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NOBr.
2-Amino-5-methylhexane, CAS: 28292-43-5, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₇N.
2-(2-Bromoethoxy)-4-methyl-1-nitro-benzene, CAS: 96315-07-0, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀BrNO₃.
2-Furoyl-LIGRLO-amide, CAS: 729589-58-6, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₃N₁₁O₈.
2-Chloro-α-fluorobenzene-d4-propanoic Acid, CAS: /, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₄D₄ClFO₂.
1,4-Bis[(4-chlorophenyl)phenylmethyl]piperazine Dihydrochloride, CAS: 856841-95-7, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₀Cl₄N₂.
(D)-2-Bromo-3-phenylpropionic Acid, CAS: 42990-55-6, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉BrO₂.
(E)-(3-Chloroprop-1-enyl)-4-bromobenzene, CAS: 104293-07-4, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈ClBr.
2-Chloro-α-fluorobenzenepropanoic Acid, CAS: 1273308-43-2, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈ClFO₂.
Buclizine (piperazine-d8) Dihydrochloride, CAS: /, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₇D₈Cl₃N₂.
Buclizine, Dihydrochloride, CAS: 129-74-8, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₇Cl₃N₂.
(L)-2-Bromo-3-phenylpropionic Acid, CAS: 35016-63-8, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉BrO₂.
(S)-3-Amino-3-(2-bromo-phenyl)-propionic acid, CAS: 275826-34-1, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀BrNO₂.
(S)-3-Amino-3-(3-bromo-phenyl)-propionic acid, CAS: 275826-35-2, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀BrNO₂.
2-Hydroxydodecanedioic Acid, CAS: 74661-16-8, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₅.
2-Methyllamotrigine Methanesulfonate, CAS: 1152091-69-4, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃Cl₂N₅O₃S.
1,1’-Selenobis[4-bromobenzene], CAS: 33834-56-9, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈Br₂Se.
1,2,3-Tribromobenzene, CAS: 608-21-9, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₃.
2-Methylthio-ADP Trisodium Salt, CAS: 475193-31-8, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇N₅O₁₀P₂S • 3Na.
2-Naphthyl Phosphate Calcium Salt Hydrate, CAS: 305808-24-6, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉O₄P • (Ca) • X(H ₂O).
1,2,4-Tribromobenzene, CAS: 615-54-3, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₃.
1,2-Bis(2,4,6-tribromophenoxy)ethane, CAS: 37853-59-1, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈Br₆O₂.
1,2-Bis(2,4,6-tribromophenoxy)ethane-13C12, CAS: /, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₁₂H₄Br₆O₂.
1,2-Bis(2,4,6-tribromophenoxy)ethane-d4, CAS: 1794620-64-6, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₄D₄Br₆O₂.
1,2-Bis(benzyloxy)-4-bromobenzene, CAS: 16047-57-7, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇O₂Br.
1,2-Dibromobenzene, CAS: 583-53-9, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂.
1,3,5-Tribromo-2-methoxy-4-methylbenzene, CAS: 41424-36-6, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇Br₃O.
2-[(5-Ethyl-1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)thio]-N-[4-(4-methoxyphenyl)-2-thiazolyl]acetamide, CAS: 552309-42-9, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀N₄O₃S₂.
1,3,5-Tribromobenzene, CAS: 626-39-1, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₃.
1,3-Dibromobenzene, CAS: 108-36-1, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂.
2-[4-(3-Methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide, CAS: 1146395-46-1, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁N₄O₂F₃.
1,4-Bis(2-chloroethoxy)-2,5-dibromobenzene, CAS: 178557-12-5, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀Br₂Cl₂O₂.
1,4-Dibromo-2,5-diiodobenzene, CAS: 63262-06-6, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂Br₂I₂.
2-[4-[(4-Nitrophenyl)methoxy]phenyl]ethyl Ester Carbamimidothioic Acid, CAS: 182004-64-4, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₃S.
1,4-Dibromo-2,5-dimethylbenzene, CAS: 1074-24-4, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈Br₂.
1,4-Dibromobenzene, CAS: 106-37-6, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂.
22-(4-Hydroxyphenyl)-23,24,25,26,27-pentanor Vitamin D3, CAS: 168408-60-4, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈O₂.
22-Oxa-9,25-dihydroxyvitamin D3, CAS: /, stock: 8.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₂O₄.
1,4-Diethyl 2-Bromobenzene-1,4-dicarboxylate, CAS: 154239-21-1, stock: 10g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃BrO₄.
1,4-dimethyl 2-bromobenzene-1,4-dicarboxylate, CAS: 18643-86-2, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉BrO₄.
23-Bromo-A-23187, CAS: 76455-82-8, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₆BrN₃O₆.
25-Hydroxy Vitamin D3 3,3’-(4-Maleimidopropanamide)propyl Ether, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₅₆N₂O₅.
1-(2-(Benzyloxy)ethoxy)-2-bromobenzene, CAS: 223555-55-3, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅BrO₂.
1-(2-Aminoethoxy)-3-bromobenzene Hydrochloride, CAS: 1193388-09-8, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀NOBr.HCl.
25-Hydroxyvitamin D3 25-Sulfate-d6 Sodium Salt, CAS: /, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇D₆NaO₅S.
25-Hydroxyvitamin D3 3-Glucuronide >90%, CAS: 170512-14-8, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₂O₈.
1-(4-Boc-Piperazino)-3,5-dibromobenzene, CAS: 1121596-44-8, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀Br₂N₂O₂.
1-(4-Bromobenzene)sulfonylpyrazole, CAS: 560105-21-7, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇BrN₂O₂S.
25-Hydroxyvitamin D3 3-Glucuronide-d6, CAS: /, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₆D₆O₈.
25-Hydroxyvitamin D3 3-Hemisuccinate, CAS: 69511-19-9, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₈O₅.
1-(4-Bromobenzenesulfonyl)-4-isocyanatopiperidine, CAS: 1016842-31-1, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₂O₃SBr.
25-Hydroxyvitamin D3 3-Hemisuccinate-13C4 (90%), CAS: /, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇¹³C₄H₄₈O₅.
25-Hydroxyvitamin D3 3-Hemisuccinate-d6, CAS: /, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₂D₆O₅.
1-(azidomethyl)-2-bromobenzene, CAS: 126799-87-9, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₃Br.
1-(Benzyloxy)-2,4-dibromobenzene, CAS: 856380-98-8, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀OBr₂.
1-(Benzyloxy)-3-bromobenzene, CAS: 53087-13-1, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrO.
1-(N-Boc-Piperidin-4-ylmethoxy)-3,5-dibromobenzene, CAS: 1257665-16-9, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₃Br₂NO₃.
1-Allyl-2-bromobenzene, CAS: 42918-20-7, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉Br.
1-Benzyl-3-bromobenzene, CAS: 27798-39-6, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁Br.
3,5-Didesamino-3,5-dioxo 6-(3-deschloro-4-chloro) Lamotrigine, CAS: /, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅Cl₂N₃O₂.
1-Benzyloxy-4-bromobenzene, CAS: 6793-92-6, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrO.
1-Bromo-2,3-dichlorobenzene, CAS: 56961-77-4, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂.
3-(4-Maleimidoacetamido)propyl-25-Hydroxy-Vitamin D3, CAS: /, stock: 1.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₄N₂O₅.
1-Bromo-2,3-dimethyl-benzene, CAS: 576-23-8, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-5-methyl-1,5-benzothiazepin-4(5H)-one, CAS: 2067323-40-2, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉NO₄S.
1-Bromo-2,4-dichloro-3-methylbenzene, CAS: 127049-87-0, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅BrCl₂.
1-Bromo-2,4-difluorobenzene, CAS: 348-57-2, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂.
3-(Bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline, CAS: 154057-56-4, stock: 5.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅BrFN.
3-Acetoxy-2-oxopropanol Dimer, CAS: /, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₈.
1-Bromo-2,4-dinitrobenzene, CAS: 584-48-5, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrN₂O₄.
1-Bromo-2,4-dinitrobenzene-d3, CAS: 1313734-81-4, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₃BrN₂O₄.
3-Acetoxy-2-oxopropanol-13C2 Dimer, CAS: /, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₄H₁₆O₈.
3-Amino-5-chloropyridine, CAS: 22353-34-0, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅N₂Cl.
1-Bromo-2,6-dichlorobenzene, CAS: 19393-92-1, stock: 5.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂.
3-Deoxy-D-arabino-hexonic Acid δ-Lactone 2,4,6-Triacetate, CAS: 72599-57-6, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O₈.
1-Bromo-2-chlorobenzene, CAS: 694-80-4, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrCl.
3-Bromo-6-chloroimidazo[1,2-b]pyridazine, CAS: 13526-66-4, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClN₃.
1-Bromo-2-fluorobenzene, CAS: 1072-85-1, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrF.
1-Bromo-2-iodobenzene, CAS: 583-55-1, stock: 6.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrI.
3-Chloroprionaldehyde Diethyl Acetal, Technical grade(Stabilized with 0.5% Calcium Carbonate), CAS: 35573-93-4, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₅ClO₂.
1-Bromo-2-methyl-4-(trifluoromethoxy)benzene, CAS: 261951-96-6, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrF₃O.
1-Bromo-2-nitrobenze, CAS: 577-19-5, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO₂.
3-Deoxy-D-arabino-hexonic Acid Calcium Salt, CAS: 79580-64-6, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄CaO₁₂.
3-Deoxy-D-erythro-hex-2-enonic Acid δ-Lactone 2,4,6-Triacetate, CAS: 22860-23-7, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₈.
1-Bromo-2-nitrobenze-d4, CAS: 1020720-09-5, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₄BrNO₂.
1-Bromo-3,4-dimethoxy-2-propylbenzene, CAS: 142601-49-8, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅BrO₂.
3-Desoxyvitamin D3, CAS: 69662-75-5, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄.
1-Bromo-3,5-bis(phenylmethoxy)benzene, CAS: 128924-04-9, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇BrO₂.
3-Ethyl 5-Methyl 2-((2-acetamidoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate, CAS: 93848-82-9, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇ClN₂O₆.
3-Iodo-3H-pyrazolo[3,4-d]pyrimidin-4-amine, CAS: 151266-23-8, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄IN₅.
1-Bromo-3,5-difluorobenzene, CAS: 461-96-1, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂.
1-Bromo-3,5-dimethoxybenzene, CAS: 20469-65-2, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO₂.
3-Isobutylglutaric Anhydride, CAS: 185815-59-2, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄O₃.
3-Methyl-2-oxobutyric Acid Calcium Salt, CAS: 51828-94-5, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄CaO₆.
1-Bromo-3-(trifluoromethyl)benzene, CAS: 401-78-5, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₃.
3-Methyl-2-oxovaleric acid calcium salt, CAS: 66872-75-1, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₆Ca.
3-Methyl-2-phenylbutanenitrile, CAS: 5558-29-2, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N.
1-Bromo-3-ethylbenzene, CAS: 2725-82-8, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
1-Bromo-3-methylbenzene-d3, CAS: 15169-02-5, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄D₃Br.
3-O-(2-Cyanoethyl)-25-hydroxyvitamin D3, CAS: /, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₇NO₂.
1-Bromo-3-phenoxybenzene, CAS: 6876-00-2, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉BrO.
1-Bromo-3-vinylbenzene, CAS: 2039-86-3, stock: 2.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇Br.
1-Bromo-4-butoxybenzene, CAS: 39969-57-8, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃BrO.
1-Bromo-4-cyclopropylbenzene, CAS: 1124-14-7, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉Br.
1-Bromo-4-ethylbenzene, CAS: 1585-07-5, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
1-Bromo-4-hexylbenzene, CAS: 23703-22-2, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇Br.
3-Propylnitrile Vitamin D3, CAS: /, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₇NO.
32a-Glycine-calcitonin (Salmon), CAS: 115472-96-3, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄₇H₂₄₂N₄₄O₅₀S₂.
1-Bromo-4-iodobenzene, CAS: 589-87-7, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrI.
1-Bromo-4-iodobenzene-13C6, CAS: 1261170-84-6, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₄BrI.
3’-Sulphated Lewis X, Methyl Glycoside, CAS: /, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₇NO₁₈S.
1-Bromo-4-nitrobenzene-d4, CAS: 350820-19-8, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₄BrNO₂.
4,6-Dichloro-3-fluoro-1H-pyrazolo[3,4-d]pyrimidine, CAS: /, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅HCl₂FN₄.
1-Bromobenzene, CAS: 108-86-1, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅Br.
1-Bromobenzene-13C6, CAS: 112630-77-0, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₅Br.
4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Monomethyl Ester Brucine Salt, CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₁Cl₂N₃O₈.
1-N-Benzyl-2-bromobenzene-1,4-diamine, CAS: 1248984-11-3, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃BrN₂.
1-[(1-amino-2-methylpropan-2-yl)sulfanyl]-4-bromobenzene, CAS: 1354952-56-9, stock: 8.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄NSBr.
(8S)-2-Bromo-α-Ergocryptine, CAS: 65700-36-9, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀BrN₅O₅.
4-(Chloromethyl)piperidine Hydrochloride, CAS: 1822-61-3, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂ClN • HCl.
1-[(1-aminopropan-2-yl)sulfanyl]-4-bromobenzene hydrochloride, CAS: 1269152-10-4, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂NSBr.HCl.
1-[(3-Bromobenzene)sulfonyl]-4-methylhomopiperazine, CAS: 1183118-31-1, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₂O₂SBr.
2-Bromo α-Ergocryptine Mesylate, CAS: 22260-51-1, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₄BrN₅O₈S.
5’-Isobromocriptine, CAS: 68944-89-8, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀BrN₅O₅.
4-(Diphenylmethylene)piperidine Trifluoroacetate, CAS: 1219623-79-6, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀F₃NO₂.
4-Aminosalicylic Acid Calcium Salt Heptahydrate, CAS: 133-15-3, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂CaN₂O₆.
1-[(3-Bromobenzene)sulfonyl]homopiperidine, CAS: 1022438-79-4, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆NO₂SBr.
1-[(4-aminobutyl)sulfanyl]-2-bromobenzene hydrochloride, CAS: 1311316-15-0, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄NSBr.HCl.
BromocriptineDiscontinued, B682600, CAS: 25614-03-3, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀BrN₅O₅.
Bromocriptine 2-Methylbutyl Analogue, CAS: 157135-98-3, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₂BrN₅O₅.
4-Amino-2,3,5-trimethylphenol, CAS: 10486-46-1, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO.
4-[Bis(2-methoxy-2-oxoethyl)amino]-3-[2-[2-[bis(2-methoxy-2-oxoethyl)amino]-5-methylphenoxy]ethoxy]-benzoate, CAS: /, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₄₀N₂O₁₂.
1-[(4-Bromobenzene)sulfonyl]-4-nitrobenzene, CAS: 75124-91-3, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈BrNO₄S.
1-[(4-Bromobenzene)sulfonyl]homopiperidine, CAS: 153439-48-6, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆NO₂SBr.
Tricaprin, CAS: 621-71-6, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₆₂O₆.
Tricaprin-d5, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₇D₅O₆.
4-Bromo-2-methyl-1-butene, CAS: 20038-12-4, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉Br.
1-[(4-Bromobenzene)sulfonyl]thiomorpholine, CAS: 223555-81-5, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂NO₂S₂Br.
1-[2-(4-Bromobenzenesulfonyl)ethyl]piperazine, CAS: 1094558-34-5, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₂O₂SBr.
4-Bromo-7-methyl-2,1,3-benzoxadiazole, CAS: 1543042-61-0, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅BrN₂O.
1-[2-(4-bromobenzenesulfonyl)ethyl]piperidin-3-amine, CAS: 1303755-33-0, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₂O₂SBr.
1-[2-(4-bromobenzenesulfonyl)ethyl]piperidin-3-ol, CAS: 1311314-89-2, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈NO₃SBr.
4-Bromopyridine-2-carboxaldehyde, CAS: 131747-63-2, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO.
4-Chlorobenzoyl-L-tryptophan Calcium Salt, CAS: 56116-62-2, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₂₈N₄O₆Cl₂Ca.
1-[2-(4-Bromobenzenesulfonyl)ethyl]piperidin-4-ol, CAS: 1000927-51-4, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈NO₃SBr.
1-[2-(aminomethyl)butyl]-3-bromobenzene, CAS: 1250487-78-5, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆NBr.
4-Cyano-2-methylpyridine, CAS: 2214-53-1, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₂.
4-Defluoro 2-Fluoro Flunarizine Dihydrochloride, CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆F₂N₂ • 2(HCl).
1-{2-[(2-Aminoethyl)sulfanyl]ethoxy}-3-bromobenzene, CAS: 1082443-87-5, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄NOSBr.
2,2’,4,4’,6,6’-Hexabromo-bibenzyl, CAS: *, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈Br₆.
4-Diphenylmethylpiperidine, CAS: 19841-73-7, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁N.
2,3,4,5,6-Pentabromobenzyl Alcohol, CAS: 79415-41-1, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Br₅O.
2,3,5,6-Tetrabromo-p-xylene, CAS: 23488-38-2, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆Br₄.
2,3,5,6-Tetrabromo-p-xylene-d6, CAS: 1007458-87-8, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈D₆Br₄.
2,3-Dibromophenol, CAS: 57383-80-9, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂O.
2,3-Dichloro-5-fluorobromobenzene, CAS: 1000577-58-1, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂FCl₂Br.
2,4,2’,4’-Tetrabromodiphenyl Ether, CAS: 5436-43-1, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₆Br₄O.
4-Isopropyl-2-pyridinecarboxylic Acid, CAS: 83282-36-4, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₂.
4-Methyl-α-phenylbenzenemethanol, CAS: 1517-63-1, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O.
2,4,2’,4’-Tetrabromodiphenyl Ether-13C6, CAS: /, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₆H₆Br₄O.
4’-Hydroxy rac-Kavain, CAS: 1401441-87-9, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O.
4’-Hydroxy rac-Kavain-d3, CAS: /, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁D₃O₄.
2,4,6-Tribromobenzenesulfonyl Chloride, CAS: 115876-73-8, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂O₂SClBr₃.
2,4,6-Tribromoiodobenzene, CAS: 21521-51-7, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂Br₃I.
2,4-Dibromobenzeneacetic Acid, CAS: 98434-44-7, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆O₂Br₂.
2,4-Dibromobenzenesulfonyl chloride, CAS: 72256-95-2, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₂ClO₂S.
4’-Sulphated Lewis X, Methyl Glycoside, CAS: /, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₇NO₁₈S.
4’Hydroxy-7,8-dehydro Kavain-d3, CAS: /, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃D₃O₄.
2,4-dichlorobromobenzene, CAS: 1193-72-2, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂.
2,5-Bis(hexyl)-1,4-dibromobenzene, CAS: 117635-21-9, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈Br₂.
4’Hydroxy-7,8-dihydro Kavain, CAS: 1174388-25-0, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆O₄.
5,10-Diformyl-5,6,7,8-tetrahydro Folic Acid Calcium Salt Hydrate, CAS: /, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅CaN₇O₉.
2,5-Bis(trifluoromethyl)bromobenzene, CAS: 7617-93-8, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃BrF₆.
2,5-Dibromobenzenesulfonamide, CAS: 7467-11-0, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NO₂SBr₂.
5,10-Diformyl-5,6,7,8-tetrahydro Folic Acid-D4 Calcium Salt Hydrate (Technical Grade), CAS: /, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇D₄CaN₇O₈ • x(H ₂O).
5,5’-(Methylazanediyl)bis(2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile), CAS: /, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₈ClN₃O₄.
2,5-Dibromobenzenesulfonyl Chloride, CAS: 23886-64-8, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₂ClO₂S.
2,5-Dibromonitrobenzene, CAS: 3460-18-2, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Br₂NO₂.
5,5’-Dinitro-BAPTA-tetramethyl Ester, CAS: 125367-35-3, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀N₄O₁₄.
5,6-Dihydro-6-ethenyl-4-hydroxy-2H-pyran-2-one, CAS: 117081-50-2, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈O₃.
2,5-Dimethylbromobenzene, CAS: 553-94-6, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
2,6-Bis(trifluoromethyl)bromobenzene, CAS: 118527-30-3, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃BrF₆.
5,6-trans-Alfacalcidol, CAS: 65445-14-9, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₂.
5-(3-Chloro-4-fluorophenyl)-3-methyl-3-(pyrimidin-5-ylmethyl)-1-(1H-1,2,4-triazol-3-yl)indolin-2-one, CAS: 1141080-15-0, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆N₆OFCl.
2,6-Dibromobenzene-1,4-diamine, CAS: 29213-03-4, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆Br₂N₂.
2,6-Dibromobenzene-1,4-diol, CAS: 3333-25-3, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂O₂.
5-(Chloromethyl)-3-[1-(4-chlorophenyl)cyclopropyl]-1,2,4-oxadiazole, CAS: 1021436-61-2, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀Cl₂N₂O.
2,6-Dibromobenzenesulfonyl Chloride, CAS: 184170-43-2, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃O₂SClBr₂.
2-(2,5-Dibromophenyl)acetic Acid, CAS: 203314-28-7, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆Br₂O₂.
5-(Methyl-d3)tetrahydrofolic Acid Calcium Salt (Mixture of Diastereomers), CAS: /, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀D₃CaN₇O₆.
5-Amino-1-(1,1-dimethylethyl)-3-[(3-methylphenyl)methyl]-1H-pyrazole-4-carbonitrile, CAS: /, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂N₄.
2-(2-Amino-3,5-dibromophenyl)cyclohexanol, CAS: /, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅Br₂NO.
2-(2-Bromophenyl)ethanol, CAS: 1074-16-4, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
5-(Ethoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylic Acid, CAS: 74936-73-5, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₂O₆.
5-Bromo-6-chloro-2,2-difluorobenzo[d][1,3]dioxole, CAS: 869188-52-3, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂BrClF₂O₂.
2-(2-Pyridyl)imidazole, CAS: 18653-75-3, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇N₃.
2-(3-Bromophenyl)ethanamine, CAS: 58971-11-2, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀NBr.
5-Chloro Lamotrigine, CAS: 77668-56-5, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆Cl₃N₅.
5-Ethyl-demethyl Lercanidipine, CAS: 786625-22-7, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₃N₃O₆.
(2R)-Propyl-butanedioic Acid 4-(1,1-Dimethylethyl) Ester, CAS: /, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₇O₄.
2-(4-Bromobenzenesulfonyl)-2-methylpropan-1-amine, CAS: 1235438-92-2, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄NO₂SBr.
2-(4-Bromobenzenesulfonyl)-2-methylpropanenitrile, CAS: 1178187-96-6, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀NO₂SBr.
5-Hydroxyvitamin D3 25-Glucuronide, CAS: 84344-78-5, stock: 8.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₂O₈.
5-Hydroxyvitamin D3 25-Glucuronide-d6, CAS: /, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₆D₆O₈.
(4S)-Brivaracetam, CAS: 357336-19-7, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀N₂O₂.
(4S)-Brivaracetam-d7, CAS: /, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₇N₂O₂.
2-(Benzyloxy)bromobenzene, CAS: 31575-75-4, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrO.
2-(Morpholine-4-carbonyl)-4-fluoro-1-bromobenzene, CAS: 951884-11-0, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁BrFNO₂.
5-Keto-D-gluconic Acid Hemicalcium Salt, CAS: 3470-36-8, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉O₇ • 1/2Ca.
5-Methyltetrahydrofolic Acid Calcium Salt Hydrate, CAS: /, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃CaN₇O₆ •xH₂O.
(R)-3-(Hydroxymethyl)-N-((S)-1-phenylethyl)hexanamide, CAS: /, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃NO₂.
(S)-3-(Hydroxymethyl)-N-((S)-1-phenylethyl)hexanamide, CAS: /, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃NO₂.
2-(S-Butylthiomethyl)-1-bromobenzene, CAS: 1309978-21-9, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅BrS.
2-(S-Cyclopentylthiomethyl)-1-bromobenzene, CAS: 1309978-20-8, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅BrS.
1-(1,1-Dimethylethyl) 2,2-Dimethyl Ester 1,2,2-Pentanetricarboxylic Acid-d7, CAS: /, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇D₇O₆.
2-Propyl-butanedioic Acid 4-(1,1-Dimethylethyl) 1-Methyl Ester-d7, CAS: /, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅D₇O₄.
2-(S-Isopropylthiomethyl)-1-bromobenzene, CAS: 1251123-28-0, stock: 7.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃SBr.
2-(S-Propylthiomethyl)-1-bromobenzene, CAS: 1248980-51-9, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃SBr.
5-Oxo Rosuvastatin, CAS: 1422619-13-3, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆FN₃O₆S.
5-Oxorosuvastatin Methyl Ester, CAS: 147118-39-6, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈FN₃O₆S.
3-(Hydroxymethyl)-hexanoic Acid 1,1-Dimethylethyl Ester-d7, CAS: /, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅D₇O₃.
Brivaracetam, CAS: 357336-20-0, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀N₂O₂.
2-Adamantyl-1-benzyloxy-4-bromobenzene, CAS: 736992-49-7, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅BrO.
2-Amino-1-(4-bromophenyl)-1-ethanol, CAS: 41147-82-4, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀NOBr.
5β-Cholestane-3β,5,6β-triol, CAS: 79254-30-1, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₈O₃.
Brivaracetam-d7, CAS: 1202896-51-2, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₇N₂O₂.
Brivaracetam-d7 (Mixture of Diastereomers), CAS: /, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₇N₂O₂.
2-Amino-5-bromobenzenethiol, CAS: 23451-95-8, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NSBr.H₂O.
2-Bromo-4,5-dimethoxytoluene, CAS: 52806-46-9, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁BrO₂.
5β-Cholestane-3β,5,6β-triol-d7, CAS: /, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₁D₇O₃.
6,7-Dihydro O-Butyl-rosuvastatin, CAS: /, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₈FN₃O₆S.
Dimethyl 2-Propylmalonate-d7, CAS: /, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇D₇O₄.
αR,4S-Brivaracetam, CAS: 357336-99-3, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀N₂O₂.
2-Bromo-1,3-difluorobenzene, CAS: 64248-56-2, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂.
6,7-Dihydro Rosuvastatin Acetonide tert-Butyl Ester, CAS: /, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₂FN₃O₆S.
6,7-Dihydro Rosuvastatin Sodium Salt, CAS: 1347362-67-7, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉FN₃NaO₆S.
αR,4S-Brivaracetam-d7, CAS: /, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₇N₂O₂.
αR-Brivaracetam, CAS: 357337-00-9, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀N₂O₂.
2-Bromo-1,4-dichlorobenzene, CAS: 1435-50-3, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂.
6-(2-Phenylethenyl)oxane-2,4-dione, CAS: 57012-11-0, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂O₃.
6-(Trifluoromethyl)pyridine-2-carbaldehyde, CAS: 131747-65-4, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄NOF₃.
αR-Brivaracetam-d7, CAS: /, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₇N₂O₂.
rac-Brivaracetam, CAS: 357335-87-6, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀N₂O₂.
2-Bromo-benzenethiol, CAS: 01/02/6320, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BrS.
2-Bromo-m-xylene, CAS: 576-22-7, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
6-Cyano-2-methylpyridine, CAS: 1620-75-3, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₂.
6-epi-Medroxy Progesterone 17-Acetate, CAS: 2242-65-1, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄O₄.
rac-Brivaracetam-d7, CAS: /, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃D₅N₂O₂.
tert-Butyl 3-((((R)-1-Amino-1-oxobutan-2-yl)amino)methyl)hexanoate-d7, CAS: /, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃D₇N₂O₃.
2-Bromoaniline, CAS: 615-36-1, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrN.
2-Bromoaniline-d4, CAS: 1643564-99-1, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₄BrN.
7,8-Epoxy-vitamin D3, CAS: 89231-90-3, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₂.
7-Chloro-1,5-dihydro-5-[2-(1-methylethyl)phenyl]-4,1-benzothiazepin-2(3H)-one, CAS: 1802013-08-6, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClNOS.
2-bromobenzene-1,4-diamine, CAS: 13296-69-0, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇N₂Br.
7-Chloro-1,5-dihydro-5-(2-methylphenyl)-4,1-benzothiazepin-2(3H)-one, CAS: 488829-66-9, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄ClNOS.
7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid, CAS: 52029-86-4, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₀N₂O₃.
2-Bromobenzenesulfonamide, CAS: 92748-09-9, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₂S.
2-Bromobenzenesulfonyl Chloride, CAS: 2905-25-1, stock: 1.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrClO₂S.
8-bromo-cGMP sodium salt, CAS: 51116-01-9, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀BrN₅NaO₇P.
9,10-Dehydro Folitixorin Chloride, CAS: 804563-04-0, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂ClN₇O₆.
2-Bromobenzenesulfonyl fluoride, CAS: 1373232-47-3, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrFO₂S.
2-Bromobenzonitrile, CAS: 2042-37-7, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrN.
9,10-Dehydro Folitixorin-(Imidazo-pteridin-d4) Chloride, CAS: /, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀D₄ClN₇O₆.
9,10-Dehydro Folitixorin-(phenylene-d4) Chloride, CAS: /, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀D₄ClN₇O₆.
2-Bromobenzyl Alcohol, CAS: 18982-54-2, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BrO.
9-[4-[Bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]-3-[2-[2-[bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]-5-methylphenoxy]ethoxy]phenyl]-3,6-bis(dimethylamino)-d12-xanthylium Bromide, CAS: /, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₄₇D₁₂BrN₄O₁₉.
2-Bromobenzyl Bromide, CAS: 3433-80-5, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆Br₂.
2-Bromoisophthaldehyde, CAS: 79839-49-9, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅BrO₂.
9-[4-[Bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]-3-[2-[2-[bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]-5-methylphenoxy]ethoxy]phenyl]-3,6-bis(dimethylamino)xanthylium Bromide, CAS: 145037-81-6, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₅₉BrN₄O₁₉.
A23187, CAS: 52665-69-7, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₇N₃O₆.
2-Bromomesitylene, CAS: 576-83-0, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁Br.
2-Bromophenol Acetate, CAS: 1829-37-4, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BrO₂.
ABP 688, CAS: 924298-51-1, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆N₂O.
ABT-639 Hydrochloride, CAS: 1235560-31-2, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀ClF₂N₃O₃S • HCi.
2-Bromophenylethylamine, CAS: 65185-58-2, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrN.
AC-265347, CAS: 1253901-26-6, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇NOS.
2-Bromostyrene, CAS: 2039-88-5, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇Br.
2-Bromotoluene, CAS: 95-46-5, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇Br.
2-[2-(4-Bromophenoxy)ethyl]-5-ethylpyridine Hydrogen Sulfate Salt, CAS: /, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈BrNO₅S.
2-[2-(4-Bromophenoxy)ethyl]-5-ethylpyridine-d4, CAS: 1346598-69-3, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂D₄BrNO.
Acid Fuchsin Calcium Salt, CAS: 136132-76-8, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇N₃O₉S₃Ca.
2-[N-(Butan-2-yl)2-bromobenzenesulfonamido]acetic Acid, CAS: 1183039-02-2, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆NO₄SBr.
2-[N-(Butan-2-yl)3-bromobenzenesulfonamido]acetic Acid, CAS: 1183427-49-7, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆NO₄SBr.
Adenosine 3’,5’-Bisphosphate Dicalcium Hydrate, CAS: /, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₇N₅O₁₈P₂.
2’,3,4-Tribromodiphenyl Ether, CAS: 147217-78-5, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₇Br₃O.
2’-Bromoacetanilide, CAS: 614-76-6, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈BrNO.
Adenosine 5′-Diphosphate bis(Cyclohexylammonium) Salt, CAS: 102029-87-8, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O₁₀P₂ • 2(C ₆H₁₃N).
Adenosine Cyclic 2’,3’-Phosphate 5’-Phosphate, CAS: 4527-92-8, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃N₅O₉P₂.
3,4,5-tribromobenzene-1-sulfonyl chloride, CAS: 1261684-47-2, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂O₂SClBr₃.
3,4-Difluoro-2-methylbromobenzene, CAS: 847502-81-2, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅BrF₂.
Afacifenacin, CAS: 877606-63-8, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆F₃N₃O₂.
AH 7614, CAS: 03/06/6326, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇NO₃S.
3,4-Difluoro-2-trifluoromethyl-bromobenzene, CAS: 1242339-23-6, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂BrF₅.
3,5-Bis(trifluoromethyl)bromobenzene, CAS: 328-70-1, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃BrF₆.
Alfacalcidol, CAS: 41294-56-8, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₂.
Alfacalcidol-d7, CAS: /, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇D₇O₂.
3,5-Difluoro-4-(trifluoromethoxy)bromobenzene, CAS: 115467-07-7, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂BrF₅O.
3,5-Difluoro-4-(trifluoromethyl)bromobenzene, CAS: 156243-64-0, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂BrF₅.
Alinidine, CAS: 33178-86-8, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃Cl₂N₃.
Amauromine, CAS: 88360-87-6, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₆N₄O₂.
3,5-Dihydroxybromobenzene, CAS: 106120-04-1, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅O₂Br.
3-(4-Bromobenzenesulfonamido)propanoic Acid, CAS: 116035-58-6, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀NO₄SBr.
Aminoguanidinium-13C Bicarbonate, CAS: /, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CH₆N₄ • CH ₂O₃.
3-Acetyl-4-bromobenzene-1-sulfonyl Chloride, CAS: 1152558-80-9, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆O₃SClBr.
3-Bromophenylboronic Acid, CAS: 89598-96-9, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BBrO₂.
3-Bromo-5-methylbenzonitrile, CAS: 124289-21-0, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrN.
3-Bromoaniline, CAS: 591-19-5, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrN.
3-Bromoaniline-d4, CAS: 81395-17-7, stock: 7.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₄BrN.
3-Bromobenzene-1,2-diamine, CAS: 1575-36-6, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇BrN₂.
3-Bromobenzene-1,2-diamine Hydrochloride, CAS: 1187830-74-5, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇N₂Br • HCl.
3-Bromobenzene-1,2-diol, CAS: 14381-51-2, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅O₂Br.
3-Bromobenzenecarbothioamide, CAS: 2227-62-5, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrNS.
3-Bromobenzenesulfonamide, CAS: 89599-01-9, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₂S.
Ammonium Hexacyanoferrate(II), CAS: 14481-29-9, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₆FeN₁₀.
anti- Calcium Sensing Receptor antibody, CAS: /, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
3-Bromobenzenesulfonyl Chloride, CAS: 2905-24-0, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrClO₂S.
3-Bromobenzenesulfonyl fluoride, CAS: 454-65-9, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrFO₂S.
Antibiotic TS 155-2, CAS: 303009-07-6, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₆₀O₁₁.
Arsenazo III, CAS: 1668-00-4, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈As₂N₄O₁₄S₂.
3-Bromonitrobenzene, CAS: 585-79-5, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO₂.
3-Bromonitrobenzene-d4, CAS: 81395-16-6, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₄BrNO₂.
Arsenazo-I Trisodium Hydrate, CAS: /, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀AsN₂Na₃O₁₁S₂ •xH₂O.
3-Bromophenyl tert-Butyldimethylsilyl Ether, CAS: 65423-56-5, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉BrOSi.
3-Bromophenylacetic Acid, CAS: 1878-67-7, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BrO₂.
3-Bromothiophenol, CAS: 6320-01-0, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅SBr.
3-Fluoro-5-morpholino-1-bromobenzene, CAS: 1129541-62-3, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁BrFNO.
3-Nitro-4-(trifluoromethoxy)bromobenzene, CAS: 95668-20-5, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NO₃F₃Br.
Atractyloside Calcium Salt, CAS: /, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₃Ca₁.₅O₁₆S₂.
3-[(4-Bromobenzene)sulfonyl]azetidine, CAS: 1706448-67-0, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀BrNO₂S.
3-[(4-Bromobenzenesulfonyl)methyl]furan-2-carboxylic Acid, CAS: 1098359-00-2, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉O₅SBr.
Auranofin, CAS: 34031-32-8, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄AuO₉PS.
Auranofin-13C6, CAS: /, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₆H₃₄AuO₉PS.
4,5-Dibromobenzene-1,2-diamine, CAS: 49764-63-8, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆Br₂N₂.
Azelnidipine, CAS: 123524-52-7, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₄N₄O₆.
Azelnidipine-d7, CAS: /, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₂₇D₇N₄O₆.
4,5-Dibromobenzene-1,2-diol (90%, technical grade), CAS: 2563-26-0, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂O₂.
BAPTA, CAS: 85233-19-8, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄N₂O₁₀.
BAPTA, Tetrasodium Salt, CAS: 126824-24-6, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄N₂O₁₀ • 4Na.
4-(4-Acetylpiperazinosulfonyl)bromobenzene, CAS: 486422-26-8, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅BrN₂O₃S.
4-(4-BOC-piperazinocarbonylmethyl)-1-bromobenzene, CAS: 1007210-75-4, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₃BrN₂O₃.
BAPTA-tetracesium Salt, CAS: 480436-84-8, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀Cs₄N₂O₁₀.
BAPTA-tetrapotassium Salt, CAS: 73630-08-7, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀K₄N₂O₁₀.
4-(4-BOC-piperazinosulfonyl)bromobenzene, CAS: 259808-63-4, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁BrN₂O₄S.
BAPTA-TMFM, CAS: 96315-11-6, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄N₂O₁₁.
4-(4-Bromobenzenesulfonyl)aniline Hydrochloride, CAS: 1172364-06-5, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀NO₂SBr • HCl.
4-(4-Ethoxycarbonyl)piperazino-1-bromobenzene, CAS: 1226808-66-7, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇BrN₂O₂.
Benzenesulfonic Acid 3-Ethyl 5-Methyl 2-[(2-Aminoethoxy)methyl]-6-methyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate, CAS: 1078163-17-3, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₂O₅ • C ₆H₆O₃S.
4-(4-Isobutoxycarbonyl)piperazino-1-bromobenzene, CAS: 1226808-71-4, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁BrN₂O₂.
4-(4-Isopropoxycarbonyl)piperazino-1-bromobenzene, CAS: 1226808-58-7, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉BrN₂O₂.
Benzhydryl Glycidyl Ether, CAS: 6669-15-4, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆O₂.
Benzyl 3-(2-(5-Methyl-2-nitrophenoxy)ethoxy)-4-nitrobenzoate, CAS: /, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀N₂O₈.
4-(Acetylamino)-3-bromobenzenesulfonyl Chloride, CAS: 88963-75-1, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BrClNO₃S.
4-(tert-Butyldimethylsilyloxymethyl)bromobenzene, CAS: 87736-74-1, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁BrOSi.
Benzyl 4-Amino-3-(2-(2-amino-5-methylphenoxy)ethoxy)benzoate, CAS: /, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₄N₂O₄.
4-Amino-3,5-dibromobenzenesulfonamide, CAS: 39150-45-3, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O₂SBr₂.
BHQ, CAS: 88-58-4, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₂.
4-Benzyloxy-1-bromobenzene, CAS: 6793-92-6, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrO.
4-Boc-1-[(3-bromobenzene)sulfonyl]homopiperazine, CAS: 1312440-85-9, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃N₂O₄SBr.
Bis(2-aminoethyl) Ether N,N,N’,N’-Tetraacetic Acid, CAS: 923-73-9, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀N₂O₉.
Bis(2-cyanoethyl)-1-(N-tert-butyloxycarbonyl)-D-erythro-D-sphingosine-1-phosphate-13C2, D2, CAS: /, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³C₂H₅₀D₂N₃O₇P.
Bovine ATP2A1 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
4-Bromo-1-fluoro-2-nitrobenzene, CAS: 364-73-8, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrFNO₂.
Bovine CAB39 (Calcium-binding protein 39) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine CABS1 (Calcium-binding and spermatid-specific protein 1) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
4-Bromo-2-fluoro-1-nitrobenzene, CAS: 321-23-3, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrFNO₂.
4-Bromo-2-fluorobenzonitrile, CAS: 105942-08-3, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃BrFN.
Bovine CAMK2N1 (Calcium/calmodulin-dependent protein kinase II inhibitor 1) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine HPCA (Neuron-specific calcium-binding protein hippocalcin) ELISA Kit (96T), CAS: /, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
4-Bromo-2-methylbenzenesulfonyl Chloride, CAS: 139937-37-4, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrClO₂S.
Bovine MICU1 (Calcium uptake protein 1, mitochondrial) ELISA Kit (96T), CAS: /, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine NCS1 (Neuronal calcium sensor 1) ELISA Kit (96T), CAS: /, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
4-Bromo-3,5-difluorophenol, CAS: 130191-91-2, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃OF₂Br.
4-Bromo-3-fluorotoluene, CAS: 452-74-4, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrF.
Bromo Heptaacetyl-D-lactoside, Stabilized with 4% Calcium Carbonate, CAS: 05/07/4753, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅BrO₁₇.
Bucladesine Calcium Salt, CAS: 938448-87-4, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(C₁₈H₂₄N₅O₈P)•Ca.
4-Bromo-3-methylveratrole, CAS: 74866-17-4, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁BrO₂.
4-Bromo-3-nitrophenylboronic Acid, CAS: 74386-13-3, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BBrNO₄.
CaCC(inh)-A01, CAS: 407587-33-1, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁NO₄S.
Caged GTP, CAS: 124830-99-5, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃N₆O₁₆P₃.
4-Bromo-benzeneacetic Acid Ethyl Ester, CAS: 14062-25-0, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁BrO₂.
4-Bromo-α-phenylbenzenemethanol, CAS: 29334-16-5, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrO.
Calcein Blue, CAS: 54375-47-2, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NO₇.
4-Bromo-α-phenylbenzenemethanol-d5, CAS: 213678-51-4, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆D₅BrO.
4-Bromo-m-xylene, CAS: 583-70-0, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
Calcifediol, CAS: 19356-17-3, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₂.
Calcifediol-d3, CAS: 1262843-45-7, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₁D₃O₂.
4-Bromo-N,N-dimethylaniline, CAS: 586-77-6, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrN.
4-Bromo-N-phenylbenzenesulfonamide, CAS: 7454-54-8, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀BrNO₂S.
Calcifediol-d6, CAS: 78782-98-6, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₈D₆O₂.
Calcitonin (salmon) xAcetate, CAS: /, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄₅H₂₄₀N₄₄O₄₈S₂.
4-Bromoaniline, CAS: 106-40-1, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrN.
4-Bromoaniline-2,3,5,6-d4, CAS: 61357-76-4, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₄BrN.
Calcitonin (salmon)-Leu-d3 Trifluoroacetic Acid Salt, CAS: /, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄₅H₂₃₇D₃N₄₄O₄₈S₂ • x( C₂HF₃O₂).
Calcitonin, Salmon, CAS: 47931-85-1, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄₅H₂₄₀N₄₄O₄₈S₂.
Calcitriol, CAS: 32222-06-3, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₃.
Calcitriol Lactone, CAS: 81203-50-1, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₀O₅.
4-Bromobenzene-1,2-diamine, CAS: 1575-37-7, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇BrN₂.
4-Bromobenzenediazonium Tetrafluoroborate, CAS: 673-40-5, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BBrF₄N₂.
Calcitriol-d6, CAS: 78782-99-7, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₈D₆O₃.
Calcitriol-dehydroxytrimethylsilyl-3,5-O-tert-butyldimethylsilyl-d6, CAS: /, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₇₄D₆O₃Si₃.
4-Bromobenzenesulfonamide, CAS: 701-34-8, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₂S.
4-Bromobenzenesulfonohydrazide, CAS: 2297-64-5, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇BrN₂O₂S.
Calcium, CAS: 7440-70-2, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca.
Calcium (-)-Hydroxycitrate, CAS: 921226-01-9, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀O₁₆Ca₃.
4-Bromobenzenesulfonyl Chloride, CAS: 98-58-8, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrClO₂S.
4-Bromobenzenesulfonyl Chloride-d4, CAS: 133872-23-8, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₄BrClO₂S.
Calcium (2E,4E)-Hexa-2,4-dienoate, CAS: 7492-55-9, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄CaO₄.
Calcium 2-Keto-4-methylvalerate Dihydrate, CAS: 51828-95-6, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂CaO₆.
4-Bromobenzenesulfonyl fluoride, CAS: 498-83-9, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrFO₂S.
Calcium 2-Oxoglutarate, CAS: 71686-01-6, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄O₅Ca.
Calcium Acetate, CAS: 62-54-4, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆CaO₄.
Calcium Alginate, CAS: 9005-35-0, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄CaO₁₉.
Calcium Arsenate, CAS: 7778-44-1, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: As₂O₈ •Ca₃.
4-Bromobenzonitrile, CAS: 623-00-7, stock: 10g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrN.
4-Bromobenzotrifluoride, CAS: 402-43-7, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₃.
4-Bromobenzyl Bromide, CAS: 589-15-1, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆Br₂.
4-Bromobenzyl Cyanide, CAS: 16532-79-9, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrN.
Calcium Beta-hydroxy-beta-methylbutyrate, CAS: 135236-72-5, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈CaO₆.
Calcium Bis(fluorosulfonyl)imide, CAS: 1906900-37-5, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaF₄N₂O₈S₄.
4-Bromobenzyl-d4 Bromide, CAS: /, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂D₄Br₂.
4-Bromobenzyl-d6 Bromide, CAS: 229948-68-9, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇D₆Br₂.
4-Bromocatechol, CAS: 17345-77-6, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BrO₂.
calcium bis(N-cyclohexylsulfamate), CAS: 139-06-0, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ₂[C₆H₁₂NO₃S-].Ca+₂.H₂O.
4-Bromofluorobenzene, CAS: 460-00-4, stock: 9.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrF.
4-Bromoisophthalic Acid, CAS: 6939-93-1, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅O₄Br.
Calcium Carbide(technical grade ~ 80%), CAS: 75-20-7, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaC₂.
Calcium Carbonate, CAS: 471-34-1, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaCO₃.
4-Bromophenetole, CAS: 588-96-5, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
4-Bromophenol Acetate, CAS: 1927-95-3, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BrO₂.
Calcium Chloride (Anhydrous), CAS: 10043-52-4, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaCl₂.
Calcium Chloride Dihydrate, CAS: 10035-04-8, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaCl₂•2[H₂O].
4-Bromophenol Acetate-13C6, CAS: /, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₆H₇BrO₂.
4-Bromophenylacetic Acid, CAS: 1878-68-8, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BrO₂.
Calcium Citrate Malate, CAS: 142606-53-9, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₆H₇O₇)ₓ.(C₄H₅O₅)y.(Ca²⁺)z.
Calcium Citrate Tetrahydrate, CAS: 5785-44-4, stock: 4.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄Ca₃O₁₈.
4-Bromophenylboronic Acid (contains varying amounts of Anhydride), CAS: 5467-74-3, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BBrO₂.
4-Bromophenylboronic Acid-d4 (contains varying amounts of Anhydride), CAS: 5467-74-3, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₄BBrO₂.
Calcium Cyclamate Dihydrate, CAS: 5897-16-5, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄N₂O₆S₂Ca•2[H₂O].
4-Bromoresorcinol, CAS: 6626-15-9, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BrO₂.
4-Bromothiophenol, CAS: 106-53-6, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BrS.
Calcium D-gluconate monohydrate, CAS: 66905-23-5, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(C₆H₁₁O₇) • Ca • H ₂O.
Calcium DL-Pantothenate, CAS: 63409-48-3, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂CaN₂O₁₀H₂O.
4-Bromotoluene, CAS: 106-38-7, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇Br.
4-Chlorobromobenzene, CAS: 106-39-8, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrCl.
Calcium Dobesilate, CAS: 117552-78-0, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀CaO₁₀S₂ • xH ₂O.
Calcium Dobesilate Hydrate, CAS: 117552-79-1, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈CaO₂S.
4-N-Amyloxybromobenzene, CAS: 30752-18-2, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅OBr.
Calcium Fluoride, CAS: 7789-75-5, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaF₂.
Calcium Gluceptate, CAS: 29039-00-7, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O₁₆Ca.
4-N-Hexyloxybromobenzene, CAS: 30752-19-3, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇BrO.
4-N-Octyloxybromobenzene, CAS: 96693-05-9, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁OBr.
Calcium Gluconate, CAS: 299-28-5, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁Ca₀.₅O₇.
4-Pentylbromobenzene, CAS: 51554-95-1, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅Br.
4-Pentylbromobenzene-d7, CAS: /, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈D₇Br.
Calcium Glycerophosphate, CAS: 27214-00-2, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₇CaO₆P.
Calcium Hydrate Bis(N-cyclohexylsulfamate), CAS: /, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2[C₆H₁₂NO₃S-].Ca • H₂O.
Calcium Hydride, CAS: 7789-78-8, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaH₂.
Calcium Hydroxide, CAS: 1305-62-0, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaH₂O₂.
4’-Bromopropiophenone, CAS: 10342-83-3, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉BrO.
4’-Bromovalerophenone, CAS: 7295-44-5, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃BrO.
Calcium Hypochlorite (Technical Grade), CAS: 7778-54-3, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca(OCl)₂.
Calcium Isopropoxide, >90%, CAS: 15571-51-4, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄CaO₂.
4’-Bromovalerophenone-d2, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁D₂BrO.
4’-Bromovalerophenone-d9, CAS: /, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₄D₉BrO.
Calcium Lactate Gluconate, CAS: 11116-97-5, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₃H₅O₃)₂Ca • (C₆H₁₁O₇)₂Ca.
Calcium Lactate Gluconate (Mixture), CAS: /, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 4(C₃H₅O₃) • 2( C₆H₁₁O₇) • 3( Ca).
5-Bromo-1,2,3-trichlorobenzene, CAS: 21928-51-8, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂BrCl₃.
5-Bromo-m-xylene, CAS: 556-96-7, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Br.
Calcium Lactate Pentahydrate, CAS: 5743-47-5, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₆Ca•5[H₂O].
Calcium Lactobionate, CAS: 110638-68-1, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₂O₂₄Ca•5[H₂O].
Bis(4-bromophenyl)acetylene, CAS: 2789-89-1, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈Br₂.
Bromobenzene-d5, CAS: 4165-57-5, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₅Br.
Calcium Levofolinate, CAS: 80433-71-2, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃CaN₇O₇.
Calcium Levulinate, CAS: 5743-49-7, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₆Ca•2[H₂O].
Bromopentafluorobenzene, CAS: 344-04-7, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆BrF₅.
Decabromodiphenyl Ether-13C12, CAS: 562099-68-7, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₁₂Br₁₀O.
Calcium Malate, CAS: 17482-42-7, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄O₅Ca.
Dibromopropamidine Dihydrochloride, CAS: 50357-61-4, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀Br₂Cl₂N₄O₂.
Calcium Methacrylate Hydrate, CAS: 16809-88-4, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₄Ca • H₂O.
Calcium Methoxide, CAS: 2556-53-8, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₄O • 1/2(Ca).
Dibromopropamidine-d6 Dihydrochloride, CAS: /, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄D₆Br₂Cl₂N₄O₂.
Dicyclopentyl-S-Bromobenzene Glutathione, CAS: /, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₆BrN₃O₆S.
Calcium N5-Methyltetrahydrofolate-13C5, CAS: /, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅¹³C₅H₂₅CaN₇O₆.
Calcium Nitrate Tetrahydrate, CAS: 13477-34-4, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca(NO₃)₂ 4H₂O.
Ebrotidine, CAS: 100981-43-9, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇BrN₆O₂S₃.
Hexabromobenzene, CAS: 87-82-1, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆Br₆.
Calcium Orotate, CAS: 22454-86-0, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆CaN₄O₈.
Calcium Orotate Hydrate, CAS: /, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆CaN₄O₈ • xH ₂O.
α-Bromobenzeneacetic Acid Ethyl Ester, CAS: 2882-19-1, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁BrO₂.
Calcium Oxide, CAS: 1305-78-8, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaO.
Calcium Peroxide Hydrate, CAS: 1305-79-9, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaH₂O₃.
Methyl 2-(3-bromophenyl)acetate, CAS: 150529-73-0, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉BrO₂.
methyl 3-(4-bromobenzenesulfonyl)propanoate, CAS: 14223-24-6, stock: 8.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁O₄SBr.
Calcium Phenylpyruvate, CAS: 54865-40-6, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄Ca₂O₆.
Calcium Phenylpyruvate, CAS: 51828-93-4, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₉H₇O₃)₂Ca.
methyl 4-(4-bromobenzenesulfinyl)butanoate, CAS: 1250092-90-0, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃O₃SBr.
Methyl α-Bromophenylacetate, CAS: 3042-81-7, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉BrO₂.
Calcium phthalate hydrate, CAS: 160535-96-6, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄O₄Ca • H₂O.
Calcium Phthalate Hydrate, CAS: /, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄O₄Ca • H₂O.
N,N-Diethyl 3-bromobenzenesulfonamide, CAS: 871269-11-3, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO₂S.
N,N-Diethyl 4-bromobenzenesulfonamide, CAS: 90944-62-0, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO₂S.
Calcium Phytate, CAS: 7776-28-5, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆Ca₆O₂₄P₆.
Calcium Propionate, CAS: 4075-81-4, stock: 10g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀CaO₄².
N,N-Dimethyl 2-bromobenzenesulfonamide, CAS: 65000-13-7, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrNO₂S.
N,N-Dimethyl 3-bromobenzenesulfonamide, CAS: 153435-80-4, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrNO₂S.
Calcium Pyruvate, CAS: 52009-14-0, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆O₆Ca.
Calcium Saccharate Tetrahydrate, CAS: 5793-89-5, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈O₈Ca•4[H₂O].
N,N-Dimethyl 4-bromobenzenesulfonamide, CAS: 707-60-8, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrNO₂S.
N-(2-Aminoethyl) 4-Bromobenzenesulfonamide, CAS: 90002-56-5, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁BrN₂O₂S.
Calcium Stearate, CAS: 1592-23-0, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₇₀O₄Ca.
Calcium Sulfate, CAS: 7778-18-9, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CaSO₄.
N-(2-Aminoethyl)-2,5-dibromobenzene-1-sulfonamide, CAS: 1039858-71-3, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀N₂O₂SBr₂.
N-(3-Chloropropyl) 4-Bromobenzenesulfonamide, CAS: 98768-71-9, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁BrClNO₂S.
Calcium Sulfate Dihydrate, CAS: 10101-41-4, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: O₄SCa•2[H₂O].
Calcium Sulfate Hemihydrate, CAS: 10034-76-1, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca • H ₂O₄S • 1/2(H ₂O).
N-(4-Fluorobenzyl) 2-bromobenzenesulfonamide, CAS: 321705-40-2, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrFNO₂S.
N-amino-4-bromobenzene-1-carboximidamide hydrochloride, CAS: 1461714-12-4, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈N₃Br.HCl.
Calcium Titanate, CAS: 12049-50-2, stock: 9.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: O₃Ti-₂.Ca+₂.
Calcium(II) Bis(nonafluorobutanesulfonyl)imide, CAS: 689282-13-1, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆CaF₃₆N₂O₈S₄.
N-Benzyl 3-bromobenzenesulfonamide, CAS: 625470-36-2, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂BrNO₂S.
N-Benzyl 4-bromobenzenesulfonamide, CAS: 3609-87-8, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂BrNO₂S.
Calcium(II) Bis(trifluoromethanesulfonyl)imide, CAS: 165324-09-4, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄CaF₁₂N₂O₈S₄.
N-Benzyl-2-bromobenzenesulfonamide, CAS: 321704-27-2, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂BrNO₂S.
Calcium-L-lactate Hydrate, CAS: 949014-28-2, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀CaO₆ • x(H ₂O).
N-BOC-3-[(3-Bromobenzene)sulfonyl]azetidine, CAS: 887593-56-8, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈BrNO₄S.
N-BOC-3-[(4-Bromobenzene)sulfonyl]azetidine, CAS: 887593-59-1, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈BrNO₄S.
CalciumMethacrylate Hydrate, CAS: 63351-83-7, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₄Ca • H₂O.
Calcobutrol, CAS: 151878-23-8, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₂Ca₃N₈O₁₈.
N-Butyl 2-bromobenzenesulfonamide, CAS: 951885-17-9, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO₂S.
N-Butyl 3-bromobenzenesulfonamide, CAS: 871269-09-9, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO₂S.
Caldiamide Sodium, CAS: 131410-50-9, stock: 4.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆CaN₅NaO₈.
N-Butyl 4-bromobenzenesulfonamide, CAS: 1984-28-7, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO₂S.
N-Cyclohexyl 3-bromobenzenesulfonamide, CAS: 871269-10-2, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆BrNO₂S.
Calindol Hydrochloride, CAS: 729610-18-8, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClN₂.
N-Cyclohexyl 4-bromobenzenesulfonamide, CAS: 7454-76-4, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆BrNO₂S.
Calindol-13C,d2 Hydrochloride, CAS: 1217828-76-6, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³CH₁₉D₂ClN₂.
Calmagite, CAS: 3147-14-6, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄N₂O₅S.
N-Cyclopropyl 4-bromobenzenesulfonamide, CAS: 331950-30-2, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀BrNO₂S.
N-Ethyl 3-bromobenzenesulfonamide, CAS: 871269-07-7, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrNO₂S.
Calmidazolium chloride, CAS: 57265-65-3, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₃Cl₇N₂O.
CALP1, CAS: 145224-99-3, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₇₅N₉O₁₀.
N-Ethyl 4-bromobenzenesulfonamide, CAS: 1984-25-4, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrNO₂S.
N-t-Butyl 4-bromobenzenesulfonamide, CAS: 93281-65-3, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO₂S.
Calphostin C, CAS: 121263-19-2, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₃₈O₁₄.
Carboxyamidotriazole, CAS: 99519-84-3, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂Cl₃N₅O₂.
N’-(2,5-Dibromobenzenesulfonyl)ethanimidamide, CAS: 1181465-78-0, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₂O₂SBr₂.
Neopentyl 4-Bromobenzenesulfonate, CAS: 14248-15-8, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅BrO₃S.
Caroverine, CAS: 23465-76-1, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇N₃O₂.
Chicken ATP2A1 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
p-Bromobenzenesulfonate Reserpic Acid Methyl Ester, CAS: 1262-67-5, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₃BrN₂O₇S.
Chicken ATP2A3 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Chicken NCS1 (Neuronal calcium sensor 1) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
PBDE 15, CAS: 2050-47-7, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈Br₂O.
PBDE 197, CAS: 117964-21-3, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂Br₈O.
Chicken ORAI1 (Calcium release-activated calcium channel protein 1) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Chicken S100A6(S100 Calcium Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Phenyl 4-Bromobenzenesulfonate, CAS: 5455-14-1, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉O₃SBr.
Chlonixin, CAS: 17737-65-4, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁ClN₂O₂.
Chlonixin-d6, CAS: /, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₅D₆ClN₂O₂.
Tetradecabromo-1,4-diphenoxybenzene, CAS: 58965-66-5, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈Br₁₄O₂.
Tetrakis(4-bromophenyl)methane, CAS: 105309-59-9, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₆Br₄.
Chlorobis(4-fluorophenyl)methane, CAS: 27064-94-4, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉ClF₂.
Chlorotriethoxytitanium, CAS: 3712-48-9, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₅ClO₃Ti.
Cilnidipine, CAS: 132203-70-4, stock: 9.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈N₂O₇.
Cilnidipine-d3, CAS: /, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₅D₃N₂O₇.
Cinnarizine, CAS: 298-57-7, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈N₂.
Cinnarizine Glucuronide, CAS: /, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇N₂O₆.
Cinnarizine-d8, CAS: 1185242-27-6, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₀D₈N₂.
Cinnarizine-d8 Glucuronide, CAS: /, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₉D₈N₂O₆.
cis Lacidipine, CAS: 103890-79-5, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₆.
cis-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-methanol, CAS: 61397-58-8, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄Cl₂N₂O₃.
CK 1827452, CAS: 873697-71-3, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄FN₅O₃.
CK 1827452-d8, CAS: /, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆D₈FN₅O₃.
Clentiazem, CAS: 96125-53-0, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅ClN₂O₄S.
Clentiazem-d6, CAS: /, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉D₆ClN₂O₄S.
Clevidipine, CAS: 167221-71-8, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃Cl₂NO₆.
Clevidipine-d5, CAS: 1346602-00-3, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈D₅Cl₂NO₆.
Cyanamide, CAS: 420-04-2, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₂N₂.
D-erythro-Sphingosine-1-phosphate, CAS: 26993-30-6, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₈NO₅P.
(R)-(+)-Propylene Oxide, CAS: 15448-47-2, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₆O.
D-erythro-Sphingosine-1-phosphate-13C2,D2, CAS: /, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆¹³C₂H₃₆D₂NO₅P.
D-Fructose 1,6-Biphosphate Dicalcium Salt, CAS: 6055-82-9, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀Ca₂O₁₂P₂.
Brivanib, CAS: 649735-46-6, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉FN₄O₃.
Brivanib Alaninate, CAS: 649735-63-7, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄FN₅O₄.
d-Glaucine, CAS: 475-81-0, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅NO₄.
d-Glaucine-d6, CAS: /, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉D₆NO₄.
D-Glucose 6-Phosphate Solution (1M in H2O), CAS: 56-73-5, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃O₉P.
D-myo-Inositol 1,2,3,4,5,6-Hexakisphosphate Sodium Salt Hydrate, Zea mays (>85% purity), CAS: /, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₈O₂₄P₆ • x(Na) • x(H ₂O).
D-Ribose, CAS: 50-69-1, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O₅.
D-Ribose-1,2-13C2, CAS: 209909-88-6, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₁₀O₅.
D-Ribose-1,3-13C2, CAS: 478511-79-4, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₁₀O₅.
D-Ribose-1,5-13C2, CAS: 213825-56-0, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₁₀O₅.
D-Ribose-1-13C, CAS: 70849-24-0, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₄H₁₀O₅.
D-Ribose-1-d, CAS: 119540-50-0, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉DO₅.
D-Ribose-13C5, CAS: 202114-47-4, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₅H₁₀O₅.
D-Ribose-13C5, CAS: /, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₅H₁₀O₅.
D-Ribose-2,3,4,5-13C4, CAS: 478506-23-9, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C¹³C₄H₁₀O₅.
D-Ribose-2,5-13C2, CAS: 213825-57-1, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₁₀O₅.
D-Ribose-2-13C, CAS: 83379-40-2, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₄H₁₀O₅.
D-Ribose-2-d, CAS: 202480-69-1, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉DO₅.
D-Ribose-3-13C, CAS: 211947-12-5, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₁₀O₅.
D-Ribose-3-d, CAS: 169783-76-0, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉DO₅.
D-Ribose-4,5-13C2, CAS: /, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₁₀O₅.
D-Ribose-4-13C, CAS: /, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₁₀O₅.
D-Ribose-4-d, CAS: /, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉DO₅.
D-Ribose-5,5’-d, CAS: 478506-32-0, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈D₂O₅.
D-Ribose-5-13C, CAS: /, stock: 4.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₁₀O₅.
D-Xylonic Acid Calcium Salt Hydrate, CAS: 72656-08-7, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₁₂ • Ca • xH₂O.
D-Xylonic Acid Calcium Salt Hydrate, CAS: /, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈CaO₁₂•xH₂O.
Darodipine, CAS: 72803-02-2, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₅.
(4S)-3,4-Dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazin-4-ol 1,1-Dioxide, CAS: 1029324-91-1, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO₄S₂.
Dechloro Chlonixin, CAS: 17782-05-7, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂N₂O₂.
(4S)-6-Chloro-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazin-4-ol 1,1-Dioxide, CAS: 160982-13-8, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄ClNO₄S₂.
(R)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide, CAS: 165117-54-4, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O₆S₃.
Dechloro Chlonixin-d7, CAS: /, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₅D₇N₂O₂.
(S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide, CAS: 154127-42-1, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O₆S₃.
(S)-Brinzolamide, CAS: 154127-19-2, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₁N₃O₅S₃.
Defluoro Flunarizine Dihydrochloride, CAS: 27064-96-6, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇FN₂ •2HCl.
Defluoro Pitavastatin Calcium Salt, CAS: 1258947-30-6, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₄₆CaF₂N₂O₈.
(S)-Brinzolamide-d5, CAS: /, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆D₅N₃O₅S₃.
3-(2-Bromoacetyl)-5-chloro-N-(3-methoxypropyl)-2-thiophenesulfonamide, CAS: 1174304-97-2, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃BrClNO₄S₂.
1,4-Bis(benzo[b]thien-4-yl)piperazine, CAS: 1420987-86-5, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂S₂.
Dehydro Azelnidipine, CAS: 918659-10-6, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₂N₄O₆.
3-Acetyl-5-chloro-2-thiophenesulfonamide, CAS: 160982-10-5, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNO₃S₂.
4-Desethylamino 4-oxobrinzolamide, CAS: 154127-41-0, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₆S₃.
1-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)-7-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butoxy)quinolin-2(1H)-one, CAS: /, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₀N₄O₄S.
1-(Benzothiophen-4-yl)-4-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butyl]piperazine, CAS: /, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄N₄S₂.
6’-Chloro-2’,3’-dihydro-spiro[1,3-dioxolane-2,4’-[4H]thieno[3,2-e][1,2]thiazine] 1’,1’-Dioxide, CAS: 1206597-10-5, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈ClNO₄S₂.
Brinzolamide, CAS: 138890-62-7, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₁N₃O₅S₃.
1-Benzo[b]thien-4-yl-piperazine, CAS: 846038-18-4, stock: 3.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂S.
1-[2-(Benzothiophen-4-yl)benzothiophen-4-yl]piperazine, CAS: 2126178-14-9, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀Cl₂N₂S₂.
Dehydro Felodipine Hydrochloride, CAS: /, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈Cl₃NO₄.
Brinzolamide Hydrochloride, CAS: 150937-43-2, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂ClN₃O₅S₃.
Brinzolamide Methanesulfonyl Amide, CAS: /, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₃N₃O₇S₄.
4-(1-Piperazinyl)-benzo[b]thiophene-2-carboxylic Acid Hydrochloride, CAS: 1700655-64-6, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅ClN₂O₂S.
4-(4-Boc-piperazin-1-yl)benzo[b]thein-2-carboxylate, CAS: 1677681-02-5, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂N₂O₄S.
Dehydro Isradipine Lactone, CAS: 1076199-91-1, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅N₃O₅.
Dehydro Nimodipine, CAS: 85677-93-6, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₂O₇.
Brinzolamide-d5, CAS: 1217651-02-9, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆D₅N₃O₅S₃.
N-Desethyl Brinzolamide, CAS: 404034-55-5, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₇N₃O₅S₃.
5-(4-Bromobutoxy)quinolin-2(1H)-one, CAS: /, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄BrNO₂.
7,7’-[(1,4-Butanediyl)bis(oxy)]bis-2(1H)quinolinone, CAS: 2116542-19-7, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀N₂O₄.
Dehydro Nimodipine-d7, CAS: /, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇D₇N₂O₇.
Dehydronitrendipine, CAS: 89267-41-4, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈N₂O₆.
N-Desethyl Brinzolamide-13C,d3, CAS: 1246816-82-9, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³CH₁₄D₃N₃O₅S₃.
N-Desethyl N-Isopropyl Brinzolamide, CAS: /, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₃N₃O₅S₃.
7-(4-Bromobutoxy-1,1,2,2,3,3,4,4-d8)-2(1H)-quinolinone, CAS: 1427053-44-8, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆D₈BrNO₂.
7-(4-Chlorobutoxy)-1-(4-chlorobutyl)quinolin-2-one, CAS: 2059954-32-2, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁Cl₂NO₂.
Dehydronitrosonisoldipine, CAS: 87375-91-5, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂N₂O₅.
Deltamethrin, CAS: 52918-63-5, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉Br₂NO₃.
O-Desmethyl Brinzolamide, CAS: 186377-56-0, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₉N₃O₅S₃.
O-Desmethyl Brinzolamide-D5, CAS: /, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄D₅N₃O₅S₃.
7-(4-Hydroxybutoxy)-2(1H)-quinolinone, CAS: 1886188-97-1, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅NO₃.
7-(Benzyloxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one, CAS: /, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₆N₂O₄.
Deltamethrin-d5(Mixture of Diastereomers), CAS: 1217633-23-2, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₄D₅Br₂NO₃.
Demethyl Isradipine, CAS: 88977-30-4, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₅.
7-(Benzyloxy)-2-(4-bromobutoxy)quinoline, CAS: /, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀BrNO₂.
7-(Phenylmethoxy)-2(1H)-quinolinone, CAS: 386273-52-5, stock: 9.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NO₂.
Demethyl Propionitrile Isradipine, CAS: 88977-31-5, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₄O₅.
Denbufylline, CAS: 57076-71-8, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₄O₃.
7-[4-(4-Benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-[(1,2,3,4-tetrahydro-2-oxo-7-quinolinyl)oxy]butyl]-2(1H)-quinolinone, CAS: 2116542-23-3, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₂N₄O₄S.
Brexpiprazole, CAS: 913611-97-9, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇N₃O₂S.
Desacetyl Diltiazem Hydrochloride, CAS: 75472-91-2, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅ClN₂O₃S.
Desacetyl Diltiazem-d4 Hydrochloride, CAS: /, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₄ClN₂O₃S.
Brexpiprazole (3,4)-Dihydro-2(1H)-quinolinone, CAS: 913612-07-4, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉N₃O₂S.
Brexpiprazole (Butylene-d8) Hydrochloride, CAS: /, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₉D₈N₃O₂S •HCl.
Desethyl Felodipine, CAS: 123853-39-4, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅Cl₂NO₄.
Brexpiprazole 4-Methyl Benzo[b]thiophene, CAS: /, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₁N₃O₂S₂.
Brexpiprazole 4-[7-Hydroxy-2(1H)-Quinoline], CAS: /, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇N₃O₂S.
Desethyl Felodipine-d3,15N, CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₃Cl₂¹⁵NO₄.
Desethyl O-Methyl Felodipine-d6,15N, CAS: /, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C¹⁷H¹¹D₆Cl₂¹⁵NO₄.
Brexpiprazole 5-1H-Quinolin-2-one, CAS: 2116542-20-0, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇N₃O₂S.
Brexpiprazole Dequinolinonyl, CAS: 913614-15-0, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂N₂OS.
DHBP Dibromide, CAS: 03/05/6159, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈Br₂N₂.
Brexpiprazole N-Oxide, CAS: 1191900-58-9, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇N₃O₃S.
Brexpiprazole S-Oxide, CAS: 1191900-51-2, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇N₃O₃S.
Brexpiprazole-d8, CAS: 1427049-19-1, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₉D₈N₃O₂S.
Ethyl 4-(4-Boc-piperazin-1-yl)benzo[b]thien-2-carboxylate, CAS: 1677681-01-4, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₂O₄S.
Dibefurin, CAS: 175448-33-6, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₈.
N-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole, CAS: 2094559-58-5, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₀N₄O₄S.
N-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole-d8, CAS: /, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₂D₈N₄O₄S.
Diethylenetriamine-pentaacetic Acid Calcium Trisodium Salt, CAS: 207226-35-5, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈CaN₃O₁₀ •3Na •x(H ₂O).
N-[7-Butoxyquinolin-2(1H)-one] Brexpiprazole Iodide, CAS: /, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₁N₄O₄S • I.
O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole (>90%), CAS: 2116542-21-1, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₀N₄O₄S.
Dihydro Tachysterol, CAS: 67-96-9, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₆O.
O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole-d8, CAS: /, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₂D₈N₄O₄S.
Dihydrocinnamyl Cilnidipine, CAS: /, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀N₂O₇.
Diisopropyl Carbonate (Stabilized with Calcium Carbonate), CAS: 6482-34-4, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₃.
Diltiazem Hydrochloride, CAS: 33286-22-5, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇ClN₂O₄S.
Diltiazem-d3 Hydrochloride, CAS: 1217623-80-7, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄D₃ClN₂O₄S.
Diltiazem-d4 Hydrochloride, CAS: 1217769-52-2, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃D₄ClN₂O₄S.
Diltiazem-d6, CAS: 1242184-41-3, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀D₆N₂O₄S.
Dimethyl 2,2’-((2-(2-(2-(Bis(2-methoxy-2-oxoethyl)amino)-5-(chlorocarbonyl)phenoxy)ethoxy)-4-methylphenyl)azanediyl)diacetate, CAS: /, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃ClN₂O₁₁.
Dimethyl2,2’-((2-(2-(2-(bis(2-methoxy-2-oxoethyl)amino)-5-(2-diazoacetyl)phenoxy)ethoxy)-4-methylphenyl)azanediyl)diacetate, CAS: 123330-90-5, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₄N₄O₁₁.
Dimethylcarbamoyl Chloride, CAS: 79-44-7, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₆ClNO.
Docusate Calcium, CAS: 128-49-4, stock: 4.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₇₄CaO₁₄S₂.
Edetate Calcium Disodium Dihydrate, CAS: 6766-87-6, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂CaN₂O₈ • 2H ₂O • 2Na.
EDTA Calcium Disodium Salt, CAS: 62-33-9, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂CaN₂Na₂O₈.
Efonidipine Hydrochloride Monoethanolate, CAS: 111011-76-8, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₈N₃O₇P • C ₂H₆O • HCl.
EGTA, CAS: 67-42-5, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₁₀.
EGTA Tetrasodium, CAS: 13368-13-3, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂Na₄O₁₀.
Eldecalcitol, CAS: 104121-92-8, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O₅.
Eldecalcitol (pre-form), CAS: 201854-22-0, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O₅.
Eldecalcitol (tachy-form), CAS: /, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O₅.
ENMD 547, CAS: 644961-61-5, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₀BrN₃O₂.
ENMD 547-d8, CAS: 1795025-33-0, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂D₈BrN₃O₂.
ent-Calindol Hydrochloride, CAS: 728930-30-1, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClN₂.
ent-Calindol-13C,d2 Hydrochloride, CAS: 1217619-32-3, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³CH₁₉D₂ClN₂.
ent-Levomefolate Calcium, CAS: /, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃CaN₇O₆.
Ethyl 2-(trifluoroacetyl)propionate, CAS: 344-00-3, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉F₃O₃.
Ethyl 2-Chloro-5-(chlorosulfonyl)-4-fluorobenzoate, CAS: 1155076-35-9, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇O₄FSCl₂.
Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, CAS: 1198615-84-7, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅BO₄.
Ethyl 3-Aminocrotonate, CAS: 7318-00-5, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO₂.
Ethyl Palmitoleate, CAS: 56219-10-4, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₂.
Ethyl Palmitoleate-d5, CAS: /, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₉D₅O₂.
Ethyl [Bis(2,2,2-trifluoroethoxy)phosphinyl]acetate, CAS: 124755-24-4, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁F₆O₅P.
Ethylenediamine-N,N,N’,N’-tetraacetic Acid Calcium Disodium Hydrate, CAS: 23411-34-9, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂CaN₂Na₂O₈•xH₂O.
Etidronate, CAS: 2809-21-4, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₈O₇P₂.
Etidronic Acid Disodium Salt, CAS: 7414-83-7, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₆Na₂O₇P₂.
Etidronic Acid-d3 Sodium Salt, CAS: /, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₅D₃O₇P₂ . Naₓ.
Felodipine, CAS: 72509-76-3, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉Cl₂NO₄.
Felodipine 3,5-Dimethyl Ester, CAS: 91189-59-2, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂NO₄.
Felodipine 3,5-Dimethyl Ester-d6, CAS: 1794786-23-4, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₁D₆Cl₂NO₄.
Felodipine-13C4, CAS: /, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₄H₁₉Cl₂NO₄.
Felodipine-13C4, d3, CAS: /, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₄H₁₆D₃Cl₂NO₄.
Fendiline Hydrochloride, CAS: 13636-18-5, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₆ClN.
Fenoprofen Calcium Hydrate, CAS: 53746-45-5, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(C₁₅H₁₃O₃) • Ca • 2(H ₂O).
Fenoprofen Calcium Salt Dihydrate, CAS: 71720-56-4, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₄•1/2Ca.
Flunarizine Dihydrochloride, CAS: 30484-77-6, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈Cl₂F₂N₂.
Flunarizine-d8 Dihydrochloride, CAS: /, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₀D₈Cl₂F₂N₂.
FLUO 3/AM, CAS: 121714-22-5, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₁H₅₀Cl₂N₂O₂₃.
Fluorapatite, CAS: 1306-05-4, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca₅FO₁₂P₃.
Folinic Acid Calcium Salt, CAS: 1492-18-8, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁CaN₇O₇.
Fosfomycin Calcium, CAS: 26016-98-8, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₅CaO₄P.
Fosfomycin Tromethamine, CAS: 78964-85-9, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₈NO₇P.
Fumaric Acid Monoethyl Ester, CAS: 04/05/2459, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈O₄.
Fumaric Acid Monoethyl Ester Calcium Salt, CAS: 62008-22-4, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇O₄•1/2Ca.
Fumaric Acid Monoethyl Ester Magnesium Salt (2:1), CAS: 83918-60-9, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄MgO₈.
Fumaric Acid Monoethyl Ester Zinc Salt (2:1), CAS: 62008-21-3, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₈Zn.
Fumaric Acid Monoethyl-d5 Ester, CAS: 1266398-64-4, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃D₅O₄.
Gadolinium Trichloride, CAS: 10138-52-0, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Cl₃Gd.
Glubionate Calcium, CAS: 12569-38-9, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C18H32CaO19.
Glycolithocholic Acid Sodium Salt, CAS: 24404-83-9, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₂NNaO₄.
GSK 1702934A, CAS: 924377-85-5, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅N₃O₂S.
Guinea pig S100A6(S100 Calcium Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
GW 542573X, CAS: 660846-41-3, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈N₂O₅.
HA-1004, CAS: 91742-10-8, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₅O₂S.
Hemin Chloride (Technical grade), CAS: 16009-13-5, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₂ClFeN₄O₄.
Hexahydrophenyl Cinacalcet, CAS: 1271930-12-1, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈F₃N.
Human ATP2C1(Calcium Transporting ATPase Type 2C Member 1) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human ATP2A1 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human ATP2A3 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human ATP2A3(Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CAB39 (Calcium-binding protein 39) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CABS1 (Calcium-binding and spermatid-specific protein 1) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CACNA1A(Voltage-dependent P/Q-type calcium channel subunit alpha-1A) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CADPS (Calcium-dependent secretion activator 1) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CADPS2 (Calcium-dependent secretion activator 2) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human Calcium Sensing Receptor ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CAMK2α(Calcium/Calmodulin-Dependent Protein Kinase II Alpha) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CAMK2N1 (Calcium/calmodulin-dependent protein kinase II inhibitor 1) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CAMK2N2(Calcium/Calmodulin Dependent Protein Kinase II Inhibitor 2) ELISA Kit (96T), CAS: /, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CAMKK2 (Calcium/calmodulin-dependent protein kinase kinase 2) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CAMKK2(Calcium/calmodulin-dependent protein kinase kinase 2) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CARHSP1 (Calcium-regulated heat-stable protein 1) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CASR(Extracellular calcium-sensing receptor) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human CIB2 (Calcium and integrin-binding family member 2) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human HPCA (Neuron-specific calcium-binding protein hippocalcin) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human MICU1 (Calcium uptake protein 1, mitochondrial) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human PDE1C(Calcium/calmodulin-dependent 3’,5’-cyclic nucleotide phosphodiesterase 1C) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human PLA2G6(85 kDa calcium-independent phospholipase A2) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human S100A13(S100 Calcium Binding Protein A13) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SLC25A12(Calcium-binding mitochondrial carrier protein Aralar1) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SLC25A13(Calcium-binding mitochondrial carrier protein Aralar2) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SLC8A1(Sodium/calcium exchanger 1) ELISA Kit (96T), CAS: /, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Hydroxy Naphthol Blue Disodium Salt (Technical Grade), CAS: 165660-27-5, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₂N₂Na₂O₁₁S₃.
Hydroxyamino Lamotrigine, CAS: /, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇Cl₂N₅O.
Hydroxyapatite, CAS: 12167-74-7, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca₅HO₁₃P₃.
Imidodiphosphoric Acid Tetrasodium Salt, CAS: 26039-10-1, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: HNNa₄O₆P₂.
Indo 1, CAS: 96314-96-4, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₁N₃O₁₂.
INDO-1, Pentapotassium Salt, CAS: 132319-56-3, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₆N₃O₁₂K₅.
Ionomycin Calcium, CAS: 56092-82-1, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁CaH₇₀O₉.
Ionomycin Free Acid, CAS: 56092-81-0, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₂O₉.
Isopropyl 5-Hydroxy-2-methyl-4-(3-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate, CAS: 1360462-97-0, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₂O₆.
Isradipine, CAS: 75695-93-1, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₅.
Isradipine-d3, CAS: 1189959-59-8, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₃N₃O₅.
α,α’-[[[2-(3,4-Dimethoxyphenyl)ethyl]imino]di-3,1-propanediyl]bis[3,4-dimethoxy-α-(1-methylethyl)benzeneacetonitrile Monohydrochloride, CAS: 190850-50-1, stock: 4.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₅₈ClN₃O₆.
α-Ethyl-α-(1-demethylethyl)-Verapamil Hydrochloride, CAS: 190850-49-8, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇ClN₂O₄.
α-Phenyl-α-[3-(phenyl-2-pyridinylmethylene)-2,4-cyclopentadien-1-yl]-2-pyridinemethanol (E/Z mixture), CAS: 2026-58-6, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₂N₂O.
α-Propyl-α-(1-demethylethyl)-Verapamil Hydrochloride, CAS: /, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₉ClN₂O₄.
KAD-1229 Calcium Hydrate, CAS: 207844-01-7, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₄•1/2Ca.
KAD-1229-d8 Calcium Hydrate, CAS: 1346603-13-1, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₈NO₄•1/2Ca.
Katacalcin, CAS: 85916-47-8, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₇H₁₅₄N₃₄O₃₆S₂.
L-α-Glutamyl-L-alanyl-L-valyl-L-seryl-L-leucyl-L-lysyl-L-prolyl-L-threonine, CAS: 182683-50-7, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₅N₉O₁₃.
L-Ribose, CAS: 24259-59-4, stock: 10g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O₅.
L-Ribose-13C5, CAS: /, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₅H₁₀O₅.
Lacidipine, CAS: 103890-78-4, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₆.
Lacidipine Monomethyl Ester, CAS: 103890-81-9, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁NO₆.
Lacidipine-d10, CAS: 1185245-62-8, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃D₁₀NO₆.
Lactobionic Acid, CAS: 96-82-2, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₁₂.
Lactobionic Acid Calcium Salt Hydrate, CAS: /, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₂CaO₂₄ • x(H ₂O).
Lamotrigine, CAS: 84057-84-1, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇Cl₂N₅.
Lamotrigine-13C3, CAS: 1188265-38-4, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₇Cl₂N₅.
Lamotrigine-13C3,d3, Major, CAS: 1246815-13-3, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₄D₃Cl₂N₅.
Lamotrigine-13C315N5, CAS: /, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₇Cl₂¹⁵N₅.
Lei-Dab 7, CAS: 1061556-49-7, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄₁H₂₃₆N₄₆O₃₉S₆.
Lercanidipine 5-Desmethyl-5-Propyl Ester, CAS: 1797124-83-4, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₅N₃O₆.
Lercanidipine 5-Desmethyl-5-Propyl Ester-d7, CAS: /, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₆D₆N₃O₆.
Lercanidipine Hydrochloride, CAS: 132866-11-6, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₂ClN₃O₆.
Lercanidipine Impurity A, CAS: 74936-74-6, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₂O₆.
Lercanidipine Impurity A-d5, CAS: /, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆D₆N₂O₆.
Lercanidipine-d3, CAS: 1190043-34-5, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₈D₃N₃O₆.
Lercanidipine-d3 Hydrochloride, CAS: 1189954-18-4, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₉D₃ClN₃O₆.
Leucovorin Calcium Salt, CAS: /, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₄₄CaN₁₄O₁₄.
Leucovorin Calcium Salt Pentahydrate, CAS: 6035-45-6, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁CaN₇O₁₂.
Leucovorin-d4 Calcium Salt Hydrate, > 90%, CAS: /, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇D₄CaN₇O₇ •xH₂O.
Levomefolate Calcium, CAS: 151533-22-1, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃CaN₇O₆.
Levomefolate Calcium-13C5, CAS: /, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅¹³C₅H₂₅CaN₇O₆.
Lomerizine Dihydrochloride, CAS: 101477-54-7, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂Cl₂F₂N₂O₃.
Lomerizine-d8 Dihydrochloride, CAS: /, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₇D₈Cl₂F₂N₂O₃.
Magnesium Phosphate Hydrate, CAS: 53408-95-0, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Mg₃O₈P₂.
Manidipine, CAS: 89226-50-6, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₈N₄O₆.
Manidipine Dihydrochloride, CAS: 89226-75-5, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₄₀Cl₂N₄O₆.
Manidipine-d4, CAS: 1189656-59-4, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₄D₄N₄O₆.
Manoalide, CAS: 75088-80-1, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₆O₅.
Methsuximide, CAS: 77-41-8, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₂.
Methsuximide-d5, CAS: 1189980-63-9, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₅NO₂.
Methyl (3,3-Diphenylpropyl)carbamate-d1, CAS: /, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈DNO₂.
Methyl Methanesulfonate, CAS: 66-27-3, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₆O₃S.
Methyldiazenyl, CAS: 64287-49-6, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₃N₂.
Mibefradil Dihydrochloride Monohydrate, CAS: 1391053-69-2, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₂ClFN₃O₄.
MJ 33 Lithium Salt, CAS: 1007476-63-2, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₃F₃LiO₆P.
ML SA1, CAS: 332382-54-4, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂N₂O₃.
MMPIP Hydrochloride, CAS: 1215566-78-1, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆ClN₃O₃.
Monkey S100A11(S100 Calcium Binding Protein A11) ELISA Kit (96T), CAS: /, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Monkey S100A6(S100 Calcium Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mordant Blue 13, CAS: 1058-92-0, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₉ClN₂Na₂O₉S₂.
Mouse Atp2a1 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Atp2a3 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Atp2a3(Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Ca-ATPase(Calcium ATPase) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cab39 (Calcium-binding protein 39) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cabs1 (Calcium-binding and spermatid-specific protein 1) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cabyr (Calcium-binding tyrosine phosphorylation-regulated protein) ELISA Kit (96T), CAS: /, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cadps (Calcium-dependent secretion activator 1) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cadps2 (Calcium-dependent secretion activator 2) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Caln1 (Calcium-binding protein 8) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Camk2n1 (Calcium/calmodulin-dependent protein kinase II inhibitor 1) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Camkk2 (Calcium/calmodulin-dependent protein kinase kinase 2) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Camlg (Calcium signal-modulating cyclophilin ligand) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cant1 (Soluble calcium-activated nucleotidase 1) ELISA Kit (96T), CAS: /, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Carhsp1 (Calcium-regulated heat-stable protein 1) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse CaSR(Calcium Sensing Receptor) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Ccbe1 (Collagen and calcium-binding EGF domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cherp (Calcium homeostasis endoplasmic reticulum protein) ELISA Kit (96T), CAS: /, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Cib2 (Calcium and integrin-binding family member 2) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Hpca (Neuron-specific calcium-binding protein hippocalcin) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse iPLA2(Phospholipase A2, Calcium Independent ) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Micu1 (Calcium uptake protein 1, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Ncs1 (Neuronal calcium sensor 1) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Orai1 (Calcium release-activated calcium channel protein 1) ELISA Kit (96T), CAS: /, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Pde1c(Calcium/calmodulin-dependent 3’,5’-cyclic nucleotide phosphodiesterase 1C) ELISA Kit (96T), CAS: /, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A1(S100 Calcium-binding Protein A 1) ELISA Kit (96T), CAS: /, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A10(S100 Calcium-binding Protein A10) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A11(S100 Calcium Binding Protein A11) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A12(S100 Calcium Binding Protein A12) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A6(S100 Calcium Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A7(S100 Calcium Binding Protein A7) ELISA Kit (96T), CAS: /, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A8(S100 Calcium Binding Protein A8) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100A9(S100 Calcium Binding Protein A9) ELISA Kit (96T), CAS: /, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse S100B(S100 Calcium Binding Protein B) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
MS 153, CAS: 130775-79-0, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O.
2-Cyano-N-(3,5-dichloro-4-methoxyphenyl)-acetamide, CAS: 1821033-10-6, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈Cl₂N₂O₂.
Mupirocin Calcium Salt, CAS: 115074-43-6, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₆Ca₀.₅O₁₀.
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile, CAS: 380843-12-9, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅Cl₂N₃O₃.
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-hydroxy-6-methoxy-3-quinolinecarbonitrile, CAS: 1460227-29-5, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃Cl₂N₃O₃.
N-(2-Chloro-2-methylpropyl)-N-(3,3-diphenylpropyl)-N-methylamine, CAS: 936491-32-6, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆ClN.
4-[(3,5-Dichloro-4-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile, CAS: 1391063-17-4, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉Cl₂N₅O₃.
Bosutinib, CAS: 380843-75-4, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉Cl₂N₅O₃.
N-(2-Chloro-2-methylpropyl)-N-(3,3-diphenylpropyl)-N-methylamine-d5, CAS: /, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₅ClN.
N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide Hydrochloride, CAS: 92564-34-6, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆ClN₅O₂S.
Bosutinib Isomer Methanoate, CAS: /, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₃Cl₂N₅O₄.
Bosutinib N-Oxide, CAS: /, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉Cl₂N₅O₄.
N-(4-Aminobutyl)-2-naphthalenesulfonamide Hydrochloride, CAS: 89108-46-3, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉ClN₂O₂S.
N-(4-Aminobutyl)-5-chloro-2-naphthalenesulfonamide Hydrochloride, CAS: 88519-57-7, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈Cl₂N₂O₂S.
Bosutinib-d8, CAS: /, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₁D₈Cl₂N₅O₃.
N-Desmethylpiperazine Hydroxy Bosutinib, CAS: /, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉Cl₂N₃O₄.
N-(6-Aminohexyl)-1-naphthalenesulfonamide Hydrochloride, CAS: 61714-25-8, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃ClN₂O₂S.
N-(6-Aminohexyl)-2-naphthalenesulfonamide Hydrochloride, CAS: 35517-14-7, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃ClN₂O₂S.
N-(Carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-glycine Calcium Salt Hydrate (>80%), CAS: /, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂Ca₃N₄O₁₂ + x(H ₂O).
N-Acetyl-cys(1)-calcitonin Salmon Trifluoroacetic Acid Salt, CAS: /, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄₇H₂₄₃N₄₄O₄₉S₂ • x(C ₂HF₃O₂).
N-Arachidonoyltaurine, CAS: 119959-65-8, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₇NO₄S.
N-Arachidonoyltaurine-d4, CAS: /, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₃D₄NO₄S.
N-Debutyl Terodiline Hydrochloride, CAS: 53936-47-3, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀ClN.
N-Desmethyl Diltiazem Hydrochloride, CAS: 130606-60-9, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅ClN₂O₄S.
N-Desmethyl Diltiazem-d3 Hydrochloride, CAS: /, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₃ClN₂O₄S.
N-Desmethyl Diltiazem-d4 Hydrochloride, CAS: 1217650-51-5, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁D₄ClN₂O₄S.
N-Desmethyl-N-acetyl Diltiazem, CAS: /, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₆N₂O₅S.
N-Desmethyl-N-acetyl Diltiazem-d4, CAS: /, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂D₄N₂O₅S.
N-Methyl-1H-pyrrol-2-amine Hydrochloride, CAS: 223500-12-7, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₂ • (HCl).
N-Methyl-N-(2,2,2-Trifluoroethyl)carbamoyl Chloride, CAS: 1505056-54-1, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅ClF₃NO.
N-Methyl-N-(3-chloropropyl)homoveratrylamine Hydrochloride, CAS: 36770-75-9, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃Cl₂NO₂.
N-[2-[[[1,4-Dihydro-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinyl]carbonyl]oxy]ethyl]-N,N-dimethylbenzenemethanaminium Iodide, CAS: 196930-16-2, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂IN₃O₆.
N-[[(6-Hydroxy-1-naphthalenyl)amino]thioxomethyl]-2-furancarboxamide, CAS: 827001-82-1, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂N₂O₃S.
N1,N3-Bis[2-(3,4-dimethoxyphenyl)ethyl]-N1,N3-dimethyl-1,3-propanediamine Dihydrochloride, CAS: 63434-11-7, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₈N₂O₄•2(HCl).
N1-Acetylspermine Trihydrochloride, CAS: 77928-70-2, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₃₁Cl₃N₄O.
N1-Acetylspermine-d3 Trihydrochloride, CAS: /, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₈D₃Cl₃N₄O.
N5-Methyllamotrigine, CAS: 1373243-86-7, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉Cl₂N₅.
NAADP-AM, CAS: 1115066-04-0, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₄N₆O₂₆P₃.
Nemadipine B, CAS: 79925-38-5, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁Cl₂NO₄.
Nemadipine B-d10, CAS: 1794971-22-4, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₁D₁₀Cl₂NO₄.
Nemadipine-A, CAS: 54280-71-6, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈F₅NO₄.
Nicardipine, CAS: 55985-32-5, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉N₃O₆.
Nicardipine Hydrochloride, CAS: 54527-84-3, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀ClN₃O₆.
Nicardipine O-Desmethyl-O-methyl(phenylmethyl)amino]ethyl) Ester Hydrochloride, CAS: /, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₄₀N₄O₆ • x(HCl).
Nicardipine O-Desmethyl-O-methyl(phenylmethyl)amino]ethyl) Ester-d6 Hydrochloride, CAS: /, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₄D₆N₄O₆.
Nicardipine-d3 Hydrochloride, CAS: 1432061-50-1, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇D₃ClN₃O₆.
Nifedipine, CAS: 21829-25-4, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₂O₆.
Nifedipine Monoamide, CAS: 114709-68-1, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₅.
Nifedipine Monoamide-d4, CAS: /, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₄N₃O₅.
Nifedipine-d6, CAS: 1188266-14-9, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₆N₂O₆.
Niguldipine Hydrochloride, CAS: 113317-61-6, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₉N₃O₆ • (HCl).
Nimodipine, CAS: 66085-59-4, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₂O₇.
Nimodipine-d7, CAS: 1246815-36-0, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉D₇N₂O₇.
Nisoldipine, CAS: 63675-72-9, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄N₂O₆.
Nisoldipine-d4, CAS: 1219795-47-7, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀D₄N₂O₆.
Nisoldipine-d7, CAS: 1189718-34-0, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇D₇N₂O₆.
Nitrendipine, CAS: 39562-70-4, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂O₆.
Nitrendipine-d5, CAS: /, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅D₅N₂O₆.
NNC 55-0396, CAS: 357400-13-6, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₀Cl₂FN₃O₂.
Norbormide, CAS: 991-42-4, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₂₅N₃O₃.
Normesuximide, CAS: 1497-17-2, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁NO₂.
Normesuximide-d5, CAS: 1185130-51-1, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆D₅NO₂.
NPS 2143, CAS: 324523-20-8, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆Cl₂N₂O₂.
NPS 2390, CAS: 226878-01-9, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O.
NS 1619, CAS: 153587-01-0, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈F₆N₂O₂.
O-Cresolphthalein Complexone Sodium Salt, CAS: 62698-54-8, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₈N₂Na₄O₁₂.
O-Desisopropyl-O-methoxyethyl Nimodipine, CAS: 70172-96-2, stock: 2.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₂O₈.
O-Desmethyl Felodipine, CAS: 150131-21-8, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂NO₄.
O-Desmethyl Felodipine-13C4, CAS: /, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³C₄H₁₇Cl₂NO₄.
O-Desmethyl Felodipine-d5, CAS: 1794827-40-9, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₅Cl₂NO₄.
O-Desmethyl O-Isobutyl Nisoldipine, CAS: /, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀N₂O₆.
Octylphosphonic Acid, CAS: 4724-48-5, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₉O₃P.
ONO 5334, CAS: 868273-90-9, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄N₄O₄S.
Ophiobolin B, CAS: 5601-74-1, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₈O₄.
Oxalic Acid Potassium Salt Dihydrate, CAS: 6100-20-5, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇KO₁₀.
Oxalyl Chloride, CAS: 79-37-8, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂Cl₂O₂.
Palladium (5% on Calcium Carbonate, Lead poisoned), CAS: 03/05/7440, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Pd.
Palladium (5% on Calcium Carbonate, unpoisoned, unreduced), CAS: 03/05/7440, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Pd.
Palmitoleoyl Chloride, CAS: 40426-22-0, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₉ClO.
Pantothenic Acid Hemicalcium Salt, CAS: 137-08-6, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂CaN₂O₁₀.
Pantothenic Acid-13C3,15N Hemicalcium Salt, CAS: 356786-94-2, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂¹³C₆H₃₂Ca¹⁵N₂O₁₀.
Patent Blue V, CAS: 3536-49-0, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₄H₆₄CaN₄Na₂O₁₄S₄.
PHA-543613 Dihydrochloride, CAS: 478148-58-2, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉Cl₂N₃O₂.
Phospho(enol)pyruvic Acid Monosodium Salt, CAS: 53823-68-0, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄NaO₆P.
Phosphocholine Chloride Calcium Salt, CAS: 4826-71-5, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃CaClNO₄P.
Phosphocholine Chloride Calcium Salt Tetrahydrate, CAS: 72556-74-2, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃CaClNO₄P • 4H₂O.
Phosphocholine Chloride Calcium Salt Tetrahydrate, CAS: 72556-74-2, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃CaClNO₄P•4H₂O.
Phosphocholine-d9 Chloride Calcium Salt, CAS: 344299-43-0, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄D₉CaClNO₄P.
Phosphoethanolamine Calcium, CAS: 10389-08-9, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₆CaNO₄P.
Phosphoseryl Phosphoserine, CAS: 1492-21-3, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄N₂O₁₁P₂.
Pigment Red 64 (Calcium Salt), CAS: 6371-76-2, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₂₂CaN₄O₆.
Pigment Yellow 62, CAS: 12286-66-7, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₆CaN₈O₁₄S₂.
Pitavastatin Calcium, CAS: 147526-32-7, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₄₆CaF₂N₂O₈.
Pitavastatin-d4 Calcium, CAS: /, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₃₈D₈CaF₂N₂O₈.
Porcine S100A11(S100 Calcium Binding Protein A11) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Porcine S100A6(S100 Calcium Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Pranidipine, CAS: 99522-79-9, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄N₂O₆.
Previtamin D3 (>80%), CAS: 1173-13-3, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O.
Prohexadione Calcium, CAS: 127277-53-6, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀CaO₅.
11-Keto β-Boswellic Acid, CAS: 17019-92-0, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₆O₄.
2-Bromo-6-nitroaniline, CAS: 59255-95-7, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BrN₂O₂.
QUIN 2, Tetrapotassium Salt, CAS: 73630-23-6, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇N₃O₁₀ • 4K.
R-(-)-Manidipine, CAS: 133082-19-6, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₈N₄O₆.
3-Acetyl-11-keto-β-boswellic Acid, CAS: 67416-61-9, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₈O₅.
3-O-Acetyl-beta-boswellic Acid, CAS: 5968-70-7, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₀O₄.
4,5-Didehydro Brimonidine, CAS: 151110-15-5, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈BrN₅.
R-(-)-Manidipine Hydrochloride, CAS: 133082-19-6, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₉ClN₄O₆.
R-(-)-Manidipine-d4, CAS: 1217718-54-1, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₄D₄N₄O₆.
Acetyl-α-boswellic Acid, CAS: 89913-60-0, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₀O₄.
α-Boswellic Acid, CAS: 471-66-9, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₈O₃.
5-Bromo-6-(1H-imidazol-4-yl)quinoxaline, CAS: /, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇BrN₄.
5-Bromo-6-isothiocyanatoquinoxaline, CAS: 134892-46-9, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₄BrN₃S.
Rabbit S100A11(S100 Calcium Binding Protein A11) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rabbit S100A6(S100 Calcium Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
β-Boswellic Acid, CAS: 631-69-6, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₈O₃.
5-Bromo-N-propylquinoxalin-2-amine, CAS: /, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂BrN₃.
5-Bromoquinazolin-6-ylthiourea, CAS: 842138-74-3, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇BrN₄S.
Rabbit S100B(S100 Calcium Binding Protein B) ELISA Kit (96T), CAS: /, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6-Amino-5-bromoquinoxaline, CAS: 50358-63-9, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrN₃.
6-Quinoxalinamine, CAS: 6298-37-9, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇N₃.
Brimonidine, CAS: 59803-98-4, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀BrN₅.
Brimonidine L-Tartrate, CAS: 70359-46-5, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆BrN₅O₆.
Brimonidine N,N-Methylene Dimer, CAS: /, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀Br₂N₁₀.
Brimonidine-2,3-dione, CAS: 182627-95-8, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀BrN₅O₂.
rac Felodipine-d3, CAS: 1189970-31-7, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₃Cl₂NO₄.
Brimonidine-d4 D-Tartrate, CAS: 1316758-27-6, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂D₄BrN₅O₆.
rac Felodipine-d8, CAS: 1346602-65-0, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₁D₈Cl₂NO₄.
Brimonidine-d4 L-Tartrate, CAS: /, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂D₄BrN₅O₆.
Hydroxy Brimonidine Trifluoroacetic Acid Salt, CAS: 1391054-10-6, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃BrF₃N₅O₃.
(2S)-2-Amino-3,3-di(methyl-d3)butanamide-4,4,4-d3, CAS: 1092540-47-0, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅D₉N₂O.
N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine, CAS: 1217439-06-9, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄N₄.
N-(4,5-Dihydro-1H-imidazol-2-yl)-6-quinoxalinamine, CAS: 91147-43-2, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁N₅.
rac-cis-Desacetyl Diltiazem Hydrochloride, CAS: 40601-99-8, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅ClN₂O₃S.
rac-Kavain, CAS: 3155-48-4, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₃.
(3R,7aS)-1,7a-Dihydro-3-phenyl-3H,5H-pyrrolo[1,2-c]oxazol-5-one, CAS: 134107-65-6, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₂.
(3R,7aS)-Tetrahydro-3-phenyl-3H,5H-pyrrolo[1,2-c]oxazol-5-one, CAS: 103201-79-2, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₂.
N-(4,5-Dihydro-1H-imidazol-2-yl)-6-quinoxalinamine-d4, CAS: /, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇D₄N₅.
N-(5-Bromo-6-quinoxalinyl)quanidine Hydrochloride, CAS: 1797986-78-7, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉BrClN₅.
rac-Kavain-d3, CAS: /, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄D₃H₁₁O₃.
rac-trans-4-Defluoro-4-methoxy Paroxetine Hydrochloride, CAS: 127017-74-7, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄ClNO₄.
(αR)-α-[[(1S)-1-(Aminocarbonyl)-2,2-di(methyl-d3)propyl-3,3,3-d3]amino]benzeneacetamide-d9, CAS: 1092540-46-9, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂D₉N₃O₂.
(αR)-α-[[(1S)-1-Cyano-2,2-di(methyl-d3)propyl-3,3,3-d3]amino]benzeneacetamide-d9, CAS: 1092540-45-8, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀D₉N₃O.
N-(8-Bromo-6-quinoxalinyl)thiourea, CAS: 1217439-05-8, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇BrN₄S.
N-tert-Butyloxycarbonyl Hydroxy Brimonidine, CAS: 1391053-57-8, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀BrN₅O₃.
Ralfinamide Mesylate, CAS: 202825-45-4, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃FN₂O₅S.
Rat Atp2a1 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
2’-Dihydro Boceprevir(Boceprevir Metabolite M28+M31 (Mixture of Diastereomers)), CAS: /, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₇N₅O₅.
2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers)), CAS: 1373318-85-4, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₈D₉N₅O₅.
O-Ethyl (5-Bromoquinoxalin-6-yl)carbamothioate (Brimonidine Impurity), CAS: 842138-75-4, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀BrN₃OS.
O-Isopropyl (5-Bromoquinoxalin-6-yl)carbamothioate(Brimonidine Impurity), CAS: /, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂BrN₃OS.
Rat Atp2a1(Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) ELISA Kit (96T), CAS: /, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Atp2a3 (Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
3-(Methyl-d3)-L-Valine-4,4,4,4’,4’,4’-d6 Hydrochloride, CAS: 1092540-48-1, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄D₉NO₂ • HCl.
Boceprevir, CAS: 394730-60-0, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₅N₅O₅.
Quinoxaline 6-Isothiocyanate, CAS: 135306-56-8, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅N₃S.
UK 14819, CAS: 91147-46-5, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀ClN₅.
Rat Atp2a3(Sarcoplasmic/endoplasmic reticulum calcium ATPase 3) ELISA Kit (96T), CAS: /, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Cabs1 (Calcium-binding and spermatid-specific protein 1) ELISA Kit (96T), CAS: /, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Boceprevir Metabolite M15, CAS: 1351791-45-1, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄N₄O₃.
Boceprevir Metabolite M15-d9, CAS: /, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅D₉N₄O₃.
Rat Cacna1a(Voltage-dependent P/Q-type calcium channel subunit alpha-1A) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Cadps (Calcium-dependent secretion activator 1) ELISA Kit (96T), CAS: /, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Boceprevir Metabolite M4, CAS: 816444-90-3, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃N₃O₄.
Boceprevir Metabolite M4-d9, CAS: 1373318-84-3, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄D₉N₃O₄.
Rat Caln1 (Calcium-binding protein 8) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat CAMK2(Calcium/Calmodulin-Dependent Protein Kinase-Ⅱ) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Boceprevir Metabolite M4-d9 Methyl Ester, CAS: 1158083-48-7, stock: 4.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆D₉N₃O₄.
Boceprevir-d9, CAS: 1256751-11-7, stock: 9.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆D₉N₅O₅.
Rat Camk2n1 (Calcium/calmodulin-dependent protein kinase II inhibitor 1) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Camkk2 (Calcium/calmodulin-dependent protein kinase kinase 2) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
D-Phenylglycinamide, CAS: 6485-67-2, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀N₂O.
Isobutyl Isocyanate, CAS: 1873-29-6, stock: 9.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉NO.
Rat Cant1 (Soluble calcium-activated nucleotidase 1) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Carhsp1 (Calcium-regulated heat-stable protein 1) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
β-Amino-α-hydroxycyclobutanebutanamide Hydrochloride, CAS: 394735-23-0, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₇ClN₂O₂.
β-Amino-α-oxo-cyclobutanebutanamide Hydrochloride, CAS: 817169-86-1, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅ClN₂O₂.
Rat CASR(Calcium Sensing Receptor) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Cib2 (Calcium and integrin-binding family member 2) ELISA Kit (96T), CAS: /, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Pivalaldehyde-d9, CAS: 90137-14-7, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅HD₉O.
Rat Hpca (Neuron-specific calcium-binding protein hippocalcin) ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Micu1 (Calcium uptake protein 1, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Ncs1 (Neuronal calcium sensor 1) ELISA Kit (96T), CAS: /, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Orai1 (Calcium release-activated calcium channel protein 1) ELISA Kit (96T), CAS: /, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat S100A11(S100 Calcium Binding Protein A11) ELISA Kit (96T), CAS: /, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat S100A6(S100 Calcium-Binding Protein A6) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat S100B(S100 Calcium Binding Protein B) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Ro 67-4853, CAS: 302841-89-0, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉NO₄.
Rosuvastatin Calcium Salt, CAS: 147098-20-2, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇FN₃O₆S•1/2Ca.
Rosuvastatin Isoamy Ester, CAS: 1197348-98-3, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₈FN₃O₆S.
S-(+)-Manidipine, CAS: 126451-47-6, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₈N₄O₆.
S-(+)-Manidipine-d4, CAS: 1217836-12-8, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₄D₄N₄O₆.
S-(+)-Niguldipine Hydrochloride, CAS: 113145-69-0, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₉N₃O₆ • (HCl).
S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin-d6 Calcium Salt, CAS: /, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇D₆FN₃O₇S•1/2Ca.
Saccharin Calcium Hydrate, CAS: 6381-91-5, stock: 6.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈CaN₂O₆S₂•3.5[H₂O].
SKF 96365 Hydrochloride, CAS: 130495-35-1, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆N₂O₃ • HCl.
Sodium Chloride, CAS: 7647-14-5, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ClNa.
Sodium Chondroitin Sulfate A, CAS: 39455-18-0, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₁₄H₂₃NO₁₅S)n • xNa.
Sodium Metaphosphate Pentahydrate, CAS: 13517-23-2, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: HNa₂O₃P•5H₂O.
Sodium Phosphate Dibasic, CAS: 7558-79-4, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: HNa₂O₄P.
Spermine, CAS: 71-44-3, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₆N₄.
Spermine-d20, CAS: /, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆D₂₀N₄.
SR 33805 Oxalate, CAS: 121346-33-6, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₂N₂O₉S.
STO-609 Acetate, CAS: 1173022-21-3, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₄N₂O₅.
Strontium Chloride, CAS: 10476-85-4, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: SrCl₂.
Sulforhodamine 101, CAS: 60311-02-6, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₀N₂O₇S₂.
SUN-B 8155, CAS: 345893-91-6, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅N₃O₃.
t-Butyl (3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate, CAS: 147489-06-3, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₆FNO₄.
t-Butyl (3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate-d5, CAS: /, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₁D₅FNO₄.
TAS 301, CAS: 193620-69-8, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₉NO₃.
Taurine, CAS: 107-35-7, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₇NO₃S.
Taurine-d4, CAS: 342611-14-7, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₃D₄NO₃S.
TC-FPR 43, CAS: 903895-98-7, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁ClN₄O₂.
Teludipine, CAS: 108687-08-7, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈N₂O₆.
Teludipine-d6, CAS: 1246833-02-2, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂D₆N₂O₆.
Tenivastatin Calcium Hydrate, CAS: 530112-57-3, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₀O₆ • 1/2(Ca) • x(H ₂O).
tert-Butyl 3-Aminopropyl(methyl) Carbamate, CAS: 150349-36-3, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₀N₂O₂.
tert-Butyl Pitavastatin, CAS: 586966-54-3, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂FNO₄.
Tetraacetoxymethyl Bis(2-aminoethyl) Ether N,N,N’,N’-Tetraacetic Acid, CAS: 887407-56-9, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₆N₂O₁₇.
Tetrandrine, CAS: 518-34-3, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₂N₂O₆.
Thapsigargin, CAS: 67526-95-8, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₀O₁₂.
TRAM-34, CAS: 289905-88-0, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇ClN₂.
trans-Eldecalcitol, CAS: 861996-34-1, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O₅.
Tribasic Calcium Phosphate, CAS: 12167-74-7, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ca₅HO₁₃P₃.
Tungsten(VI) Oxide, CAS: 1314-35-8, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: O₃W.
Tyrphostin A9, CAS: 10537-47-0, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂N₂O.
Verapamil Ethyl Methanethiosulfonate, Bromide, CAS: 353270-25-4, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₅BrN₂O₆S₂.
Verapamil Hydrochloride, CAS: 152-11-4, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₉ClN₂O₄.
Verapamil-d3 Hydrochloride, CAS: /, stock: 9.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆D₃ClN₂O₄.
Verapamil-d6 Hydrochloride, CAS: 1185032-80-7, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₃D₆ClN₂O₄.
Verapamil-d7 Hydrochloride, CAS: 1188265-55-5, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂D₇ClN₂O₄.
Vitamin D2 β-D-Glucuronide Sodium Salt, CAS: 85701-30-0, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₁NaO₇.
Vitamin D3, CAS: 67-97-0, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O.
Vitamin D3 Hemisuccinate, CAS: 64889-68-5, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₈O₄.
Vitamin D3 N-acetylglucosaminide, CAS: 175409-16-2, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₅₇NO₆.
Vitamin D3 O-t-Butyldimethylsilyl Ether, CAS: 87649-56-7, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₈OSi.
Vitamin D3-d3, CAS: 80666-48-4, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₁D₃O.
Vitamin D3-d6, CAS: 118584-54-6, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₈D₆O.
Vitamin D3-d7, CAS: 1627523-19-6, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇D₇O.
Vitamin D3-d7 (Major), CAS: 1627523-19-6, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇D₇O.
YM 2447690, CAS: 837424-39-2, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃ClFN₃O₃.
Ziconotide Polyacetate, CAS: 107452-89-1, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀₂H₁₇₂N₃₆O₃₂S₇ •xC₂H₄O₂.
Zofenopril Calcium Salt, CAS: 81938-43-4, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₄₄CaN₂O₈S₄.
Zofenopril-d5 Calcium Salt, CAS: /, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₃₄D₁₀CaN₂O₈S₄.
Zonisamide, CAS: 68291-97-4, stock: 2.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₂O₃S.
Zonisamide-13C2-15N, CAS: 1188265-58-8, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₂H₈N¹⁵NO₃S.
Zonisamide-d4, CAS: 1020720-04-0, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄D₄N₂O₃S.
ZQ 16, CAS: 376616-73-8, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O₂S.
[[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-phosphonium Bromide, CAS: 154057-58-6, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₀BrFNP.
[[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-phosphonium-d5 Bromide, CAS: /, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₂₅D₅BrFNP.
{1-[(Methylamino)methyl]cyclopropyl}methanol, CAS: 959238-63-2, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO.
Bivalirudin (Asn9Gln) Trifluoroacetic Acid Salt, CAS: /, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₉H₁₄₀N₂₄O₃₃ . (C ₂HF₃O₂)ₓ.
Bivalirudin 1-11 Fragment Trifluoroacetic Acid Salt, CAS: /, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₆₃N₁₅O₁₅ . (C₂HF₃O₂)ₓ.
Bivalirudin 12-20 Fragment Trifluoroacetic Acid Salt (Impurity), CAS: /, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₇₇N₉O₁₉•xC₂HF₃O₂.
Bivalirudin 2-20 Fragment Trifluoroacetic Acid Salt, CAS: /, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈₉H₁₃₁N₂₇O₂₇ (xCF₃CO₂H).
Bivalirudin Des-Gly Fragment Trifluoroacetic Acid Salt (Impurity), CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₆H₁₃₅N₂₃O₃₂•xC₂HF₃O₂.
Bivalirudin α-ASPA 9 Analog Trifluoroacetic Acid Salt (Impurity), CAS: /, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₈H₁₃₇N₂₃O₃₄•xC₂HF₃O₂.
Bivalirudin β-ASPA 9 Analog Trifluoroacetic Acid Salt (Impurity), CAS: /, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₈H₁₃₇N₂₃O₃₄•xC₂HF₃O₂.
Bivalirudin Plus-Gly Fragment Trifluoroacetic Acid Salt (Impurity), CAS: /, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀₀H₁₄₁N₂₅O₃₄•xC₂HF₃O₂.
Bivalirudin Trifluoroacetic Acid Salt, CAS: 1124915-67-8, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₈H₁₃₈N₂₄O₃₃ . (C ₂HF₃O₂)ₓ.
Bivalirudin-(D-Phe-12) (Bivalirudin Impurity B), CAS: /, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₈H₁₃₈N₂₄O₃₃•xC₂HF₃O₂.
Bivalirudin-d4, CAS: /, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₈H₁₃₄D₄N₂₄O₃₃.
des-(Glu13)-Bivalirudin Trifluoroacetic Acid Salt, CAS: /, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉₃H₁₃₁N₂₃O₃₀ • x( C₂HF₃O₂).
[3-20} Bivalirudin Trifluoroacetic Acid Salt, CAS: /, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈₄H₁₂₂N₂₂O₃₁ • x(C ₂HF₃O₂).
[5-20] Bivalirudin Trifluoroacetic Acid Salt, CAS: /, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₃H₁₀₃N₁₇O₂₉ • x( C₂F₃O₂H).
(22R,23R)-28-Homo Brassinolide, CAS: 82373-95-3, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₀O₆.
(22RS,23RS)-28-Homo Brassinolide, CAS: 74174-44-0, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₀O₆.
(22S,23S)-28-Homo Brassinolide, CAS: 80483-89-2, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₀O₆.
(22S,23S,24S)-24-Ethylbrassinone, CAS: 83510-06-9, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₀O₅.
28-Nor Brassinolide, CAS: 77736-43-7, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₆O₆.
28-Nor Brassinolide-d3, CAS: 313350-52-6, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₃D₃O₆.
3,24-Diepibrassinolide, CAS: 163514-19-0, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₈O₆.
Brassinolide >90%, CAS: 72962-43-7, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₈O₆.
Castasterone, CAS: 80736-41-0, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₈O₅.
Epi Brassinolide, 90%, CAS: 78821-43-9, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₈O₆.
Laxogenine, CAS: 1177-71-5, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₂O₄.
Norteasterone, CAS: 105319-58-2, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₆O₄.
tris-Epibrassinolide, CAS: 78821-42-8, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₈O₆.
(1R)-(1S,2S,3R,5S)-Pinanediol-N-(N-pyrazinylphenylalaninoyl)-1-amino-3-methyl-butane-1-boronate, CAS: 205393-22-2, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₉BN₄O₄.
(1R)-(1S,2S,3R,5S)-Pinanediol-N-(N-pyrazinylphenylalaninoyl)-1-amino-3-methylbutane-1-boronate-d8, CAS: /, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₁D₈BN₄O₄.
(1R)-(1S,2S,3R,5S)-Pinanediol-N-(N-pyrazinylphenylalaninoyl)-1-aminohexyl-1-boronate, CAS: /, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₁BN₄O₄.
(1R)-(1S,2S,3R,5S)-Pinanediol-N-(N-pyrazinylphenylalaninoyl)-1-aminopentyl-1-boronate, CAS: /, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₉BN₄O₄.
(1R,2R)-(1S,2S,3R,5S)-Pinanediol-N-(N-pyrazinylphenylalaninoyl)-1-aminopentyl-1-boronate, CAS: /, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₉BN₄O₄.
(1R,2R)-Bortezomib, CAS: 1132709-15-9, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₄.
(1R,2R)-Bortezomib-d5, CAS: /, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀D₅BN₄O₄.
(1S)-(αR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-pentyl-4,6-methano-1,3,2-benzodioxaborole-2-methanamine Trifluoroacetic Acid Salt, CAS: /, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₁BF₃NO₄.
(1S)-3-Hydroxy Bortezomib, CAS: /, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₅.
(1S)-3-Hydroxy Bortezomib-d8, CAS: /, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇D₈BN₄O₅.
(1S,2R)-Bortezomib, CAS: 1132709-16-0, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₄.
(1S,2R)-Bortezomib-d5, CAS: /, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀D₅BN₄O₄.
(1S,2S)-Bortezomib, CAS: 1132709-14-8, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₄.
(1S,2S)-Bortezomib-d5, CAS: /, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀D₅BN₄O₄.
(3aS,4S,6S,7aR)-2-Butylhexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborole, CAS: 85167-10-8, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₅BO₂.
(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-2-pentyl-4,6-methano-1,3,2-benzodioxaborole, CAS: 476335-09-8, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₇BO₂.
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Hydrochloride, CAS: 779357-85-6, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₉BClNO₂.
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt, CAS: 179324-87-9, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉BF₃NO₄.
(αS)-(1R,2R,3S,5R)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt, CAS: 1310383-72-2, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉BF₃NO₄.
(αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride, CAS: 205393-21-1, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆BClN₂O₃.
(αS,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-methanamine Hydrochloride, CAS: 945606-99-5, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈BNO₂.
(R)-(3-Methyl-1-(pyrazine-2-carboxamido)butyl)boronic Acid, CAS: /, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆BN₃O₃.
(R)-Hydroperoxy Des(boric Acid) Bortezomib, CAS: 886979-78-8, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₄.
(R)-Hydroperoxy Des(boric Acid) Bortezomib Dimer, CAS: /, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₆N₈O₆.
(R)-Hydroxy Des(boric Acid) Bortezomib, CAS: 289472-78-2, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₃.
(R)-Hydroxy-O-ethyl Des(boric Acid) Bortezomib, CAS: /, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈N₄O₃.
(R)-N-(1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide, CAS: /, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₄O₄.
(R)-N-(1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide-d8, CAS: /, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄D₈N₄O₄.
(R)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide, CAS: /, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₄O₃.
(R)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide-d9, CAS: /, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₃D₉N₄O₃.
(R,R)-Hydroxy Des(boric Acid) Bortezomib, CAS: /, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₃.
(S)-1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-aminium Chloride, CAS: /, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁ClN₂O₃.
(S)-Benzyl (1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)carbamate, CAS: /, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆N₂O₅.
(S)-Hydroperoxy Des(boric Acid) Bortezomib, CAS: 886979-81-3, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₄.
(S)-Hydroxy Des(boric Acid) Bortezomib, CAS: 289472-81-7, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₃.
(S)-Hydroxy-O-ethyl Des(boric Acid) Bortezomib, CAS: /, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈N₄O₃.
(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide, CAS: /, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₄O₄.
2-Pyrazinecarbonyl Chloride, CAS: 19847-10-0, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃ClN₂O.
2-[(2-Pyrazinylcarbonyl)-Bortezomib, CAS: /, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇BN₆O₅.
3-Hydroxy Bortezomib, CAS: /, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₅.
3-Hydroxy Bortezomib-d6, CAS: /, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₆BN₄O₅.
3-Methyl-3-(phenylmethoxy)butanamide, CAS: 121490-17-3, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₂.
Afuresertib, CAS: 1047644-62-1, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇Cl₂FN₄OS.
Bortezomib, CAS: 179324-69-7, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₄.
Bortezomib Trimer, CAS: 390800-88-1, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₆₉B₃N₁₂O₉.
Bortezomib-D8 (Major), CAS: /, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇D₈BN₄O₄.
D-Phenylalanine-bortezomib, CAS: /, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄BN₅O₅.
Des-pyrazinecarboxaldehyde Bortezomib, CAS: 948294-96-0, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃BN₂O₃.
Desisobutyl-n-butyl Bortezomib, CAS: 1104011-35-9, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅BN₄O₄.
Desisobutyl-n-pentyl Bortezomib, CAS: /, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇BN₄O₄.
Doramapimod, CAS: 285983-48-4, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₇N₅O₃.
Ixazomib-13C2,15N, CAS: /, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂¹³C₂H₁₉BCl₂N¹⁵NO₄.
LY 2228820, CAS: 862507-23-1, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇FN₆O₆S₂.
LY 2228820-d9, CAS: /, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈D₉FN₆O₆S₂.
N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib, CAS: 862894-96-0, stock: 1.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₄O₃.
(+)-Amabiline, CAS: 17958-43-9, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₄.
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib, CAS: /, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₃D₉N₄O₃.
N-((R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)pyrazine-2-carboxamide, CAS: /, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀BN₃O₃.
(+)-Lycopsamine Hydrochloride (~90%), CAS: /, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₅ • HCl.
N-(2-Pyrazinylcarbonyl)-D-phenylalanine, CAS: 1608986-16-8, stock: 9.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃N₃O₃.
N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-hydroxy-3-methylbutyl]-L-phenylalaninamide, CAS: /, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄BN₅O₆.
(+)-Lycopsamine N-Oxide, CAS: 95462-15-0, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₆.
(+)-Lycopsamine N-Oxide-D7, CAS: /, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈D₇NO₆.
N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-hydroxy-3-methylbutyl]-L-phenylalaninamide-d6, CAS: /, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₈D₆BN₅O₆.
N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-L-phenylalaninamide, CAS: 1194235-41-0, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄BN₅O₅.
(+)-Lycopsamine-D7, CAS: /, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈D₇NO₅.
(+)-N-[1-(S)-Ethoxycarbonxyl-3-phenylpropyl]-L-alanine, CAS: 82717-96-2, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁NO₄.
N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-L-phenylalaninamide-d5, CAS: /, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉D₅BN₅O₅.
N-Pyrazinylcarbonyl-L-phenylalanine, CAS: 114457-94-2, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃N₃O₃.
(+)-Nilic Acid Methyl Ester, CAS: 65830-31-1, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₃.
(+/-)-2-Acetylaminobutanoic Acid, CAS: 114285-09-5, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO₃.
N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester, CAS: 73058-37-4, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₃O₃.
N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide, CAS: 289472-80-6, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄N₄O₂.
(+/-)-2-Acetylaminobutanoic Acid-d3, CAS: 1219397-36-0, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈D₃NO₃.
(+/-)-Homohistidine, CAS: 5817-77-6, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁N₃O₂.
N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide, CAS: 1446194-56-4, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₂.
N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-Carbamic Acid 1,1-Dimethylethyl Ester, CAS: 1187479-72-6, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₃BN₂O₅.
(-)-(2S,3S)-Viridifloric Acid Ethyl Ester-d7, CAS: /, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁D₇O₄.
(-)-N-(1-R-Ethoxycarbonxyl-3-phenylpropyl)-D-alanine, Benzyl Ester, CAS: 93836-47-6, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇NO₄.
1,2-Bis(4-hydroxyphenyl)-2-hydroxypropane, CAS: 154928-56-0, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₃.
Tipifarnib, CAS: 192185-72-1, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₂Cl₂N₄O.
(-)-N-(1-R-Ethoxycarbonxyl-3-phenylpropyl)-L-alanine Benzyl Ester, CAS: 93841-86-2, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇NO₄.
(-)-N-[1-(R)-Ethoxycarbonxyl-3-phenylpropyl)-D-alanine, CAS: 122076-80-6, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁NO₄.
1,2-Bis(4-hydroxyphenyl)-2-hydroxypropane-d3, CAS: /, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃D₃O₃.
2,2-Bis(4-hydroxyphenyl)propane-phosgene Copolymer, CAS: 25971-63-5, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₁₈H₂₀O₃)n . (HCl)n.
(-)-N-[1-(R)-Ethoxycarbonxyl-3-phenylpropyl]-L-alanine, CAS: 84324-12-9, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁NO₄.
(2R)-2,4-dihydroxy-3,3-dimethylbutanoic acid, CAS: 1112-33-0, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₄.
2,2-Bis(4-hydroxyphenyl)propanol, CAS: 142648-65-5, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₃.
2,2-Bis(4-hydroxyphenyl)propanol-d11, CAS: /, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₅D₁₁O₃.
(2R)-2-(Acetylamino)butanoic Acid-d3, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈D₃NO₃.
(2R)-2-(Acetylamino)butanoic Acid-d5, CAS: /, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆D₅NO₃.
2,2-Bis-(4-hydroxyphenyl)hexafluoropropane, CAS: 1478-61-1, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀F₆O₂.
2,2-Bis-(4-hydroxyphenyl)hexafluoropropane-d4, CAS: /, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₆D₄F₆O₂.
(2R)-2-Hydroxy-3-methylbutanoic Acid, CAS: 17407-56-6, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O₃.
(2R)-2-Hydroxy-4-(methylthio)butanoic Acid Calcium Salt, CAS: 71597-86-9, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈CaO₆S.
2,2’-Isopropylidenediphenol, CAS: 7559-72-0, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₂.
2,4-Bis(4-hydroxyphenyl)-4-methyl-1-pentene, CAS: 13464-24-9, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₂.
(2R)-2-Methyl-butanoic Acid Ethyl Ester, CAS: 40917-00-8, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₂.
(2R)-2-Methyl-butanoic Acid Ethyl Ester-d5, CAS: /, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉D₅O₂.
2,4’-Bisphenol A, CAS: 837-08-1, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₂.
2,4’-Bisphenol A-d8, CAS: /, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈D₈O₂.
(2R)-2-Methyl-butanoic Acid Methyl Ester, CAS: 55449-44-0, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₂.
(2R)-2-Methyl-butanoic Acid Methyl Ester-d3, CAS: /, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉D₃O₂.
2-Isopropenylphenol (Stabilized with 0.5% 3,6-Di-t-butylcatechol), CAS: 10277-93-7, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O.
2’-Hydroxy-2,4,4-trimethylflavan, CAS: 5026-12-0, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₂.
(2R)-2-Oxiranylmethyl Ester Butanoic Acid, CAS: 60456-26-0, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂O₃.
(2R)-3-Hydroxyisovaleroyl Norcarnitine tert-Butyl Ester, CAS: /, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₉NO₅.
3,3’,5-Trichlorobisphenol A, CAS: 40346-55-2, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃Cl₃O₂.
3,3’-Dichlorobisphenol A, CAS: 79-98-1, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Cl₂O₂.
(2R)-3-Methyl-2-{[(prop-2-en-1-yloxy)carbonyl]amino}butanoic Acid, CAS: 132402-46-1, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅NO₄.
(2R,3R)-1-Ethyl 2,3-Bis(acetyloxy)butanedioic Acid Ester, CAS: 1250430-45-5, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₈.
3,5,3’,5’-Tetrachlorobisphenol A, CAS: 79-95-8, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂Cl₄O₂.
3,5,3’,5’-Tetrachlorobisphenol A-13C12, CAS: /, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₁₂H₁₂Cl₄O₂.
(2R,3R)-4-Ethoxy-2,3-dihydroxy-4-oxobutanoic acid, CAS: 608-89-9, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₆.
(2R,3R)-4-Hydroxy-2,3-bis(phenylmethoxy)-butanoic Acid, CAS: 1293913-16-2, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₅.
3,5,3’,5’-Tetrachlorobisphenol A-d6, CAS: /, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₆D₆Cl₄O₂.
3,5-Dichlorobisphenol A, CAS: 14151-65-6, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Cl₂O₂.
(2R,3R)-rel-2,3-Dihydroxy-2-methylbutanoic Acid Sodium Salt, CAS: /, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉NaO₄.
(2R,3R)-Viridifloric Acid, CAS: 17233-93-1, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₄.
3-(4-Hydroxyphenyl)-1,1,3-trimethyl-5-indanol, CAS: 10527-11-4, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₂.
3-Chlorobisphenol A, CAS: 74192-35-1, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅ClO₂.
(2R,3R)-Viridifloric Acid-d7, CAS: /, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇D₇O₄.
(2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic Acid, CAS: 79276-23-6, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅N₃O₆.
4,4’-(1,3,3-Trimethyl-1-propene-1,3-diyl)bisphenol, CAS: 57244-54-9, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₂.
4,4’-Isopropylidenebis[2-(2,6-dibromophenoxy)ethanol], CAS: 4162-45-2, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀Br₄O₄.
(2R,3S)-α-Diazo-3-[(1R)-1-hydroxyethyl]-β,4-dioxo-2-azetidinebutanoic Acid (4-Nitrophenyl)methyl Ester, CAS: 74288-39-4, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₄O₇.
(2R,3S)-rel-2,3-Dihydroxy-2-methylbutanoic Acid Sodium Salt, CAS: /, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉NaO₄.
4-Isopropenylphenol (Stabilized with ~1% Hydroquinone), CAS: 4286-23-1, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O.
4-Nonyl Phenol Diethoxylate, CAS: 20427-84-3, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₃.
(2R,3R)-2,3-Bis(acetyloxy)-butanedioic Acid Mono[(10R)-5-(aminocarbonyl)-10,11-dihydro-5H-dibenz[b,f]azepin-10-yl] Ester, CAS: 475674-45-4, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂N₂O₉.
(2S)-2-(Acetylamino)-4-(methylsulfinyl)butanoic Acid, CAS: 108646-71-5, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃NO₄S.
4-Nonyl Phenol Monoethoxylate, CAS: 104-35-8, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈O₂.
4-Nonyl Phenol-13C6 Diethoxylate, CAS: 1346602-11-6, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³C₆H₃₂O₃.
(2S)-2-(dimethylamino)butanoic acid, CAS: 1448220-61-8, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₂.
(2S)-2-Amino-4-azidobutanoic Acid Hydrochloride, CAS: 942518-29-8, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈N₄O₂ • (HCl).
4-Nonyl Phenol-13C6 Monoethoxylate, CAS: 1346600-52-9, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁¹³C₆H₂₈O₂.
4’-O-Benzyl Bisphenol A β-D-Glucuronic Acid Methyl Ester, CAS: /, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂O₈.
(2S)-2-Amino-4-morpholinebutanoic Acid Dihydrochloride, CAS: 1689522-41-5, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈Cl₂N₂O₃.
(2S)-2-Amino-4-[[(1,1-dimethylethoxy)carbonyl]amino]butanoic Acid Methyl Ester Hydrochloride, CAS: 3350-15-0, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₁ClN₂O₄.
4’-O-Benzyl Bisphenol A β-D-Glucuronide, CAS: /, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₀O₈.
4’-O-Benzyl Bisphenol A Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 2.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₈O₁₁.
(2S)-2-Amino-benzenebutanoic Acid Benzyl Ester Tosylate Salt, CAS: 117560-24-4, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇NO₅S.
(2S)-2-Amino-benzenebutanoic Acid Methyl Ester Hydrochloride, CAS: 60425-49-2, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆ClNO₂.
4’-O-Benzyl Bisphenol A Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester-13C12, CAS: /, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃¹³C₁₂H₃₈O₁₁.
4’-O-Benzyl Bisphenol A-d6 Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₂D₆O₁₁.
(2S)-2-bromo-4-ethoxy-4-oxobutanoic acid, CAS: 1332610-01-1, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉O₄Br.
(2S)-2-Hydroxy-2-methyl-3-oxobutanoic Acid Phenylmethyl Ester, CAS: 442159-35-5, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₄.
Bis(2,3-dibromopropoxy)tetrabromobisphenol A, CAS: 21850-44-2, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀Br₈O₂.
Bisphenol A, CAS: 80-05-7, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₂.
(2S)-2-Methyl-butanoic Acid Ethyl Ester, CAS: 10307-61-6, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₂.
(2S)-2-Methyl-butanoic Acid Ethyl Ester-d5, CAS: /, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉D₅O₂.
Bisphenol A (Dimethyl-d3) Bis-(β-D-glucuronide), CAS: /, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆D₆O₁₄.
Bisphenol A 4-O-4’-O-Di(tri-O-benzoyl-β-D-glucuronic Acid Methyl Ester), CAS: /, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₁H₆₀O₂₀.
(2S)-2-Methyl-butanoic Acid Methyl Ester, CAS: 10307-60-5, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₂.
(2S)-2-Methyl-butanoic Acid Methyl Ester-d3, CAS: /, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉D₃O₂.
Bisphenol A Bis(2,3-dihydroxypropyl) Ether(Mixture of Diastereomers), CAS: 5581-32-8, stock: 4.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₆.
Bisphenol A Bis(diphenyl phosphate), CAS: 5945-33-5, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₃₄O₈P₂.
(2S)-2-Methylbutanoic Acid (1S,3S,7S,8S,8aR)-8-[2-[(2R)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3-hydroxy-7-methyl-1-naphthalenyl Ester, CAS: 1114834-63-7, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂O₅.
(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4,4-difluorobutanoic Acid, CAS: 467442-21-3, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇F₂NO₄.
Bisphenol A Bis-(β-D-glucuronide) Sodium Salt, CAS: /, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂O₁₄ • xNa.
Bisphenol A Bis-(β-D-glucuronide)-13C12 Disodium Salt, CAS: /, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅¹³C₁₂H₃₀Na₂O₁₄.
(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-[[(phenylmethoxy)carbonyl]amino]butanoic Acid, CAS: 252049-08-4, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈N₂O₅.
(2S)-2-{[(tert-Butoxycarbonyl)amino]methyl}-3-methylbutanoic Acid, CAS: 191664-14-9, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₁NO₄.
Bisphenol A Bissulfate Diammonium Salt, CAS: 857283-05-7, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂N₂O₈S₂.
Bisphenol A Bissulfate Disodium Salt, CAS: 10040-44-5, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Na₂O₈S₂.
(2S)-2-{[Methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanoic Acid, CAS: 1004316-92-0, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈N₄O₄S.
(2S)-N-Boc-2-amino-4-azido-butanoic Acid Methyl Ester, CAS: 359781-97-8, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈N₄O₄.
Bisphenol A Bissulfate Disodium Salt-13C12, CAS: /, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₁₂H₁₄Na₂O₈S₂.
Bisphenol A Bissulfate-d6 Disodium Salt, CAS: /, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈D₆Na₂O₈S₂.
(2S)-N-[(1,1-Dimethylethoxy)carbonyl]-L-alanyl-(2S)-2-hydroxy-3-methylbutanoyl-L-alanyl-2-hydroxy-3-methyl-butanoic Acid, CAS: 144678-63-7, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆N₂O₉.
(2S)-[(2’S)-Amino-(3’S)-methyl-1-pentyloxy]-3-phenylpropionyl-methionine Sulfone, Isopropyl Ester, Hydrochloride, CAS: 1356019-46-9, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₉ClN₂O₆S.
Bisphenol A Di(methyl-d3) Bis(diphenyl Phosphate), CAS: /, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₂₈D₆O₈P₂.
Bisphenol A Dibenzyl Ether-13C12, CAS: /, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³C₁₂H₂₈O₂.
(2S)-2-[[4-(4-Chlorophenoxy)phenoxy]methyl]-1-pyrrolidinebutanoic Acid Hydrochloride, CAS: 929915-58-2, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅Cl₂NO₄.
(2S,3’S)-N-[3-t-Butoxycarbonyl-3-benzyloxycarbonylamino-propyl]]azetidine-2-carboxylic Acid, t-Butyl Ester, CAS: 1235453-07-2, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₆N₂O₆.
Bisphenol A Diglycidyl Ether, CAS: 1675-54-3, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₄.
Bisphenol A Disulfate Dipyridine Salt-d6, CAS: /, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₀D₆N₂O₈S₂.
(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tert-butoxy)butanoic Acid, CAS: 117106-20-4, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉NO₅.
Bisphenol A β-D-Glucuronide, CAS: 267244-08-6, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₈.
(2S,3R)-3-Hydroxy-2-(6-phenylpicolinamido)butanoic Acid, CAS: 1247729-31-2, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₄.
Bisphenol A Monobenzyl Ether, CAS: 42781-88-4, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂O₂.
Bisphenol A Monosulfate Disodium-13C12, CAS: /, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₁₂H₁₄Na₂O₅S.
(2S,3S)-2,3-Dihydroxy-butanoic Acid Methyl Ester, CAS: 1932552-43-6, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O₄.
Bisphenol A Monosulfate Sodium Salt, CAS: 847696-37-1, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NaO₅S.
Bisphenol A Monosulfate Sodium Salt-d6 (90%), CAS: /, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₆NaO₅S.
(2S,3S)-2-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)butanoic Acid, CAS: 87500-74-1, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₅O₉S₂.
(2S,3S)-3-Amino-2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]butanoic Acid Trifluoroacetic Acid Salt, CAS: /, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₅O₆S • x(C ₂HF₃O₂).
Bisphenol A-13C12, CAS: 263261-65-0, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₁₂H₁₆O₂.
Bisphenol A-13C12 β-D-Glucuronide, CAS: 1313730-08-3, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₁₂H₂₄O₈.
2-Amino-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine, CAS: /, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉FN₂.
(2S,3S)-3-Hydroxy-2-methylbutanoic Acid, CAS: 84567-98-6, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀O₃.
(2S,3S)-3-Hydroxy-2-methylbutanoic Acid-d3, CAS: /, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇D₃O₃.
Bisphenol A-13C2, CAS: 263261-64-9, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³C₂H₁₆O₂.
Bisphenol A-d6, CAS: 86588-58-1, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₆O₂.
2-Chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine, CAS: 132813-14-0, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇ClFN.
4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2(1H)-one, CAS: 132812-72-7, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈FNO.
(2S,3S)-Viridifloric Acid, CAS: 17132-48-8, stock: 2.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₄.
(2S,3S)-Viridifloric Acid-d7, CAS: /, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇D₇O₄.
Bisphenol A-d6 Diglycidyl Ether, CAS: 1346600-09-6, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈D₆O₄.
Bisphenol A-d6 β-D-Glucuronide, CAS: 1610029-53-2, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈D₆O₈.
(2S,3S,3’’S)-N-[3-(3-Acetoxy-3-methoxycarbonylpropanamido)-3-tert-butoxycarbonylpropanoyl]azetidine-2-carboxylic Acid tert-butyl Ester, CAS: 201283-56-9, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₁₀.
(2S,3S,3’’S)-N-[3-(3-Acetoxy-3-methoxycarbonylpropanamido)-3-tert-butoxythiocarbonylpropanoyl]azetidine-2-thiocarboxylic Acid tert-Butyl Ester, CAS: 201283-57-0, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₈S₂.
Bisphenol A-d8, CAS: 92739-58-7, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈D₈O₂.
Bisphenol AF-13C12, CAS: /, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₁₂H₁₀F₆O₂.
Blonanserin, CAS: 132810-10-7, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀FN₃.
Blonanserin C, CAS: 132811-84-8, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆FN₃.
(2S,3S,3’’S)-N-[3-(3-acetoxy-3-methoxycarbonylpropanamino)-3-tert-butoxycarbonylpropanyl]azetidine-2-carboxylic Acid tert-Butyl Ester, CAS: 344299-89-4, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₀N₂O₈.
Bisphenol AP, CAS: 1571-75-1, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₂.
Bisphenol AP Mono-β-D-glucuronide, CAS: /, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆O₈.
Blonanserin N-Oxide, CAS: 142838-82-2, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀FN₃O.
Blonanserin-d5, CAS: 1346599-86-7, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅D₅FN₃.
(2Z)-Methyl 4-Bromo-2-(methoxyimino)-3-oxo-butanoic Acid Ester-d3, CAS: /, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅D₃BrNO₄.
(3aR,6aS)-Dihydro-6-hydroxy-2,2-dimethyl-furo[3,4-d]-1,3-dioxol-4(3aH)-one, CAS: 1056473-59-6, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O₅.
Bisphenol AP Monosulfate, CAS: /, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₅S.
Bisphenol AP-13C6, CAS: /, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₆H₁₈O₂.
(3R)-3-Amino-4,4,4-trifluorobutanoic Acid Hydrochloride, CAS: 1018811-44-3, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆NO₂F₃ • HCl.
(3R)-3-Hydroxybutyric Acid-1-13C, CAS: /, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³CH₈O₃.
Bisphenol AP-d5, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃D₅O₂.
Bisphenol B, CAS: 77-40-7, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈O₂.
Bisphenol B Mono-β-D-glucuronide, CAS: /, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆O₈.
Bisphenol B Monosulfate, CAS: /, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈O₅S.
(3S)-3,4-Dihydroxybutanoic Acid Ethyl Ester, CAS: 108585-47-3, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₄.
(3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-hydroxy-butanoic Acid Methyl Ester, CAS: 136703-59-8, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₉NO₅.
Bisphenol B-13C6, CAS: /, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³C₆H₁₈O₂.
Bisphenol B-d8, CAS: /, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀D₈O₂.
(±)-2-Acetoxybutyric Acid, CAS: 19947-43-4, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₄.
Bisphenol C, CAS: 79-97-0, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₂.
Bisphenol C Mono-β-D-glucuronide, CAS: /, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆O₈.
(±)-2-Bromobutyric Acid, CAS: 80-58-0, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇BrO₂.
(±)-Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone, CAS: 79-50-5, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₃.
Bisphenol C Monosulfate, CAS: /, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₅S.
Bisphenol C-Phosgene Copolymer, CAS: 31780-23-1, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₂₀H₂₄O₃)n . (HCl)n.
(±)-OPC-4, CAS: 136845-17-5, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₃.
(cis/trans)-2-(4-Benzofurazanylmethylene)-3-oxo-butanoic Acid (Methyl-d3) Ester, CAS: 1185237-60-8, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₇D₃N₂O₄.
Bisphenol E, CAS: 05/08/2081, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₂.
Bisphenol E Mono-β-D-glucuronide, CAS: /, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂O₈.
(E)-2-(N-Propylbut-2-enamido)butanoic Acid, CAS: /, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₉NO₃.
Bisphenol E Monosulfate, CAS: /, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₅S.
Bisphenol E-13C6, CAS: /, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³C₆H₁₄O₂.
Bisphenol E-d12, CAS: /, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂D₁₂O₂.
Bisphenol F bis(3-chloro-2-hydroxypropyl) Ether Para-Para, CAS: 235741-59-0, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂Cl₂O₄.
(E)-3-Hexenyl Butanoate, CAS: 53398-84-8, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₂.
(E)-Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate, CAS: 203186-58-7, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅NO₃.
Bisphenol G, CAS: 127-54-8, stock: 2.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₂.
Bisphenol G Mono-β-D-glucuronide, CAS: /, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆O₈.
(αR)-2,3-Dihydro-4-methoxy-α-(methylamino)-7-nitro-γ-oxo-1H-Indole-1-butanoic Acid, CAS: 1227675-52-6, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₃O₆.
Bisphenol G Monosulfate, CAS: /, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₅S.
Bisphenol P, CAS: 2167-51-3, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆O₂.
(αR)-Acetyloxybenzenebutanoic Acid Methyl Ester, CAS: 138276-23-0, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆O₄.
(αR)-Hydroxy-benzenebutanoic Acid, CAS: 29678-81-7, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₃.
Bisphenol P Mono-β-D-glucuronide, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄O₈.
Bisphenol P Monosulfate, CAS: /, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆O₅S.
(αR)-α-Amino-2,3-dihydro-4-methoxy-7-nitro-γ-oxo-1H-Indole-1-butanoic Acid, CAS: 845555-94-4, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅N₃O₆.
Bisphenol P-13C4, CAS: /, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³C₄H₂₆O₂.
Bisphenol P-d16, CAS: /, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₀D₁₆O₂.
(αR,βR)-β-(2,4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic Acid, CAS: 166948-49-8, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃F₂N₃O₃.
Bisphenol Z, CAS: 843-55-0, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₂.
Bisphenol Z Mono-β-D-glucuronide, CAS: /, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈O₈.
(αR,βR)-β-(2,4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic Acid-d3, CAS: 1329610-75-4, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀D₃F₂N₃O₃.
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic Acid, CAS: 483340-19-8, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃F₂N₃O₃.
Bisphenol Z Monosulfate, CAS: /, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₅S.
Bisphenol Z-13C12, CAS: /, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₁₂H₂₀O₂.
(αS)-Cyclohexanebutanoic Acid α-[[(1S)-1-Carboxyethyl]amino]cyclohexanebutanoic Acid α-Ethyl Benzyl Diester, CAS: /, stock: 2.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₃NO₄.
(αS)-Cyclohexanebutanoic Acid α-[[(1S)-1-Carboxyethyl]amino]cyclohexanebutanoic Acid α-Ethyl Ester, CAS: 460720-14-3, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₇NO₄.
